Functional Role and Plasticity of GABAA receptors in the mouse hippocampus by Schneider Gasser, Edith Marianne
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2007
Functional Role and Plasticity of GABAA receptors in the mouse
hippocampus
Schneider Gasser, Edith Marianne
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-163739
Dissertation
Published Version
Originally published at:
Schneider Gasser, Edith Marianne. Functional Role and Plasticity of GABAA receptors in the mouse
hippocampus. 2007, University of Zurich, Faculty of Science.
 Functional Role and Plasticity of GABAA Receptors in the 
Mouse Hippocampus 
 
 
 
Dissertation 
zur 
Erlangung der naturwissenschaftlichen Doktorwürde 
(Dr. sc. nat.) 
vorgelegt der 
Mathematisch-naturwissenschaftlichen Fakultät 
der 
Universität Zürich 
von 
 
Edith Marianne Schneider Gasser 
von 
Seeberg BE 
 
 
Promotionskomitee 
Prof. Dr. Peter Sonderegger (Vorsitz) 
Prof. Dr. Beat Gähwiler 
Prof. Dr. Jean-Marc Fritschy (Leitung der Dissertation) 
 
Zürich, 2007 
 
 

  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Para Sebastian y Martín 
 
 
 

  Table of Contents 
TABLE OF CONTENTS.................................................................................................................................1 
SUMMARY.......................................................................................................................................................3 
ZUSAMMENFASSUNG..................................................................................................................................5 
GENERAL INTRODUCTION .......................................................................................................................9 
1. ADULT HIPPOCAMPAL FORMATION AND ITS INTERNEURON DIVERSITY ...............................................10 
1.1. Functional role of interneurons .......................................................................................................13 
2. GABAA RECEPTOR-MEDIATED INHIBITORY TRANSMISSION................................................................16 
2.1. Phasic (fast and slow) inhibition......................................................................................................17 
2.2. Tonic inhibition................................................................................................................................18 
2.3. Modulation of phasic and tonic inhibition .......................................................................................19 
3. GABAA RECEPTOR DIVERSITY............................................................................................................21 
3.1. GABAA receptor diversity in the hippocampus ................................................................................23 
3.2. Pharmacology of GABAA receptors .................................................................................................27 
4. ANIMAL MODELS FOR THE DISSECTION OF GABAA RECEPTOR FUNCTIONS.........................................28 
4.1. GABAA receptor α subunit knock-in mice........................................................................................30 
4.2. GABAA receptor expression and assembly in mice lacking individual GABAA receptor α subunits32 
5. REFERENCES .......................................................................................................................................34 
AIMS ...............................................................................................................................................................35 
1. SPECIFIC SUBTYPES OF GABAA RECEPTORS MEDIATE PHASIC AND TONIC FORMS OF INHIBITION IN 
HIPPOCAMPAL PYRAMIDAL NEURONS (PUBLICATION 1) ...............................................................................36 
2. INTERNEURONS IN THE HIPPOCAMPAL CA1 AREA EXHIBIT REGION-SPECIFIC TONIC INHIBITION 
MOSTLY MEDIATED BY α1-GABAA RECEPTORS (PUBLICATION 2) ...............................................................36 
3. IMMUNOFLUORESCENCE IN BRAIN SECTIONS: SIMULTANEOUS DETECTION OF PRESYNAPTIC AND 
POSTSYNAPTIC PROTEINS IN IDENTIFIED NEURONS (PUBLICATION 3, OPTION C)...........................................36 
4. REORGANIZATION OF GABAERGIC CIRCUITS MAINTAINS GABAA RECEPTOR-MEDIATED 
TRANSMISSION ONTO CA1 INTERNEURONS IN α1 SUBUNIT-NULL MICE (PUBLICATION 4) ............................37 
RESULTS........................................................................................................................................................39 
1. SPECIFIC SUBTYPES OF GABAA RECEPTORS MEDIATE PHASIC AND TONIC FORMS OF INHIBITION IN 
HIPPOCAMPAL PYRAMIDAL NEURONS ...........................................................................................................39 
Abstract...................................................................................................................................................39 
Introduction ............................................................................................................................................40 
Materials and Methods ...........................................................................................................................42 
Results.....................................................................................................................................................46 
Discussion...............................................................................................................................................59 
Acknowledgments....................................................................................................................................64 
Grants .....................................................................................................................................................64 
References...............................................................................................................................................64 
2. INTERNEURONS IN THE HIPPOCAMPAL CA1 AREA EXHIBIT REGION-SPECIFIC TONIC INHIBITION 
MOSTLY MEDIATED BY α1-GABAA RECEPTORS...........................................................................................71 
Abstract...................................................................................................................................................71 
Introduction ............................................................................................................................................72 
Methods...................................................................................................................................................73 
Results.....................................................................................................................................................76 
Discussion...............................................................................................................................................86 
References...............................................................................................................................................89 
3. IMMUNOFLUORESCENCE IN BRAIN SECTIONS: SIMULTANEOUS DETECTION OF PRESYNAPTIC AND 
POSTSYNAPTIC PROTEINS IN IDENTIFIED NEURONS .......................................................................................93 
Abstract...................................................................................................................................................93 
Introduction ............................................................................................................................................94 
Materials.................................................................................................................................................97 
EQUIPMENT..........................................................................................................................................98 
REAGENT SETUP..................................................................................................................................98 
 1
 2 
Procedure .............................................................................................................................................100 
Immunofluorescence staining: Incubation in primary antibodies ........................................................104 
Immunofluorescence staining: Incubation in secondary antibodies.....................................................104 
Microscopy and image analysis............................................................................................................106 
Timing...................................................................................................................................................107 
? TROUBLESHOOTING......................................................................................................................108 
Anticipated results ................................................................................................................................109 
Acknowledgements................................................................................................................................114 
References.............................................................................................................................................115 
4. REORGANIZATION OF GABAERGIC CIRCUITS MAINTAINS GABAA RECEPTOR-MEDIATED 
TRANSMISSION ONTO CA1 INTERNEURONS IN α1 SUBUNIT-NULL MICE......................................................119 
Abstract.................................................................................................................................................119 
Introduction ..........................................................................................................................................120 
Methods ................................................................................................................................................122 
Electrophysiology .................................................................................................................................125 
Results...................................................................................................................................................128 
Discussion.............................................................................................................................................145 
Acknowledgments .................................................................................................................................151 
List of Abbreviations.............................................................................................................................151 
References.............................................................................................................................................152 
GENERAL DISCUSSION...........................................................................................................................159 
1. FUNCTIONAL ROLE OF GABAA RECEPTORS IN PYRAMIDAL CELLS....................................................160 
2. TONIC INHIBITION IN INTERNEURONS................................................................................................165 
2.1. GABAA receptors involved in tonic inhibition in CA1 interneurons ..............................................165 
2.2. Strata differences in tonic conductance in interneurons: Functional role of GABA transporters?
..............................................................................................................................................................166 
3. PLASTICITY OF THE GABAERGIC SYSTEM........................................................................................168 
REFERENCES.............................................................................................................................................171 
ACKNOWLEDGEMENTS.........................................................................................................................185 
CURRICULUM VITAE..............................................................................................................................186 
PUBLICATIONS .........................................................................................................................................188 
  Summary 
In the mammalian brain, fast inhibitory neurotransmission is mostly mediated by GABAA 
receptors, which belong to the superfamily of ligand-gated ion channels. GABAA receptors 
form chloride channels and are the target of major drugs in clinical use, such as 
benzodiazepines which have sedative, anxiolytic, muscle-relaxant and anti-epileptic 
properties. GABAA receptor subtypes differing in subunit composition, functional 
properties, and pharmacological profile are differentially distributed in the brain and 
exhibit a synaptic or extrasynaptic distribution according to cell type and area. Therefore, 
GABAA receptors subtypes might regulate the activity of distinct neuronal circuits. 
Studies of GABAA receptor-mediated neurotransmission have focused mainly on synaptic 
receptors, which are activated upon vesicular release of GABA in a transient ('phasic') 
manner. However, in recent years it has become evident that perisynaptic and extrasynaptic 
GABAA receptors, which are persistently ('tonically') activated by low GABA 
concentrations, play a crucial role in the regulation of neuronal excitability under 
physiological and pathophysiological conditions. 
In this thesis, we investigated whether specific diazepam-sensitive GABAA receptor 
subtypes expressed in pyramidal cells and interneurons of the hippocampus are involved in 
phasic and tonic inhibition. As strategy, we used knock-in mice carrying diazepam-
insensitive receptors generated by a histidine to arginine point mutation in the α1, α2, α3, 
or α5 subunit affecting a residue crucial for binding. By comparing the effects of diazepam 
on evoked inhibitory postsynaptic currents from pyramidal cells in different knock-in and 
wildtype mice, we showed that α1- and α2-GABAA receptors mediate fast phasic 
inhibition mostly on dendrites and soma, respectively. Furthermore, we determined the 
contribution of extrasynaptic α5-GABAA receptors to slow spontaneous inhibitory 
postsynaptic currents and to tonic inhibition by recording from triple knock-in 
α1α2α3 (α123) mice, in which only the α5 subunit remains sensitive to diazepam. We 
demonstrated that slow sIPSCs and tonic inhibition involve activation of the same pool of 
extrasynaptic or perisynaptic receptors containing the α5 subunit.  
In interneurons, we analyzed the contribution of GABAA receptors exclusively to tonic 
inhibition. Mostly α1-GABAA receptors and, in certain interneurons, α2-GABAA receptors 
were found to mediate tonic inhibition, indicating a distinct subcellular distribution 
compared to pyramidal cells. Unexpectedly, interneurons in stratum oriens consistently had 
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a higher tonic conductance than interneurons in stratum radiatum and lacunosum-
moleculare, suggesting differences in extracellular GABA concentration between these 
layers. Some interneurons in stratum lacunosum-moleculare completely lacked tonic 
conductance, indicating that tonic inhibition can also be cell-specific. 
In the third part of the thesis, we studied the compensatory changes that occur in GABAA 
receptor expression and function in identified interneurons from mice carrying a targeted 
deletion of the α1 subunit gene (α10/0). We developed a novel immunostaining protocol 
based on fixation of living tissue slices to allow the simultaneous detection of postsynaptic 
proteins and interneuron markers. We investigated the expression of GABAA receptor 
subunits and their synaptic or extrasynaptic location according to their colocalization with 
gephyrin in parvalbumin-, calretinin-, calbindin-, neuropeptide Y- or somatostatin-
containing interneurons. In α10/0 mice, synaptic α2- and α3-GABAA receptors were greatly 
increased in a cell-type specific manner to compensate for the loss of the α1 subunit. More 
synaptic receptors were evident in interneurons from α10/0 mice, suggesting a 
rearrangement of GABAergic circuits, but phasic and tonic inhibition were largely 
unchanged, as assessed by patch clamp recordings. The amplitude of mIPSCs was reduced, 
suggesting a change in GABA affinity of postsynaptic receptors or presynaptic changes in 
vesicular GABA release. Finally, we showed that compensatory changes occurring in α10/0 
mice are sufficient to protect against kainic acid-induced seizures, indicating that 
GABAergic inhibition remains operative in these mutant mice.  
Altogether, our results demonstrate the importance of specialized, cell-type specific 
GABAA receptors mediating tonic inhibition in the CA1 area of the hippocampus, and 
reveal that activation of extrasynaptic receptors is mostly regulated by extracellular GABA 
concentration, which varies across layers. The extensive morphological reorganization of 
GABAA receptors occurring in interneurons of α10/0 mice highlights the plasticity of 
GABAergic synapses to fully compensate for the absence of a major GABAA receptor 
subtype. This plasticity likely reflects the potential for continuous adaptations of 
GABAergic transmission in the brain to maintain the function of neuronal circuits during 
pathological challenges. 
  Zusammenfassung 
Im Gehirn des Säugetiers wird der grösste Teil der schnellen inhibitorischen 
Neurotransmission durch GABAA-Rezeptoren vermittelt, die zur Superfamilie der Ligand-
gesteuerten Ionenkanäle gehören. GABAA-Rezeptoren bilden Chloridkanäle aus und sind 
das Ziel wichtiger Medikamente im klinischen Gebrauch, wie Benzodiazepine, welche 
sedierende, anxiolytische, muskelrelaxierende und antieptileptische Eigenschaften haben. 
GABAA-Rezeptor-Subtypen, die sich in der Zusammensetzung der Untereinheiten, der 
funktionalen Eigenschaften und dem pharmakologischen Profil unterscheiden sind im 
Gehirn unterschiedlich verteilt und weisen eine synaptische oder extrasynaptische 
Verteilung auf, abhängig vom Zelltyp und Hirnareal. Daher können verschiedene GABAA-
Rezeptoren die Aktivität spezifischer neuronaler Schaltkreise regulieren. Studien über 
GABAA-Rezeptor vermittelte Neurotransmission haben sich meist auf synaptische 
Rezeptoren gerichtet, die durch transiente (`phasische`) vesikuläre Abgabe von GABA 
aktiviert werden. Allerdings zeigte sich unlängst, dass perisynaptische und 
extrasynaptische GABAA-Rezeptoren, welche dauerhaft (`tonisch`) durch niedrige GABA-
Konzentrationen aktiviert werden, eine entscheidende Rolle in der Regulierung neuronaler 
Reizbarkeit unter physiologischen und pathophysiologischen Bedingungen spielen.  
In dieser Arbeit haben wir untersucht ob spezifische, Diazepam-sensitive GABAA-
Rezeptor-Subtypen, die in Pyramidenzellen und Interneuronen des Hippokampus 
exprimiert werden, an phasischer und tonischer Inhibition beteiligt sind. Wir haben dafür 
'knock-in' Mäuse mit Diazepam-insensitiven Rezeptoren benutzt, die durch eine Histidin- 
zu Arginin-Punktmutation der für die Bindung entscheidenden Aminosäure auf der α1, α2, 
α3 oder α5 Untereinheit erzeugt wurden. Durch Vergleichen der Wirkung von Diazepam 
auf hemmende postsynaptische Ströme von Pyramidenzellen verschiedener 'knock-in'  und 
Wildtyp-Mäuse haben wir gezeigt, dass α1- und α2-GABAA-Rezeptoren schnelle 
phasische Hemmung hauptsächlich auf Dendriten und Soma vermitteln. Weiter haben wir 
den Beitrag von extrasynaptischen α5-GABAA-Rezeptoren an langsamen, spontanen, 
hemmenden postsynaptischen Strömen und an tonischer Hemmung durch Messungen an 
dreifach 'knock-in' α1α2α3 (α123) Mäusen bestimmt, in welchen nur die α5 Untereinheit 
Diazepam-sensitiv bleibt. Wir haben gezeigt, dass langsame sIPSCs und tonische 
Hemmung mit einer Aktivierung desselben Pools von extra- und perisynaptischen 
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Rezeptoren einhergeht, die die α5 Untereinheit enthalten. In Interneuronen haben wir 
ausschliesslich den Beitrag von GABAA-Rezeptoren an tonischer Hemmung untersucht.  
Zumeist α1-GABAA- und, in gewissen Interneuronen, α2-GABAA-Rezeptoren vermitteln 
tonische Hemmung, was auf eine ausgeprägte subzelluläre Verteilung im Vergleich zu 
Pyramidenzellen hindeutet. Überraschenderweise hatten Interneuronen im Stratum Oriens 
durchwegs eine höhere tonische Leitfähigkeit als solche im Stratum Radiatum und 
Lacunosum-Moleculare, was auf Unterschiede in der extrazellulären GABA-Konzentration 
zwischen diesen Schichten schliessen lässt. In einigen Interneuronen im Stratum 
Lacunosum-Moleculare fehlte die tonische Leitfähigkeit vollständig, was zeigt, dass 
tonische Hemmung auch zellspezifisch sein kann. 
Im dritten Teil dieser Arbeit haben wir die kompensatorischen Veränderungen in der 
Expression und Funktionalität der GABAA-Rezeptoren in spezifischen Interneuronen von 
Mäusen mit einer Deletion der α1 Untereinheit (α10/0) untersucht. Wir haben ein neues 
Protokoll für eine Immunfärbung entwickelt, das auf einer Fixierung von lebenden 
Gewebeschnitten basiert und den gleichzeitigen Nachweis von postsynaptischen Proteinen 
und `marker`-Proteinen für Interneuronen ermöglicht. Wir haben die Expression von 
GABAA-Rezeptor-Untereinheiten untersucht und deren synaptische oder extrasynaptische 
Lokalisation gemäss deren Kolokalisierung mit Gephyrin in Interneuronen, welche 
Parvalbumin, Calretinin, Calbindin, Neuropeptide Y oder Somatostatin enthalten. In α10/0 
Mäusen waren synaptische α2- und α3-GABAA-Rezeptoren auf eine zelltypische Weise 
stark vermehrt, um den Verlust der α1-Untereinheit zu kompensieren. In Interneuronen 
von α10/0 Mäusen gab es mehr synaptische Rezeptoren, was eine Umstellung der 
GABAergen Schaltkreise andeutet, aber phasische und tonische Hemmung waren 
weitgehend unverändert, was mittels patch-clamp Messungen festgestellt wurde. Die 
Amplitude von mIPSCs war reduziert, was auf eine Veränderung der GABA-Affinität von 
postsynaptischen Rezeptoren oder presynaptischen Veränderungen vesikulärer GABA-
Ausschüttung hindeutet. Schliesslich haben wir gezeigt, dass kompensatorische 
Veränderungen in α10/0 Mäusen zum Schutz vor Kainat-induzierten epileptischen Anfällen 
ausreichen, was zeigt, dass GABAerge Hemmung in diesen Mutanten funktionsfähig 
bleibt. 
Zusammenfassend zeigen unsere Ergebnisse die Bedeutung von spezialisierten, zelltyp-
spezifischen GABAA-Rezeptoren zur Vermittlung tonischer Hemmung im CA1 Bereich 
Zusammenfassung
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des Hippokampus, und dass die Aktivierung der extrasynaptischen Rezeptoren 
hauptsächlich über die extrazelluläre GABA-Konzentration reguliert wird, welche über die 
verschiedenen Schichten variiert. Die extensive morphologische Reorganisation der 
GABAA-Rezeptoren in Interneuronen von α10/0 Mäusen heben die Plastizität von 
GABAergen Synapsen hervor, die das Fehlen eines bedeutenden GABAA-Rezeptor-
Subtyps vollständig kompensieren. Diese Plastizität zeigt das Potential für kontinuierliche 
Anpassungen der GABAergen Transmission im Hirn, um die Funktionsfähigkeit 
neuronaler Schaltkreise auch während pathologischer Herausforderungen zu gewährleisten. 
  

  General Introduction 
In the mammalian brain, neuronal activity is mostly regulated by GABA (γ-aminobutyric 
acid)-releasing inhibitory neurons. GABA is a neurotransmitter that acts on two main types 
of receptors: (i) ionotropic receptors called GABAA and GABAC, which differ in 
pharmacological properties; and (ii) metabotropic receptors called GABAB (Barnard et al., 
1998; Chebib and Johnston, 1999). Fast inhibitory neurotransmission in the CNS is mostly 
mediated by the GABAA receptors, heteropentameric chloride channels mostly composed 
of 2α, 2β and 1γ subunits (Tretter et al., 1997; Barnard et al., 1998; Farrar et al., 1999; 
Sieghart and Sperk, 2002). Most studies of inhibitory neurotransmission mediated by 
GABAA receptors have focused on receptors located at the synaptic cleft. However, in 
recent years it has become evident that GABA diffusing out the synaptic cleft can also 
persistently activate perisynaptic and extrasynaptic GABAA receptors, and that this tonic 
inhibition plays a crucial role in the regulation of neuronal excitability (Semyanov et al., 
2003; Stell et al., 2003). GABAA receptors with different subunit composition are located 
in specific subcellular areas in defined cell types and brain areas. In pyramidal cells from 
the hippocampus, α5-GABAA receptors preferentially have an extrasynaptic location 
whereas α1- and α2-GABAA receptors are synaptically located in different subcellular 
compartments (Brunig et al., 2002). In interneurons, α1-GABAA receptors are abundantly 
expressed in both synaptic and extrasynaptic locations (Gao and Fritschy, 1994). In this 
thesis, we investigated whether specific GABAA receptor subtypes expressed in pyramidal 
cells and interneurons of the hippocampus are involved in different forms of inhibitory 
currents. Moreover, tonic conductance in different hippocampal interneurons from stratum 
oriens, radiatum and lacunosum-moleculare was compared.  
In the brain, around 50% of the GABAA receptors contain the α1 subunit (Benke et al., 
1994). In the hippocampal formation, α1-GABAA receptors are particularly abundant in 
interneurons, indicating that these receptors play a major role in interneuronal inhibitory 
signaling. Interestingly, deletion of the α1 subunit gene results in a viable phenotype (Sur 
et al., 2001; Vicini et al., 2001), implying that there are compensatory alterations in the 
GABAergic system to keep neuronal activity under control (Kralic et al., 2002b; Kralic et 
al., 2006; Ogris et al., 2006). In the hippocampus, a general upregulation of the α2, α3 and 
α4 subunits was observed, but the compensatory mechanisms at cellular and subcellular 
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level were not identified. Considering the importance of GABAA receptor plasticity in the 
normal functioning of the brain (Fritschy and Brunig, 2003), it is critical to determine some 
of the mechanisms underlying this plasticity. Therefore, we investigated how the loss of 
the α1 subunit is compensated for in hippocampal interneurons. We analyzed the changes 
in GABAA receptor subtype expression and subcellular location. Phasic and tonic 
inhibitory currents were also investigated to determine the functional correlates of these 
compensatory changes. Finally, we tested the susceptibility of the α1 knock-out mice 
(α10/0) to kainic acid-induced seizures in a mouse model of temporal epilepsy (Bouilleret et 
al., 1999) to assess how the absence of α1-GABAA receptors affects the functioning of the 
inhibitory system.  
 
1. Adult hippocampal formation and its interneuron diversity 
The hippocampal formation is part of the limbic system. It is one of the most studied areas 
of the mammalian central nervous system because it has an easily identifiable structure and 
mediates major aspects of learning and memory (Eichenbaum, 2000; Scoville and Milner, 
2000). The hippocampal formation is composed of three areas: the Ammon's Horn or 
Cornu Ammonis (CA1-CA3); also known as the "hippocampus proper", the dentate gyrus 
(DG), and the subiculum. The CA and DG both contain a layer of principal neurons: 
pyramidal cells in the CA and granule cells in the DG. Numerous local interneurons are 
present in each region. CA1 pyramidal cells, for example, are innervated by at least 12 
distinct types of interneurons (Somogyi and Klausberger, 2005). Nevertheless, the CA1 
area is probably the cortical area with the least heterogeneous neuronal population and the 
smallest number of extrinsic inputs, which makes it a favorite area for studying the cortical 
network. The laminar alignment of pyramidal cells makes it relatively easy to study the 
relationship between distinct cell types and the basic cortical circuit. There are five known 
glutamatergic inputs to CA1 pyramidal cells: from the CA3 area, the entorhinal cortex, the 
thalamus, the CA1 area, and the amygdala (Li et al., 1994; Somogyi and Klausberger, 
2005). 
Interneurons are highly diverse and functionally specialized in the mammalian central 
nervous system. The mapping of axonal arbors to specific domains across the dendritic 
trees of their targets has provided important clues to the specific functional roles carried 
out by various interneuron subtypes (Freund and Buzsaki, 1996). For example, 
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interneurons that innervate pyramidal cell somata regulate the local generation of Na+-
dependent action potentials, but inhibition arriving at dendritic locations regulates dendritic 
Ca2+-dependent action potentials (Miles et al., 1996). The major types of hippocampal 
interneurons, classified according to their axonal arbors, are axo-axonic cells (Chandelier), 
axo-somatic cells (Basket) and axo-dendritic cells (oriens lacunosum-moleculare {O-LM} 
cells, bistratified, Schaffer collateral-associated and perforant pathway-associated). Some 
of the most useful characterizations of interneuron subtypes have been based on 
neurochemical content, such as the presence of calcium-binding proteins like parvalbumin 
(PV), calbindin (CB) and calretinin (CR), or of neuromodulators, including somatostatin 
(SOM), neuropeptide Y (NPY), vasoactive intestinal peptide (VIP), cholecystokinin (CCK) 
and nitric oxide synthase. However, neurochemically defined cells can possess different 
functional properties. For example parvalbumin-containing cells comprise not only basket 
and axo-axonic cells, but also subgroups of O-LM and bistratified cells. Therefore, 
parvalbumin is a marker of multiple interneuron subtypes. A summary of interneuron 
classes according to axonal arborization and neurochemical markers in the CA1 area is 
given in Table 1 and Figure 1 (McBain and Fisahn, 2001).  
Characterization based on functional properties is even more problematic. Classical 
subdivisions were based on action potential firing patterns such as regular, irregular or 
clustered (Parra et al., 1998), but the generation of action potentials results from the 
combinations of several intrinsic voltage-gated conductances that overlap in time and have 
unique expression patterns throughout interneuronal sub-populations. Different expression 
and functional properties of voltage-gated potassium channels have provided the best 
insights into determinants of interneuron function. Within the hippocampus, K+-channel 
subunits Kv3.1b and Kv3.2, which activate at highly depolarized potentials, are expressed 
in all parvalbumin-containing neurons, whereas Kv3.2 is also found in somatostatin-
containing neurons. Both of these subpopulations show fast-spiking phenotypes and a 
large, sharp and brief afterhyperpolatization (AHP) (Freund and Buzsaki, 1996; Morin et 
al., 1996). The spatial distribution of channels is also an important determinant of 
interneuron function. The density of both Na+ and K+ currents is higher in dendrites of 
interneurons (Martina et al., 2000) so that action potentials can be initiated at dendritic 
sites, ensuring rapid signaling. Depending on the nature of the excitatory stimulus, action 
potential initiation can switch between the soma and the dendrites. 
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Figure 1. Domain-specific innervation of hippocampal interneurons. a) Camera lucida reconstructions of 
three interneurons showing the domain-specific innervation of pyramidal cells by their axons. Stratum oriens-
lacunosum-moleculare (O-LM) cell with the axon (red) innervating to distal dendrites from pyramidal cells. 
A basket cell projects its axon (green) to the pyramidal soma and proximal dendrites. A bistratified cell sends 
its axon to apical (yellow) and basal (blue) dendrites. The cartoon of a pyramidal cell shows the approximate 
location of the basal and apical dendrites. b) The laminar distribution of dendritic and axonal arbors of 
different types of interneurons containing calcium-binding proteins and neuropeptides in the hippocampus. 
Circles mark the soma and lines the predominant orientation of the dendritic tree. Boxes in purple represent 
the laminae to which the axon of each interneuron type extends. Turquoise boxes indicate that other 
interneurons are targets. PV, parvalbumin; CR, calretinin; CB, calbindin; Som, somatostatin; VIP, vasoactive 
intestinal peptide; CCK, cholecystokinin. Figure from (McBain and Fisahn, 2001). 
 
 
New molecular techniques like single-cell RT-PCR in combination with 
electrophysiological classification have become a powerful tool for exposing the functional 
diversity of GABAergic neurons at the cellular, microcircuit and systems levels. Each type 
of interneuron expresses a specific combination of ion channels and the pattern of 
expression in the surface membrane generates a type of electrical behavior (Markram et al., 
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2004). A correlation map between the ion-channel genes expressed in an interneuron and 
its electrical phenotype provides a coefficient of correlation that gives a surprisingly highly 
accurate prediction of the electrophysiological parameters, given the lack of knowledge 
about the quantities of mRNA or protein produced by each gene (Toledo-Rodriguez et al., 
2004). Correlation coefficients are independent of interneuronal morphology. 
Another classification based on the ratio of excitatory and inhibitory inputs that different 
interneurons receive indicates whether a cell is activated in a feedforward (afferent volleys 
directly activate the inhibitory cell) or a feedback (recurrent collateral volleys activate the 
inhibitory cell) manner (Gulyas et al., 1999), which is essential for the accurate modeling 
of interneuron circuits.  
 
1.1. Functional role of interneurons  
Interneurons have traditionally been considered as regulators of principal neuron activity. 
In addition to that role, their network connectivity and intrinsic voltage-gated currents are 
finely tuned to permit the control of rhythmic activity of principal cells and other 
populations of interneurons.  
Given the diversity of interneurons in the cerebral cortex, a temporally structured 
synchronous activity might be an organizational necessity for neuronal integration, 
coincidence detection, discrimination and binding of events (Singer, 1999). The most 
prominent rhythms are oscillations in the theta (~4–12 Hz) and gamma (~30–80 Hz) 
frequency bands, ultra-fast oscillations (~200 Hz) and sharp wave activity, all of which 
represent the synchronous discharge of principal neurons. A common feature of these 
different oscillations is their dependence on inhibitory interneurons (Buzsaki et al., 1983; 
Buzsaki, 2002). Therefore, by controlling spike timing and sculpting neuronal rhythms, 
inhibitory interneurons play a key role in regulating neuronal circuits and behavior. 
Hippocampal network oscillations at various frequencies are correlated with certain 
behaviors. Theta oscillations occur during whole-body movement (Harris et al., 2002), 
memory tasks and rapid-eye-movement sleep (Csicsvari et al., 1999). During theta 
oscillations the majority of pyramidal cells in the CA1 area exhibit a very low firing rate 
with the highest firing probability during or shortly after the trough of the theta cycles 
recorded extracellularly in the pyramidal layer. Sharp wave-associated high-frequency 
ripples (120-200 Hz) of around 100 ms duration occur in the CA1 area of the hippocampus 
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during slow-wave sleep and consummatory behaviors (Buzsaki et al., 1983). Some 
pyramidal cells forming cell assemblies fire together, reinforcing their connections in the 
network by the high synchrony of discharge within a few milliseconds in each ripple cycle 
(Buzsaki, 1989). Gamma oscillations are not restricted to a single brain state. They occur 
during network activity at lower frequencies (Csicsvari et al., 2003) and also 
simultaneously with theta oscillations, the power of the gamma oscillations being 
modulated by the phase of the theta cycles.  
In vivo recordings of identified interneurons in the hippocampal formation indicate that 
their firing pattern is strongly correlated with various network oscillations (Klausberger et 
al., 2003; Klausberger et al., 2004). During theta oscillations recorded extracellularly in the 
pyramidal cell layer, axo-axonic cells exhibit the highest firing probability around the peak 
of the oscillation (Klausberger et al., 2003); parvalbumin immunopositive basket cells fire 
at the descending phase; and bistratified cells innervating stratum radiatum and oriens and 
O-LM cells fire at the trough of the oscillation. Curiously, the highest probability of 
pyramidal cell firing coincides with maximal O-LM and bistratified cell firing. During 
ripple oscillations, parvalbumin-expressing basket cells and bistratified cells increase their 
discharge frequency. Basket cells fire at the highest amplitude of the ripple and bistratified 
cells fire with high frequency throughout the entire ripple episode. Axo-axonic cells 
slightly increase their firing activity at the beginning of the ripples, but become silent after 
the highest amplitude of the ripple episode, and appear suppressed even after ripple 
episodes. O-LM cell firing was specifically suppressed for the duration of ripple episodes. 
These results indicate that interneurons within a connectivity class exhibit similar firing 
patterns during a given network oscillation. Interneuron type-specific firing patterns point 
to a role in structuring the activity of pyramidal cells via their target domain, and in the 
accurate timing and synchronization of pyramidal cell discharge (Somogyi and 
Klausberger, 2005).  
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TABLE 1. Types of GABAergic interneurons in the CA1 area of the hippocampus 
(Somogyi and Klausberger, 2005) 
Interneuron  Neurochemical 
content 
Cell body 
location 
Cell type 
innervation 
Zone of GABAergic synapse 
axo-axonic 
 
basket  
 
 
 
bistratified 
 
O-LM 
 
Schaffer collateral 
associated  
LM-R-PP associated 
 
LM-PP associated 
 
neurogliaform 
 
trilaminar 
 
back-projection 
 
hippocampo-septal 
 
interneuron specific I 
 
interneuron specific II 
 
PV 
 
PV 
CCK 
CCK, VIP 
 
PV, SOM, NPY 
 
PV, SOM 
 
CB, CCK 
 
CCK 
 
CCK 
 
? 
 
- 
 
? 
 
CB, SOM 
 
CR 
 
VIP 
str. pyramidale 
 
str. pyramidale 
str. radiatum-LM 
str. pyramidale 
 
str. pyramidale 
 
str. oriens 
 
str. radiatum-LM 
 
str. radiatum-LM 
 
str.radiatum-LM 
 
str. LM 
 
str. oriens 
 
str. oriens 
 
str. oriens 
 
str. pyramidale 
 
str. radiatum-LM 
 
PC 
 
PC, PV  
PC, CCK  
PC, CCK  
 
PC, basket  
 
PC, INT 
 
PC, INT 
 
PC 
 
PC 
 
PC 
 
PC 
 
PC 
 
INT 
 
CB, CR 
 
CCK, VIP 
 
axon initial segments  
 
somata and proximal dendrites 
somata and proximal dendrites 
somata and proximal dendrites 
 
proximal and distal dendrites 
 
distal dendrites 
 
apical and basal dendrites 
 
distal dendrites, dentate gyrus 
 
subiculum, presubiculum, 
dentate gyrus 
dendritic shafs and spines 
 
str. oriens, radiatum and LM 
dendrites and subiculum 
somata and dendrites, CA3/ 
dentate gyrus 
str. oriens, str. radiatum, 
CA3/dentate gyrus, septum 
str. oriens and radiatum 
 
str. radiatum 
LM, lacunosum-moleculare; O-LM, oriens-lacunosum-moleculare; LM-R-PP, lacunosum-moleculare-
radiatum-perforant path; LM-PP, lacunosum-moleculare-perforant path; PV, parvalbumin; CR, calretinin; 
CB, calbindin; SOM, somatostatin; VIP, vasoactive intestinal peptide; NPY, neuropeptide Y; CCK, 
cholecystokinin; str., stratum; PC, pyramidal cell; INT, interneuron. 
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2. GABAA receptor-mediated inhibitory transmission  
GABA is synthesized in the cytoplasm of GABAergic cells by the irreversible 
decarboxylation of glutamate catalyzed by the enzyme glutamic acid decarboxylase 
(GAD), and is transported actively into synaptic vesicles by a vesicular carrier. When 
GABA is released into the synaptic cleft, it can either bind to postsynaptic GABAA 
receptors, postsynaptic or presynaptic GABAB receptors, and glial and neuronal GABA 
transporters, which take it up into presynaptic terminals or glial cells or diffuse away from 
the synaptic cleft and persistently activate extrasynaptic GABAA receptors (Owens and 
Kriegstein, 2002).  
The binding of two GABA molecules to the GABAA receptor leads to a conformational 
change of the receptor into an open state, leading to an influx or efflux of chloride (Cl-), 
depending on the membrane potential and the concentration of Cl- in the extracellular and 
intracellular space. The reversal potential of the GABA current varies with the chloride 
equilibrium potential (ECl), but changes in K+ and Na+ concentrations have very little 
effect. The ECl is close to the resting membrane potential (around -60 mV at 20°C). In adult 
neurons, there is generally an influx of Cl-, which hyperpolarizes the membrane. This 
hyperpolarization is the inhibitory postsynaptic potential (IPSP). When ECl is close to the 
resting membrane potential, no IPSP is observed even though GABAA channels are open. 
Moreover, because the opening of GABA receptors decreases the membrane resistance, 
GABA still has an inhibitory effect on postsynaptic activity. This ‘silent inhibition` reduces 
the amplitude of postsynaptic depolarization and consequently prevents the generation of 
postsynaptic action potentials (shunting effect). When ECl is more positive than the resting 
membrane potential, a depolarization occurs. This excitatory effect of GABA has been 
observed in young GABAergic synapses which lack the chloride-extruding potassium 
chloride co-transporter KCC2 and the cytosolic carbonic anhydrase isoform CAVII and 
instead accumulate chloride by way of the sodium- and potassium-coupled co-transporter 
NKCC1 (Ben-Ari, 2002; Rivera et al., 2005). Recent studies show that the depolarizing 
action of GABA can also occur in some mature neurons, mostly in GABAA receptors 
located in axons and presynaptic terminals (Chavas and Marty, 2003; Stein and Nicoll, 
2003; Szabadics et al., 2006).  
In recordings with equal intra- and extracellular Cl- concentrations to minimize 
rectification (variation of conductance as a function of membrane potential), the mean 
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GABAA receptor single-channel conductance is around 30 pS. The amplitude of a single-
spike IPSP varies from 0.6 to 4.2 mV due to the fact that a presynaptic action potential 
activates, at each trial, a variable number of active zones. Approximately 300 GABAA 
channels are open at the peak of the single-spike IPSP. A major contributor to the 
amplitude variability is the large variation in the postsynaptic receptor number (Nusser et 
al., 1997), but at large synapses, postsynaptic GABAA receptors are not fully occupied, so 
amplitude variation originates from fluctuations in transmitter concentration.  
The affinity of GABAA receptors for GABA is relatively low, of the order of 10-20 μM. 
GABAA receptor channel openings are either brief (mean duration of 2.5 ms) or in bursts 
(mean duration of 20-50 ms) (Bormann, 1986). The opening frequency of the GABAA 
channels decreases when GABA concentrations are increased (0.5 μM), leading to a 
reduction in GABA conductance known as GABAA receptor desensitization. Marked 
differences in desensitization kinetics have been reported between different GABAA 
receptor subtypes. For example, extrasynaptic α3-containing receptors desensitize very 
slowly (Devor et al., 2001). 
 
2.1. Phasic (fast and slow) inhibition  
Phasic inhibition refers to the transient and specific activation of GABAA receptors 
following brief exposure to a high concentration of GABA released from presynaptic 
vesicles. IPSCs are classified as fast or slow according to their amplitude and kinetics.  
Fast IPSCs (Figure 2a) usually result from the rapid activation of receptors immediately 
beneath the release site. They peak rapidly (0.5 to 5 ms) and decay with a two-time 
constant ranging from 3 to 10 milliseconds. Several thousand GABA molecules are 
liberated into the synaptic cleft, generating a peak GABA concentration in the millimolar 
range (Nusser et al., 2001; Mody and Pearce, 2004) that results in the near-synchronous 
opening of the ion channels. The degree of receptor occupancy often varies between 
synapses on different neurons, and can even vary between synapses on a single neuron 
(Nusser et al., 1997; Hajos et al., 2000).  
Slow IPSCs (Figure 2b) result from the activation of synaptic and perisynaptic receptors as 
a result of GABA diffusing out of the synaptic cleft (spillover); they peak slower than 5 ms 
and decay monoexponentially, ranging from 30 to 100 milliseconds. Slow IPSCs have 
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been described as occurring at low frequency (0.01 Hz) in pyramidal cells from the 
hippocampus (Pearce, 1993; Prenosil et al., 2006). Slow currents can still be considering 
phasic, in the sense that they are temporally related to the release event, but whether they 
arise from one or separate several types of GABAergic synapses has still to be investigated 
(Banks and Pearce, 2000; Wei et al., 2003).  
The IPSC decay time depends on the length of time GABAA receptors remain in the open 
state. This state depends on transmitter uptake or diffusion and receptor desensitization. 
For small-amplitude IPSCs, the mean open time of the channels determines their decay 
time. However, large postsynaptic currents result from a greater presynaptic release of 
GABA and the slower removal of GABA from the cleft. 
A major role of phasic GABAA receptor-mediated inhibition (fast and slow) is to prevent 
the overexcitation of neurons and thereby avoid the development of seizures, nevertheless 
interneurons have more complex roles, which depend crucially on the subcellular synapse 
location and ISPC timing. Both of these variables determine key properties of neuronal 
networks including: the generation of rhythmic activities (Buzsaki and Chrobak, 1995; 
Singer et al., 1996; Freund, 2003; Whittington and Traub, 2003; Somogyi and Klausberger, 
2005); the precise coincidence detection timing at the soma of pyramidal cells and the 
broad detection timing on dendrites (Pouille and Scanziani, 2001); and the excitatory or 
inhibitory actions of GABA depolarization (Gulledge and Stuart, 2003; Williams and 
Stuart, 2003). Thus, minor spatial or temporal alterations in interneuronal activity may alter 
the way in which information is processed across neuronal networks. 
 
2.2. Tonic inhibition  
Even a low GABA concentration (micromolar range) in the extracellular space is sufficient 
for persistent or 'tonic' activation of GABAA receptors with high GABA affinity (Figure 
2c). Tonic inhibition was first identified in cerebellar granule cells, in which application of 
the GABAA receptor antagonists bicuculline and gabazine not only blocked sIPSCs, but 
also decreased the holding current that was required to clamp cells at a given membrane 
potential (Kaneda et al., 1995). This reduction in input conductance was associated with a 
decreased number of open GABAA receptor channels (Brickley et al., 1996). Tonic 
activation of GABAA receptors was found to be prominent in embryonic neurons before 
synapse formation (Owens et al., 1999; Demarque et al., 2002). Subsequent studies 
General Introduction
 
19 
indicate that GABA-mediated tonic conductance exists in numerous adult neuron types, 
including: granule cells of the dentate gyrus (Nusser and Mody, 2002; Chandra et al., 
2006a, b), thalamocortical relay neurons of the ventral basal complex (Porcello et al., 2003; 
Chandra et al., 2006b); layer V principal neurons in the somatosensory cortex (Yamada et 
al., 2006); CA1 pyramidal cells (Bai et al., 2001; Prenosil et al., 2006); and many 
inhibitory interneurons in the CA1 region of the hippocampus (Semyanov et al., 2003; 
Glykys et al., 2007).  
The charge carried by the activation of tonically active GABAA receptors can be more than 
three times larger than that produced by phasic events (Nusser and Mody, 2002; Mody and 
Pearce, 2004; Farrant and Nusser, 2005). Tonic GABA conductance produces a shunt that 
affects excitability and gain control in the cells (Semyanov et al., 2003; Semyanov et al., 
2004). Thus, for a given excitatory input, the size and duration of excitatory postsynaptic 
potentials (EPSPs) will be reduced, along with the probability that an action potential will 
be generated. If step-current injections of increasing amplitude are used to evoke action 
potentials in granule cells, blockade of tonic inhibition decreases the current required to 
achieve a given firing rate (Brickley et al., 1996; Hamann et al., 2002). The best 
demonstration that tonic inhibition is crucial for regulating neuronal excitability comes 
from the genetic ablation of extrasynaptic receptors. In α60/0 mice, for example, the 
missing tonic GABA current of cerebellar granule cells is replaced by a continuously 
active K+ conductance of equal magnitude (Brickley et al., 2001).  
 
2.3. Modulation of phasic and tonic inhibition 
The most important difference between receptors mediating phasic and tonic inhibition is 
their affinity for GABA and the speed and extent of their desensitization. Receptors 
containing the δ subunit are involved in tonic inhibition due to their high affinity for 
GABA and slow desensitization kinetics (Brickley et al., 1996; Brickley et al., 2001; 
Nusser and Mody, 2002). Changes in extracellular GABA by modulation of GABA release 
and uptake determine the magnitude of tonic conductance and the kinetics of slow phasic 
events. In the hippocampus, it has been shown that stimulation of interneuronal firing by 
the glutamate-receptor agonist kainate increases the GABAA receptor-mediated tonic 
conductance in interneurons and pyramidal cells (Kullmann and Semyanov, 2002), 
whereas blockade of action-potential firing with tetrodotoxin reduces this tonic 
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conductance (Petrini et al., 2004). The contribution of interneurons to the generation of 
network oscillations might also be affected by tonic inhibition. Moreover, it has been 
suggested that differences in the tonic conductance of interneurons and pyramidal cells 
might contribute to the homeostatic regulation of phasic inhibition in pyramidal cells. 
Thus, blockade of tonic inhibition selectively enhances the excitability of interneurons, 
leading to an increase in the frequency of IPSCs in pyramidal cells (Semyanov et al., 
2003). 
GABA transporters, notably GAT-1, also influence ambient GABA concentrations: this 
transporters can rapidly redistribute between surface and intracellular compartments, and 
their function can be altered by phosphorylation (Quick et al., 2004) or intramolecular 
interactions (Hansra et al., 2004). So even if GABA release is unchanged, it is possible that 
ambient GABA concentrations, and thereby tonic inhibition, can be modulated by changes 
in uptake.  
Variations in the phasic response kinetics can originate from the probabilistic nature of 
quantal transmitter release, from stochastic behavior of the receptors, or from fluctuations 
of the transmitter concentration in the cleft. Multivesicular release of GABA is also 
responsible for changes in cleft GABA concentrations (Auger et al., 1998). GABA released 
from two or more vesicles not only increases the peak amplitude of a phasic event, but also 
slows down its decay. 
Another mechanism contributing to the modulation of tonic inhibition is the GABAB-
mediated control of GABA release by autoreceptors.  
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Figure 2. Modes of GABAA receptor activation. a) Phasic activation of postsynaptic receptors immediately 
beneath the release site (yellow). The diffuse blue shading indicates the spread of released GABA. The trace 
shows the average waveform of a miniature IPSC (mIPSC) recorded in the presence of the sodium blocker 
tetrodotoxin. The charge transfer is shaded. GAT, GABA transporter. b) Phasic activation of postsynaptic 
and perisynaptic receptors due to GABA 'spillover' (blue). The current record below shows a slow IPSC 
evoked by electrical stimulation. The area of the mIPSC is superimposed for comparison. c) Tonic activation 
of extrasynaptic receptors by a low concentration of ambient GABA, which persists despite GAT activity. 
The trace shows the tonic current that results from the stochastic opening of extrasynaptic receptors and the 
change in the holding current following application of the GABAA antagonist gabazine (SR-95531). The 
shaded area represents the charge carried by tonically active GABAA receptors. Figure from (Farrant and 
Nusser, 2005). 
 
 
3. GABAA receptor diversity  
The pronounced heterogeneity of GABAergic interneurons is paralleled by an extensive 
diversity of GABAA receptor subtypes. The region- and domain-specific location of these 
receptor subtypes offers an opportunity to gain insights into the role of defined neuronal 
circuits.  
GABAA receptors belong to the superfamily of ligand-gated ion channels. They are hetero-
oligomeric glycoproteins with a high structural heterogeneity. At least 21 subunits 
(α1−6, β1−3, γ1−3, δ, ε, ρ1−2, π and ρ1−3) have been revealed by cDNA cloning (Barnard 
et al., 1998; Bonnert et al., 1999; Sieghart and Sperk, 2002; Whiting, 2003). All subunits 
are similar in size (450-550 amino acids) and are strongly conserved among species. The 
common elements of the subunit structure include a large extracellular N-terminal 
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hydrophilic domain, four hydrophobic membrane-spanning segments (M1-4) and an 
extracellular C-terminal domain (Lovinger, 1997). GABAA receptor heterogeneity has 
important functional consequences because subunit composition dictates not only the 
biophysical properties (binding and gating) of the receptors, but also their subcellular 
distribution and therefore different modes of activation and different pharmacological 
actions (Pirker et al., 2000; Sieghart and Sperk, 2002; Farrant and Nusser, 2005). The 
subunit composition of GABAA receptors and their cellular and subcellular location is 
summarized in Table 2 (Fritschy and Brunig, 2003; Mohler et al., 2005).  
As previously mentioned, most GABAA receptors are composed of 2α/2β/1γ subunits. 
Immunohistochemical, pharmacological and functional analyses of GABAA receptors 
indicate that the majority of GABAA receptors contain a single type of α- and β- subunit 
variant. The major GABAA receptor subtype is assembled from the subunits α1β2γ2 and is 
ubiquitously distributed throughout the brain, with only a few brain regions lacking this 
subtype (granule cell layer of the olfactory bulb, reticular nucleus of the thalamus, spinal 
cord motoneurons) (Pirker et al., 2000; Fritschy and Brunig, 2003; Mohler et al., 2005). 
Receptors containing the α2 and α3 subunits are less abundant and are co-expressed 
frequently with the β3 and γ2 subunits. α2-containing receptors are found in hippocampal 
pyramidal neurons, olfactory bulb, striatum, nucleus accumbens, septum, dentate gyrus, 
amygdala and hypothalamus. α3-containing receptors are strongly present in the 
glomerular and external plexiform layers of the olfactory bulb, inner layers of the cerebral 
cortex, reticular thalamic nucleus, superior colliculus, amygdala, and cranial nerve nuclei 
(Sieghart and Sperk, 2002). α5-containing receptors are expressed along with β1-3 and γ2 
subunits (Fritschy and Mohler, 1995; Pirker et al., 2000). They are of minor abundance in 
the brain but are highly expressed in the hippocampus, olfactory bulb and hypothalamus. In 
general, most GABAA receptors co-assembled with γ2 subunits are located at synapses 
(Somogyi et al., 1996), as the γ2 subunits interact with the anchoring protein gephyrin for 
postsynaptic clustering (Essrich et al., 1998). An exception has been observed in pyramidal 
cells from the hippocampus, where in most of the α5-GABAA receptors, the γ2 subunit 
does not co-localize with gephyrin (Brunig et al., 2002; Crestani et al., 2002). 
Other types of subunit like δ and ε exist in functional receptors. The δ subunit has a 
restricted distribution in the brain, being highly expressed in cerebellar and hippocampal 
granule cells, thalamus, and olfactory bulb. As δ subunits are not anchored at synapses, 
General Introduction
 
23 
they are found exclusively in extrasynaptic sites, (Nusser et al., 1998; Pirker et al., 2000; 
Stell et al., 2003; Sun et al., 2004). α6βδ combinations have been detected in the 
cerebellum, and α4βδ combinations in the thalamus (Sieghart and Sperk, 2002). The ε 
subunit is only expressed in the hypothalamus, thalamus and substantia nigra (Sieghart and 
Sperk, 2002). Finally, the ρ-subunits are expressed primarily in the retina, and correspond 
to the so-called GABAC receptors (Bormann, 2000). 
 
3.1. GABAA receptor diversity in the hippocampus  
In the hippocampal formation, pyramidal cells express a high level of α1, α2 and α5 
subunits and a low level of α4 subunits (Figure 3). α1-GABAA receptors are located 
postsynaptically in the majority of somatodendritic synapses, whereas α2-GABAA 
receptors are particularly abundant in the axon initial segment (Fritschy et al., 1998). In the 
soma of hippocampal pyramidal cells, α1 and α2-GABAA receptor subtypes are also 
segregated into distinct synapses from two separate populations of basket cells (Nyiri et al., 
2001; Klausberger et al., 2002). Fast-spiking interneurons expressing the neurochemical 
marker PV synapse with pyramidal cells through α1-GABAA receptors (Klausberger et al., 
2002), whereas regular-spiking CCK interneurons form GABAergic synapses through α2-
GABAA receptors (Nyiri et al., 2001). CB1-type cannabinoid receptors are localized 
presynaptically, on the terminals of CCK-positive basket cells. These receptors mediate 
depolarization-induced suppression of inhibition, a form of short-term synaptic plasticity 
induced by calcium concentration increases in postsynaptic cells (Diana and Marty, 2004). 
Therefore, endogenous cannabinoids modulate hippocampal circuits containing α2-
GABAA receptors. The distribution of α1- and α2- containing receptors in synapses 
formed by different interneurons is further confirmed by our own work, in which the 
activation of segregated pathways activates either α1- or α2-GABAA receptors, distal 
extracellular stimulation (stratum radiatum or lacunosum-moleculare) activates α1-
GABAA receptors, and proximal stimulation (stratum pyramidale or stratum oriens) mostly 
activates α2-GABAA receptors (Prenosil et al., 2006). α4- and α5-GABAA receptors have 
an extrasynaptic localization, being distributed throughout the somatodendritic 
compartments of pyramidal cells (Brunig et al., 2002; Chandra et al., 2006b; Glykys et al., 
2007; Shen et al., 2007). Depending on the ambient GABA concentration, these receptors 
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are tonically activated (Scimemi et al., 2005). Thus, α5-GABAA receptors are activated 
under elevated GABA concentrations (Caraiscos et al., 2004), whereas at low GABA 
concentrations, the activation of α4-GABAA receptors predominates. Although a large 
pool of α5-GABAA receptors is extrasynaptic, (Serwanski et al., 2006), postembedding 
immunogold electron microscopy of the intact hippocampus showed that there is also a 
pool of α5-GABAA receptors present at GABAergic synapses in dendrites of hippocampal 
pyramidal cells. This suggests that the α5-GABAA receptor may play a functional role in 
phasic inhibition. 
Immunocytochemical studies indicate that a large proportion of α1β2γ2 receptors are 
located on interneurons from the hippocampus (Fritschy and Mohler, 1995; Sperk et al., 
1997; Pirker et al., 2000). All PV-positive interneurons and 50% of CR-positive neurons 
contain the α1 subunit, whereas CB interneurons are devoid of the α1 subunit. Similarly, 
most interneurons positive for NPY, and a subset of SOM-positive cells, contain the α1 
subunit in contrast to CCK- and VIP-containing cells, which lack the α1 subunit (Gao and 
Fritschy, 1994). The cell-specific expression of GABAA receptors containing the α1 
subunit among subsets of hippocampal interneurons points to a pronounced functional 
specialization of these cells and supports the conclusion that disinhibition may be of major 
functional relevance in regulating the balance between excitation and inhibition in 
hippocampal circuits. Contrary to pyramidal cells, the α1 subunit appears to have a mostly 
extrasynaptic distribution, which contributes to tonic inhibition (Glykys et al., 2007). Other 
α subunits are poorly expressed in CA1 interneurons, with the α3 and α5 subunits being 
virtually absent.  
It is important to note that the expression of GABAA receptor subunits in rodents does not 
necessarily correspond to that in humans. For example, the α3 subunit is virtually absent in 
rodent hippocampus but is strongly expressed in the CA1 area of the human hippocampus 
(Loup et al., 2000). 
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TABLE 2. GABAA receptor subtypes (Fritschy and Brunig, 2003; Mohler et al., 2005) 
Subunit 
composition 
Regional and neuronal localization Subcellular localization 
α1β2γ2
 
 
 
 
Cerebral cortex (layers I-VI, selected interneurons and 
pyramidal cells); hippocampus (selected interneurons 
and pyramidal cells); amygdala, olfactory bulb (mitral 
cells and interneurons), thalamic relay neurons; 
cerebellum (Purkinje cells and granule cells); deep 
cerebellar nuclei; basal forebrain; substantia nigra pars 
reticulata; inferior colliculus; brainstem 
Synaptic (soma and dendrites); 
extrasynaptic in all neurons with 
high expression 
α2β3γ2 Cerebral cortex (layers I-IV); hippocampal formation 
(pyramidal cells); amygdala (pyramidal cells); olfactory 
bulb (granule cells); striatum (spiny stellate cells); 
inferior olivary neurons (mainly on dendrites); 
hypothalamus; superior colliculus; motor neurons 
Synaptic, enriched in axon initial 
segment of cortical and 
hippocampal pyramidal cells 
α3βnγ2 Cerebral cortex (pyramidal cells in layers V and VI); 
hippocampus (some hilar cells); amygdala; olfactory 
bulb (tufted cells), thalamic reticular neurons; 
cerebellum (Golgi type II cells); medullary reticular 
formation; inferior olivary neurons; superior colliculus; 
brainstem; spinal cord; medial septum; basal forebrain 
cholinergic neurons; raphé and locus coeruleus 
(serotonergic and catecholaminergic neurons) 
Mainly synaptic, including some 
axon initial segments; 
extrasynaptic in inferior olivary 
neurons 
α4βnδ Dentate gyrus (granule cells); thalamus Extrasynaptic 
α5β3γ2 Hippocampus (pyramidal cells); olfactory bulb (granule 
cells, periglomerular cells); cerebral cortex; amygdala; 
hypothalamus; superior colliculus; superior olivary 
neurons; spinal trigeminal neurons; spinal cord 
Extrasynaptic in hippocampus, 
cerebral cortex, olfactory bulb; 
synaptic in trigeminal nucleus, 
superior olivary nucleus, some 
dendrites in hippocampus 
α6β2,3δ 
α6β2,3γ2
Cerebellum (granule cells); dorsal cochlear nucleus Synaptic (cerebellar glomeruli) 
and extrasynaptic on granule-cell 
dendrites and soma 
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Figure 3. Diagrammatic representation of the subcellular distribution of GABAA receptor subtypes in 
a CA1 hippocampal pyramidal cell. CCK, cholecystokinin; PV, parvalbumin (Fritschy and Brunig, 2003) 
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3.2. Pharmacology of GABAA receptors 
The GABAA receptor contains a variety of topographically distinct sites capable of binding 
clinically active substances such as benzodiazepines (sedatives, anxiolytics, hypnotics, 
muscle relaxants, and anticonvulsants), barbiturates (hypnotic and anticonvulsant), 
neurosteroids (anxiolitic, sedative, anaesthetic) and ethanol. These substances are allosteric 
agonists at the GABAA receptor and reversibly potentiate total GABAA currents. The 
structural heterogeneity of GABAA receptors also leads to pharmacological heterogeneity. 
Classical benzodiazepines such as diazepam, flunitrazepam and clonazepam bind at the 
interface between the α1/2/3/5 and γ2-subunits (Pritchett et al., 1989; Puia et al., 1992; Sigel 
et al., 1998; Mohler, 2006). Benzodiazepines increase the opening frequency of the 
GABAA receptor and decrease the mean closed time. The different benzodiazepine actions 
are mediated by specific α-GABAA receptors (Table 3). For instance, the sedative and 
amnesic action of diazepam is mediated by α1-GABAA receptors, whereas the anxiolytic 
effect is mediated by α2-GABAA receptors (Mohler et al., 2002; Mohler, 2006). The 
dissection of receptor pharmacology has been achieved by generating lines of point-
mutated mice as described in Section 4.  
Barbiturates interact with an allosteric site distinct from that of benzodiazepines and, in 
contrast to benzodiazepines, the presence of a γ subunit is not necessary for them to exert 
their effects. Barbiturates increase the duration of each opening of the GABAA receptor. At 
high concentrations, barbiturates can also open GABAA channels directly, another effect 
that distinguishes them from the benzodiazepines.  
Neurosteroids, such as allotetrahydrodeoxycorticosterone (THDOC), act preferentially on 
diazepam-insensitive receptors containing the α4/6 and δ subunits (Belelli et al., 2002; 
Brown et al., 2002; Wohlfarth et al., 2002), and increase both the open probability and the 
duration of burst openings. Either or both of these effects result in an increase of GABA 
currents. It is important to note that the I/V curves evoked in the presence or absence of 
agonists reverse at the same potential, so that the ion selectivity of the channel is unaltered 
(Rogers et al., 1994). Similarly, ethanol acts on receptors containing the α4/6 and δ subunits 
(Sundstrom-Poromaa et al., 2002; Wallner et al., 2003; Hanchar et al., 2005) (Table 3).  
Bicuculline, SR-95531 and picrotoxin reversibly decrease total GABAA current; they are, 
respectively, competitive, competitive, and non-competitive antagonists of the GABAA 
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receptors and are potent anticonvulsants (Macdonald and Barker, 1978; Newland and Cull-
Candy, 1992). GABAA receptor antagonists are useful for the experimental investigation of 
tonic and phasic inhibition because their function depends on the affinity of the receptors 
for GABA and on the conditions of the receptor activation. For example, SR-95531 at sub-
micromolar concentrations selectively blocks phasic currents (Bai et al., 2001; Stell and 
Mody, 2002; Semyanov et al., 2003; Yeung et al., 2003), which is consistent with the 
underlying receptors having a lower affinity for GABA than those that mediate tonic 
current (Stell and Mody, 2002). The channel blocker penicillin also selectively blocks 
phasic currents, reflecting the low occupancy of tonic receptors (Yeung et al., 2003). 
Furosemide is another antagonist with selectivity for α6-GABAA receptors (Korpi et al., 
1995). 
 
4. Animal models for the dissection of GABAA receptor functions  
The use of pharmacological compounds to investigate the functional role of specific 
GABAA receptors has limitations, because few compounds show clear subunit selectivity. 
Therefore genetic approaches are used. In the past years several knock-in and knock-out 
mice for one or more GABAA receptor subunits have been generated. Knock-in mice that 
carry point mutations in the amino acid responsible for the binding of modulatory drugs 
like diazepam have enabled the exploration of the pharmacological role of defined GABAA 
receptor subtypes (Rudolph et al., 1999; Low et al., 2000; Crestani et al., 2001; Crestani et 
al., 2002; van Rijnsoever et al., 2004) and provided a potent tool for studying the 
organization of inhibitory circuits at a functional level (Marowsky et al., 2004). Knock-out 
mice for specific GABAA receptor subtypes have not only provided important insights into 
the functions of GABAA receptor subtypes but also insights into the compensatory changes 
that may occur, which are of relevance to understanding inhibitory plasticity and 
interpreting a possible behavioral phenotype due to the mutation.  
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TABLE 3. GABAA receptor subtype ligands and pharmacological action (Fritschy and 
Brunig, 2003; Mohler et al., 2005; Rudolph and Mohler, 2006) 
Drug Interaction with the GABAA 
receptor subunits  
Pharmacological action 
Diazepam (BZ) α1 
 
 
α2 
 
 
α3 
 
α5 
Sedative, anterograde amnesia, anticonvulsion, 
tolerance to sedation, ethanol potentiation 
 
Anxiolytic, myorelaxation, modulation of rhythmic 
EEG 
 
Anticonvulsion, myorelaxation 
 
Anterograde amnesia*, muscle relaxation, 
associative and spatial memory, tolerance to 
sedation  
Zolpidem (BZ) 
 
α1 
 
Sedative, hypnotic, anticonvulsion, EEG power 
reduction in non-REM sleep 
 
Zaleplone (BZ) α1 Hypnotic 
 
Indiplon (BZ) α1 Hypnotic 
 
L-838 417 (BZ) α2, α3, α5 partial agonist, α1 
inverse agonist 
Anxiolytic 
Ocinaplon (BZ) α2, α3, α5 partial agonist, α1 full 
agonist 
Anxiolytic 
L-655 708 (BZ) partial inverse agonist for α5 Memory enhancer, anxiogenic 
Ethanol  
 
α4β3δ, α6β3δ high sensitivity; 
α4β2δ, α6β2δ medium sensitivity 
Sedative, anxiolytic 
Neurosteroids 
(THDOC) 
δ−containing receptors and α1, α3 
receptors in combination with β1 
Anxiolytic, sedative, anaesthetic 
Intravenous 
anesthetics 
(etomidate, 
propofol) 
β3-containing receptors Sedative, anaesthetic 
Gabodaxol α1 and α3 at the GABA site Hypnotic 
* tested in α50/0 mice; BZ, benzodiazepine site ligands.    
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4.1. GABAA receptor α subunit knock-in mice 
Point mutations were introduced into specific diazepam-sensitive GABAA receptor α 
subunit genes to obtain diazepam-insensitive GABAA receptors with intact expression and 
physiological function, thus avoiding developmental compensatory mechanisms. A 
histidine residue at a conserved position (α1-H101, α2-H101, α3-H126, and α5-H105) 
forms a high-affinity diazepam-binding site, whereas an arginine residue (α4-R99 and α6-
R100) is unable to do so. When an arginine residue replaces the histidine residue in the α1, 
α2, α3 and α5 subunits, recombinant receptors become diazepam insensitive (Wieland et 
al., 1992; Benson et al., 1998). To elucidate the involvement of defined GABAA receptor 
subtypes in different actions of diazepam in vivo, diazepam-insensitive mice [α1(H101R), 
α2(H101R), α3(H126R) and α5(H105R)] were generated. The respective behavioral 
deficit in different α subunit knock-in mice in response to diazepam treatment is attributed 
to the respective GABAA receptor subtype. Immunoblotting, immunohistochemistry, and 
immunofluorescence analysis reveal that the mutant receptor α1-3 subunits are expressed 
at normal levels, with unaltered regional and subcellular distributions. In α5(H105R) mice, 
a 30% reduction in expression of the α5 subunit in the hippocampus was observed, but the 
regional and subcellular localization was unchanged (Crestani et al., 2002). 
Studies with α1(H101R) knock-in mice reveal that the sedative, amnesic and, in part, the 
anticonvulsant action of diazepam is mediated by α1-GABAA receptors (Rudolph et al., 
1999). The effects of diazepam on electroencephalogram (EEG) patterns, such as REM-
sleep suppression and reduction of slow-wave sleep, were largely unchanged after 
diazepam treatment in α1(H101R) knock-in mice, implying that EEG changes induced by 
diazepam are not mediated by α1-GABAA receptors (Tobler et al., 2001). Moreover, the 
sedative-hypnotic and anticonvulsant action of zolpidem is mediated by α1-GABAA 
receptors (Crestani et al., 2000). Zolpidem reduces REM sleep and increases non-REM 
sleep in both α1(H101R) knock-in and wildtype mice, implying that the effect of zolpidem 
on EEG sleep is not mediated by α1-GABAA receptors. However, the EEG power 
reduction in non-REM sleep is mediated by α1-GABAA receptors (Kopp et al., 2004a).  
In α2(H101R) knock-in mice the anxiolytic and myorelaxant action of diazepam is absent 
at low diazepam doses (0.5 and 1 mg/kg) but the sedative and anticonvulsant action 
remains unaffected (Low et al., 2000; Morris et al., 2006). Thus α2-GABAA receptors 
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mediate the anxiolytic-like and myorelaxant actions of diazepam. Furthermore, the loss of 
the righting reflex by a combination of diazepam and low-dose alcohol is closely 
dependent on the activation of the α2-GABAA receptors (Tauber et al., 2003). In 
α2(H101R) knock-in mice, theta activity enhancement in REM sleep and waking by 
diazepam is reduced compared to wildtype mice. Furthermore the diazepam-induced 
suppression of delta activity in non-REM sleep is more pronounced in α2(H101R) knock-
in mice, suggesting that α2-GABAA receptors are relevant for the modulation of rhythmic 
brain activities by benzodiazepines (Kopp et al., 2004b).  
In α3(H126R) knock-in mice, the myorelaxant action of diazepam is partially removed 
(Crestani et al., 2001). The effects of diazepam on EEG sleep do not differ from wildtype, 
suggesting that α3-GABAA receptors are not critical for them (Kopp et al., 2003). This is 
also the case for α1(H101R)/ α3(H126R) double-mutant mice (Kopp et al., 2004a). In the 
thalamic reticular nucleus (nRt), the involvement of α3-GABAA receptors in thalamic 
giant depolarizing potentials (tGDPs) was analyzed with α3(H126R) knock-in mice. 
Benzodiazepine enhancement of tGDP amplitude and duration persisted in nRt neurons in 
α3(H126R) knock-in mice, indicating that the α3-GABAA receptors are not critical for 
tGDP generation, and that α5-GABAA receptors, which are transiently expressed in nRt 
neurons in early postnatal development, are probably involved (Pangratz-Fuehrer et al., 
2007). 
Also in α5(H105R) knock-in mice, the myorelaxant action of diazepam is partially 
removed (Crestani et al., 2001). α5(H105R) knock-in mice, which have a partial deficit of 
the α5-GABAA receptor, display selective changes in associative learning, memory 
performance and trace-fear conditioning (tone and foot shock separated by time) but not in 
delay-fear conditioning (tone and foot shock overlapping), and showed enhanced freezing 
compared to wildtype (Crestani et al., 2002). This indicates that α5-GABAA receptors are 
control elements of the temporal association of threat cues in trace-fear conditioning. Thus 
neuronal inhibition in the hippocampus mediated via α5-GABAA receptors is critical in 
controlling the regulation of the acquisition and expression of associative memory 
(Crestani et al., 2002; Yee et al., 2004). A downregulation of α5-GABAA receptors in the 
dentate gyrus is responsible for the manifestation of tolerance to the sedative action of 
diazepam. Thus, the chronic activation of α5-GABAA receptors is crucial for the normal 
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development of sedative tolerance to diazepam, which manifests itself in conjunction with 
α1-GABAA receptors (van Rijnsoever et al., 2004). 
The knock-in mice were also used to determine the changes in transcript levels induced by 
acute diazepam administration. In wildtype animals, diazepam reduced the expression 
levels of the calcium/calmodulin-dependent protein kinase II, as well as those of brain-
derived neurotrophic factor, MAP kinase phosphatase, transcription factor GIF, c-fos and 
nerve growth factor-induced gene-A. None of these transcripts were changed in the 
α1(H101R) knock-in mice after treatment with diazepam. Thus, the sedative action of 
diazepam is correlated with a selective downregulation of transcripts involved in the 
regulation of neuronal plasticity and neurotrophic responses. Most transcript changes are 
transient, except for the decrease of the CaMKIIα transcript. This long-term alteration may 
be involved in rebound phenomena and, under chronic treatment, in the development of 
tolerance and dependence (Huopaniemi et al., 2004). 
Knock-in mice have provided the general result that GABAA receptors with different α 
subunits mediate distinct behavioral effects of diazepam, but the cellular correlates of the 
point mutation, as well as the neuronal circuits mediating this action, are still unknown. To 
address this question, genetically engineered mice carrying specific point mutations in a 
defined cell type and area needed to be created. Furthermore, with electrophysiological 
recordings it is potentially possible to assign a specific behavioral role to interneuronal 
circuits that signal through specific GABAA receptors. The selective drug sensitivity of the 
receptors in different knock-in mice therefore opens up the possibility of a detailed 
functional analysis. In this thesis we aim to characterize the functional role of different 
GABAA receptors in pyramidal cells and interneurons of the hippocampus using a 
combination of electrophysiological and immunohistochemical methods. 
 
4.2. GABAA receptor expression and assembly in mice lacking individual 
GABAA receptor α subunits 
Genetic ablation of individual GABAA receptor subunits revealed that the α subunit is 
required for receptor assembly. Therefore, mice lacking an α subunit gene provide insight 
into the function of specific GABAA receptor subtypes and allow us to address the question 
of whether compensatory changes in the expression of other GABAA receptor subunits or 
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other receptors or channels occur. The answers to these questions are important for 
interpreting the role of the receptor type and the plasticity of the inhibitory system.  
So far, the α1, α3, α4, α5 and α6 subunits have been knocked out. α4, α5 and α6 subunits 
constitute a minor part of the GABAA receptor subtypes and are found predominantly in 
extrasynaptic sites in specific brain areas, as noted above. In the α5 knock-out mice, no 
upregulation of other α subunits was evident (Collinson et al., 2002), whereas in α6 knock-
out mice the α1 subunit was also downregulated. In α4 knock-out mice, a decrease in the 
amount of tonic inhibition was observed, but no data about other α subunit expression exist 
(Chandra et al., 2006b). The fact that the knock-out of individual GABAA receptor subunits 
leads to secondary changes with respect to the formation of receptors, and compensatory 
upregulation, increases the complexity of the phenotypes and reflects the homeostatic 
regulation that prevents neuronal circuits from becoming hyper- or hypoactive.  
Two lines of α1 knock-out mice (α10/0) have been generated to examine the role of α1-
GABAA receptors in vivo (Sur et al., 2001; Vicini et al., 2001). Αlthough there is a loss of 
more than 50% of all GABAA receptors in α10/0 mice, they are viable, and exhibit a mild 
phenotype (30% reduction in body weight and tremor when handling) (Kralic et al., 
2002b). An upregulation of α2 and α3 subunits and a downregulation of β2/3 and γ2 
subunits occurs in these mice, representing compensatory changes that suggest important 
network reorganization (Vicini et al., 2001; Kralic et al., 2002a; Kralic et al., 2006). The 
compensatory changes are region- and cell-type specific. The compensatory upregulation 
of GABAA receptors in α10/0 mice does not show a change in regional or cellular 
distribution. For example, in Purkinje cells from cerebellum that express only the α1 
subunit, a complete loss of GABAergic inhibitory currents is observed (Fritschy et al., 
2006; Kralic et al., 2006). In brain regions where other α subunits are also expressed, an 
upregulation of these α subunits is observed. For example, the α3 subunit that is expressed 
in the molecular layer of the cerebellum, it is also increased in α10/0 mice. Moreover, the 
extrasynaptic or synaptic localization of the receptors is not changed: receptors with an 
extracellular localization keep their extracellular localization, and synaptic receptors 
remain synaptic (Kralic et al., 2006). α10/0 mice retain juvenile inhibitory synaptic currents 
until adulthood because mIPSCs have prolonged kinetics (Vicini et al., 2001; Goldstein et 
al., 2002; Bosman et al., 2005).  
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α1 knock-out mice lose the affinity for zolpidem (Kralic et al., 2002b) but are more 
sensitive to the sedative effects of diazepam, as determined by locomotor activity (Kralic et 
al., 2002b). This discrepancy reflects compensatory changes in the expression of GABAA 
receptors caused by the lack of the α1 subunit throughout development. Deletion of α1 
subunit-containing receptors did not alter the anxiolytic, ataxic, anticonvulsant, or hypnotic 
effects of ethanol, or acute functional tolerance to ethanol, but did increase sensitivity to 
the locomotor-stimulating effects of ethanol (Kralic et al., 2003). 
In conclusion, α10/0 mice are a potent tool for studying several aspects of GABAAergic 
inhibition, such as: compensatory changes in GABAA receptor expression in different brain 
areas (Kralic et al., 2006; Ogris et al., 2006); changes in IPSCs (Goldstein et al., 2002; 
Bosman et al., 2005); pharmacological effects of benzodiazepines (Kralic et al., 2002a; 
Kralic et al., 2002b; Kralic et al., 2003); homeostatic inhibition (balance between phasic 
and tonic inhibition) (Ortinski et al., 2006); synaptogenesis (Fritschy et al., 2006); and 
developmental changes of inhibitory synaptic currents and quanta release (Vicini et al., 
2001; Barberis et al., 2005; Bosman et al., 2005).  
Using immunohistochemical and electrophysiological techniques, we used  α10/0 mice to 
study the compensatory changes that occur in defined hippocampal interneurons, and their 
functional consequences in vivo. Such a study allows us to learn about the plasticity of the 
inhibitory system at the cellular level and consequently provides information about defined 
neuronal circuits. 
 
5. References 
See page # 171 
  Aims 
Using a combination of electrophysiological and immunohistochemical techniques, this 
thesis aims to investigate the functional significance of GABAA receptor diversity in the 
hippocampus, as well as the compensatory mechanisms by which the interneuronal 
GABAergic system overcomes the lack of an α1-GABAA receptor subtype. We focus 
mainly on the role of extrasynaptic receptors, which in recent years have been shown to be 
as important as synaptic receptors in GABAAergic inhibitory signaling. We address the 
following questions: 
● Which GABAA receptors mediate phasic (fast and slow) and tonic forms of 
inhibition in CA1 pyramidal cells? (Publication 1) 
● Can we selectively stimulate a type of GABAA receptor? (Publication 1) 
● Do slow events and tonic currents share the same pool of extrasynaptic receptors? 
(Publication 1) 
● Does tonic inhibition exists when the GABA uptake machinery is intact in 
pyramidal cells and interneurons? (Publications 1 and 2) 
● Which GABAA receptors mediate tonic inhibition in CA1 interneurons? 
(Publication 2) 
● What determines the differences in tonic conductance in interneurons? Is it an 
intrinsic property of the cells? (Publication 2) 
 ● How can we use immunofluorescence techniques to visualize synaptic GABAA 
receptors in identified interneurons? (Publication 3) 
 ● Which changes occur in GABAA receptor expression and location in α1 knock-
out mice (α10/0)? (Publication 4) 
 ● What are the functional consequences of the lack of the α1 subunit in 
interneurons? (Publication 4) 
 ● Are the compensatory changes in α10/0 mice sufficient to protect against a 
pathological challenge such as epilepsy? (Publication 4) 
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1. Specific subtypes of GABAA receptors mediate phasic and tonic 
forms of inhibition in hippocampal pyramidal neurons (Publication 
1) 
We performed whole-cell voltage-clamp recordings in pyramidal cells from wildtype, 
single (α1, α2, α3), double (α12) and triple (α123) knock-in mice (described in the 
Introduction, section 4.1) to determine which α-containing GABAA receptors are involved 
in: 1) Evoked inhibitory postsynaptic currents (eIPSCs) with stimulation proximal or distal 
to the soma; 2) Spontaneous fast and slow inhibitory postsynaptic currents (sIPSC); and 3) 
Tonic inhibition under intact uptake machinery. To assess whether tonic inhibition and 
slow sIPSCs share the same pool of α-containing GABAA receptors, we investigated the 
effects of high and low doses of picrotoxin (PIC) on tonic currents, and fast and slow 
sIPSCs from wildtype mice. The remaining experiments described in publication 1 were 
performed by my colleague G. Prenosil. 
 
2. Interneurons in the hippocampal CA1 area exhibit region-specific 
tonic inhibition mostly mediated by α1-GABAA receptors 
(Publication 2) 
We performed whole-cell voltage-clamp recordings in stratum oriens, stratum radiatum 
and stratum lacunosum-moleculare interneurons from wildtype, single (α1, α2, α3, α5), 
double (α12, α23) and triple (α123) knock-in mice (described in the Introduction, section 
4.1), to analyze the involvement of α-containing GABAA receptors in tonic inhibition. To 
analyze whether differences in tonic conductance are an intrinsic property of interneurons, 
we recorded the different spiking patterns in current clamp.  
 
3. Immunofluorescence in brain sections: simultaneous detection of 
presynaptic and postsynaptic proteins in identified neurons 
(Publication 3, option C) 
The immunofluorescent visualization of the expression of different GABAA receptors in 
identified interneurons was limited by the fact that the strong tissue fixation required for 
optimal detection of most intracellular markers (such as calcium-binding proteins and 
Aims
 
37 
neuromodulators) can mask several postsynaptic epitopes (such as GABAA receptors and 
gephyrin). We therefore investigated several types of tissue preparation and fixation in 
order to simultaneously achieve the optimal preservation of cell morphology and the 
detection of soluble cell markers and synaptic proteins. We succeed in develope a novel 
protocol overcoming the mentioned limitations. 
 
4. Reorganization of GABAergic circuits maintains GABAA receptor-
mediated transmission onto CA1 interneurons in α1 subunit-null 
mice (Publication 4) 
By applying the newly established immunofluorescence protocol (described in Publication 
3), and whole-cell voltage-clamp recordings from interneurons in wildtype and α1 knock-
out mice (α10/0), we studied the compensatory changes in GABAA receptor expression and 
localization in five major populations of interneurons. We then investigated the sIPSCs, 
miniIPSCs (mIPSCs) and tonic GABAAergic currents from α10/0 mice and tested the 
susceptibility of α10/0 mice against kainic acid-induced seizures. The patch clamp 
recordings in this study were performed by G. Prenosil and V. Duveau performed the 
kainic acid injection analysis. 
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Abstract 
The main inhibitory neurotransmitter in the mammalian brain, γ-aminobutyric acid 
(GABA), mediates multiple forms of inhibitory signals, such as fast and slow inhibitory 
postsynaptic currents and tonic inhibition, by activating a diverse family of ionotropic 
GABAA receptors. Here, we have investigated whether distinct GABAA receptor subtypes 
mediate these various forms of inhibition using as approach mice carrying a point mutation 
in the α-subunit rendering individual GABAA receptor subtypes insensitive to diazepam 
without altering their GABA sensitivity and expression of receptors. Whole-cell patch-
clamp recordings were performed in hippocampal pyramidal cells from single, double, and 
triple mutant mice. Comparing diazepam effects in knock-in and wildtype mice allowed 
determining the contribution of α1, α2, α3, and α5 subunit containing GABAA receptors 
to phasic and tonic forms of inhibition. Fast phasic currents were mediated by synaptic α2-
GABAA receptors on the soma and by synaptic α1-GABAA receptors on the dendrites. No 
contribution of α3- or α5-GABAA receptors was detectable. Slow phasic currents were 
produced by both synaptic and perisynaptic GABAA receptors, judged by their strong 
sensitivity to blockade of GABA reuptake. In the CA1 area, but not in the subiculum, 
perisynaptic α5-GABAA receptors contributed to slow phasic currents. In the CA1 area the 
diazepam-sensitive component of tonic inhibition also involved activation of α5-GABAA 
receptors and slow phasic and tonic signals shared overlapping pools of receptors. These 
results demonstrate that the major forms of inhibitory neurotransmission in hippocampal 
pyramidal cells are mediated by distinct GABAA receptors subtypes. 
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Introduction 
In the mammalian central nervous system α-aminobutyric acid (GABA) is the main 
inhibitory neurotransmitter, activating GABAA receptors on target neurons either in a 
phasic or a tonic fashion (Farrant and Nusser 2005; Mody and Pearce 2004). GABAA 
receptors are composed of five subunits, most frequently two α, two β, and one γ subunit. 
Different subunit isoforms (α1-6, β1-4, γ1-3, δ, ε, π, θ) give rise to a considerable diversity 
of GABAA receptors (Barnard et al. 1998; Mohler et al. 2002; Sieghart and Sperk 2002) 
that are differentially expressed in the brain and localized in different cell types and 
subcellular areas (Fritschy and Mohler 1995; McKernan and Whiting 1996; Pirker et al. 
2000). Although much is known about the distribution and subcellular location of major 
GABAA receptor subtypes, the functional significance of this diversity is less well 
understood, chiefly due to a lack of pharmacological tools that distinguish between the 
different subtypes. The presence of a γ2 or γ3 subunit is required for the formation of a 
benzodiazepine-binding site (Knoflach et al. 1991; Pritchett et al. 1989). Additionally, the 
α subunit variant determines activation and de-activation kinetics of GABAA receptors 
(Banks and Pearce 2000; Bosman et al. 2002; Hutcheon et al. 2000; Vicini et al. 2001) and 
their affinity for classical benzodiazepines (Scholze et al. 1996; Smith et al. 2001) such as 
diazepam (diazepam). Mutation of a conserved histidine residue (His 101 in the α1 
subunit) into an arginine renders the corresponding GABAA receptor diazepam-insensitive 
(Benson et al. 1998; Rudolph et al. 1999; Wieland et al. 1992). Using gene targeting to 
introduce this point-mutation in various α subunit variants in vivo, it has been shown that 
different GABAA receptor subtypes mediate distinct effects of diazepam (Rudolph and 
Mohler 2004). In particular, its sedative properties are mediated by α1-GABAA receptors 
(McKernan et al. 2000; Rudolph et al. 1999) and its anxiolytic effects by α2-GABAA 
receptors (Low et al. 2000). It can therefore be assumed that specific neuronal circuits use 
distinct GABAA receptor subtypes differing in α subunit variant.  
Two major modes of GABAA receptor-mediated inhibitory transmission can be observed 
in mammalian CNS: phasic inhibition mediated by synaptic receptors and tonic inhibition 
mediated by extrasynaptic receptors (Farrant and Nusser 2005; Mody and Pearce 2004). In 
the hippocampal formation, phasic inhibitory postsynaptic currents (IPSCs) can further be 
subdivided into GABAA, fast and GABAA, slow IPSCs based on kinetics and amplitude 
(Pearce 1993). GABAA, fast IPSCs are mediated mostly by somatic and proximal dendritic 
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synapses (Freund and Buzsaki 1996), whereas GABAA, slow IPSCs are thought to originate 
at distal dendritic sites (Banks et al. 1998). GABAA, slow IPSCs exhibit on average a larger 
charge transfer than GABAA, fast IPSCs; their prolonged time course and their sensitivity to 
GABA reuptake inhibitors (Banks et al. 2000) suggested that they are activated by GABA 
spillover. 
The subunit composition and function of tonically activated GABAA receptors varies 
across brain regions and cell types. In cerebellum, dentate gyrus, neocortex and thalamic 
relay nuclei, tonic inhibition is mediated by diazepam-insensitive GABAA receptors 
containing α6 or α4 subunits together with the δ subunit (Brickley et al. 1996; Nusser and 
Mody 2002; Porcello et al. 2003; Stell et al. 2003; Sun et al. 2004; Cope et al., 2005; 
Drasbek and Jensen, 2005; Mtchedlishvili and Kapur, 2006). In the CA1 area, tonic 
inhibition is mediated by diazepam-sensitive GABAA receptors in interneurons and, to 
lesser extent pyramidal cells, when ambient GABA concentration is increased (Scimemi et 
al. 2005; Semyanov et al. 2003). At low GABA concentrations activation of GABAA 
receptors containing the α4 subunit was found to dominate (Scimemi et al. 2005). So far, 
however, no single GABAA receptor subtype has been found to have an exclusive synaptic 
or extrasynaptic location, but several lines of evidence suggest that specific GABAA 
receptors selectively participate in different forms of inhibition. Unraveling this selectivity 
would help understanding how distinct behaviors and diazepam effects are linked with the 
diverse forms of GABAergic inhibition. 
The aim of the present work was to investigate whether diazepam-sensitive GABAA 
receptors differing in α subunit composition mediate distinct modes of GABAergic 
inhibition in the hippocampal formation. Whole-cell patch-clamp recordings of CA1 and 
subicular pyramidal cells were performed on acute slices from knock-in mice carrying a 
histidine-to-arginine point-mutation in either the α1, α2 or α3 subunit gene to render the 
respective GABAA receptor diazepam-insensitive. Using this approach in single (α1, α2, 
α3), double (α12), and triple (α123) mutant mice to pharmacologically isolate GABAA 
receptors containing different α subunits, we investigated the contribution of identified 
diazepam-sensitive GABAA receptor subtypes to evoked and spontaneous IPSCs and to 
tonic inhibition in the hippocampus. A particular focus was put on characterization of 
GABAA, slow IPSCs, as they share elements of both phasic and tonic type of GABAergic 
inhibition. 
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Materials and Methods 
Generation of mutant mice 
Experiments were performed in 129/SvJ knock-in mice carrying diazepam-insensitive 
GABAA receptor subtypes obtained by a histidine-to-arginine point-mutation in the α1, α2, 
or α3 subunit gene [α1(H101R), α2(H101R) and α3(H126R)] (Low et al. 2000; Rudolph 
et al. 1999) introduced into the mouse genome by homologous recombination in embryonic 
stem cells. Mice carrying a point mutation in both α1 and α2 subunits (α12) were obtained 
by crossing double heterozygous mice born from homozygous α1(H101R) and α2(H101R) 
intercrosses. Homozygous α1(H101R)/α2(H101R) offspring were identified by PCR 
analysis from tail biopsy. Likewise, triple mutants, carrying point-mutated α1, α2 and α3 
subunits (α123) were generated by crossing double homozygous α1(H101R)/α2(H101R) 
and α1(H101R)/α3(H126R) mice, which yielded offspring homozygous for α1(H101R) 
but heterozygous for α2(H101R) and α3(H126R) subunits. These were crossed again with 
each other to obtain mice homozygous for all three point-mutations, as confirmed by PCR 
analysis. All experiments were approved by the cantonal Veterinary Office of Zurich and 
were performed in accordance with the European Community Council Directive 
(86/609/EEC). 
Immunohistochemistry 
Mice (P21) were anaesthetized with sodium pentobarbital (Nembutal, 50 mg/kg i.p., Abbot 
Laboratories, Chicago, IL) and were perfused transcardially with 4% paraformaldehyde 
dissolved in 0.15 M sodium phosphate buffer containing 15% saturated picric acid 
solution. The brain was extracted, post-fixed for 4 h in the same solution, incubated 
overnight in sodium citrate buffer (pH 4.5), and boiled for 60 sec in a microwave oven for 
antigen retrieval (Fritschy et al. 1998). They were then cryoprotected with 30% sucrose in 
phosphate buffered saline, frozen with dry-ice and cut in 40 μm parasagittal sections using 
a freezing microtome. Free-floating sections were processed for immunoperoxidase 
staining using antibodies against the α1, α2, α3, and α5 subunit, as described (Fritschy et 
al. 1998). For antibody characterization see Fritschy and Mohler (1995).  
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Slice preparation 
Mice from both sexes (P18-24) were anaesthetized with inhaled isoflurane and decapitated. 
The brain was quickly removed and placed in ice-cold artificial cerebrospinal fluid (ACSF, 
composition in mM: NaCl 125, NaHCO3 26, NaH2PO4 1.25, KCl 2.5, MgCl2 1, CaCl2 2.5, 
glucose 11, oxygenated with 95% O2 / 5% CO2). The brain was affixed to a vibratome 
stage (Microm HM 650 V, Microm International AG, Volketswil, Switzerland) with 
cyanoacrylate and kept in the ice-cold ACSF for slicing. Parasagittal 300-350 μm thick 
hippocampal slices were prepared and incubated at 33°C for 20 min, prior to being stored 
at room temperature (25°C) in oxygenated ACSF. For the recording of GABAA, slow IPSCs, 
mice (P24-30) were anaesthetized with Nembutal and were perfused transcardially with 50 
ml ice-cold sucrose-ACSF (composition in mM: NaCl 87, NaHCO3 26, NaH2PO4 1.25, 
KCl 2.5, MgCl2 9, CaCl2 0.5, sucrose 75, glucose 25). Parasagittal slices (310 μm thick) 
were cut in sucrose-ACSF, transferred to normal ACSF, and incubated and stored as 
above. 
Electrophysiological recordings and data analysis 
Slices were visualized with a CCD camera (PCO Vx45; Till Photonics, Germany) mounted 
on an upright microscope (BX51WI; Olympus, Switzerland), equipped with a long 
working distance water-immersion objective (Xlumplan FI 20X, 0.95 numerical aperture), 
a fourfold magnification changer, Nomarski-type differential interference contrast and 
infrared illumination. Patch electrodes were pulled from borosilicate glass (GC150TC; 
Clark Instruments, UK) and had an open tip resistance of 3-4 MΩ when filled with the 
internal solution. 2 mM kynurenic acid was added to the external ACSF solution to block 
excitatory synaptic transmission. Recordings were made using a Multiclamp 700A patch-
clamp amplifier (Axon Instruments, Inc. USA), filtered at 4 kHz, digitized at 20 kHz, 
stored and analyzed using IGOR Pro software (Wave Metrics, Lake Oswego, USA). 
Access resistance was monitored for all experiments and they were not included in further 
analysis if it changed by more than 20% during the recording. 
Evoked IPSCs 
Whole-cell voltage-clamp recordings from CA1 pyramidal cells of wildtype (WT), α1, α2, 
α3, α12 and α123 mutant mice were made at room temperature (25°C) with continuous 
superfusion (1-2 ml/min) of ACSF. External stimulation (0.1-10 μA) was delivered every 
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10 sec with a constant current stimulus isolator (WPI, Florida, USA) through a bipolar, 
custom-made electrode from polytetrafluoroethylene-insulated platinum-iridium wire of 50 
μM in diameter (Advent, UK). Evoked IPSCs (eIPSC) were recorded at a holding potential 
of 0 mV with a low chloride containing internal solution (composition in mM: CsGlu 130, 
EGTA 1, HEPES 10, MgATP 5, NaGTP 0.5, NaCl 5, pH 7.3, 295 mOsm). Access 
resistance was around 10-12 MΩ.  
To assess the contribution of different GABAA receptor subtypes to eIPSCs in slices from 
WT and knock-in mice, diazepam (1 μM, dissolved in DMSO) was bath-applied after 15 
minutes of baseline recordings and eIPSCs were recorded for another 15-30 minutes. The 
average eIPSC amplitude after application of diazepam was normalized to the peak 
amplitude of the average baseline eIPSC. No significant difference in the diazepam effect 
was observed between mono- and bi-exponential fittings, and therefore we chose the 
mono-exponential method. The increase in amplitude and τ after diazepam application in 
each line of mutant mice was compared to wildtype mice using one-way ANOVA followed 
by Bonferroni’s post-hoc multiple comparisons tests (SPSS 11.5; Lead Technology, USA). 
In all experiments “n” refers to the number of cells recorded. In average 1 to 2 cells were 
recorded from one animal.  
Spontaneous GABAA, fast and GABAA, slow IPSCs 
We recorded spontaneous GABAergic events to reliably distinguish between GABAA, slow 
and GABAA, fast and to facilitate the comparison of results from two hippocampal regions. 
Whole-cell voltage-clamp recordings of spontaneous IPSCs (sIPSC) from CA1 and 
subiculum pyramidal cells from wildtype and α123 mutant mice were obtained at room 
temperature with a holding potential of –60 mV and a high chloride containing internal 
solution (composition in mM: CsCl 100, MgCl2 2, EGTA 1, ATP 2, GTP 0.3, HEPES 40, 
pH 7,2, 300 mOsm). Experiments with the GABA reuptake inhibitor NO711 (2 μM, 
dissolved in DMSO) were performed in the presence of the GABAB receptor antagonist 
CGP 55845 (1 μM, dissolved in DMSO). Continuous recordings started after the holding 
current had stabilized. Spontaneous events were recorded for a 10-15 min baseline period 
and for the same amount of time in the presence of each drug tested. Banks et al. (2002) 
reported an increase in frequency of GABAA, slow sIPSCs with age in rats, while other 
parameters such as amplitude and kinetics remained unchanged. We checked for the age 
dependency of GABAA, slow sIPSCs in wildtype mice by recording from 34 animals ranging 
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from P15 to P35. As in rats, the frequency of GABAA, slow sIPSCs was higher in older 
animals. However, we observed a steep increase around P19 (results not shown), whereas 
in rats the mean frequency of GABAA, slow sIPSCs was reported to increase gradually with 
age. Based on this result, all subsequent sIPSC recordings were performed in mice between 
P20 and P25. 
Spontaneous events were detected offline automatically with the ‘Mini Analysis’ software 
(Synaptosoft, USA) with the detection threshold being set five times higher than the RMS 
level of baseline noise. All detected events were counted for analysis of frequency. For 
analysis of kinetics and amplitude only currents without subsequent contaminating events 
in the decaying phase were considered. Spontaneous events having an onset-to-peak rise 
time greater than 5 ms were classified as GABAA, slow sIPSCs, remaining events were 
classified as GABAA, fast sIPSCs (Banks et al. 2000). Amplitude, rise time and decay time 
constants for single GABAA, slow sIPSCs were calculated by the ‘Mini Analysis’ software. 
Kinetics of GABAA, fast sIPSCs was also calculated individually, whereas their amplitude 
was determined from an average trace for each recorded cell. This minimized 
contamination by noise as, in general, the signal-to-noise ratio was smaller for GABAA, fast 
than for GABAA, slow sIPSCs. The effects of diazepam and NO711 on sIPSCs were 
calculated from the average value of pooled sIPSCs from single experiments before and 
after drug application. Statistical significance was determined by paired Student’s t-tests. 
Tonic inhibition recordings 
Tonic inhibition was determined by the change in holding current after application of the 
GABAA receptor antagonist picrotoxin (2 or 100 μM dissolved in DMSO). Sensitivity to 
diazepam (1 μM) or L-655,708 (5 μM) was measured by first applying the drug to the bath 
solution and then assessing the effect of picrotoxin. Whole-cell recordings from CA1 
pyramidal cells in wildtype and α123 mutant mice were made at a holding potential of -60 
mV with a high chloride containing internal solution. GABAB receptors were blocked with 
the antagonist CGP 55845 (1 μM). Recordings were analyzed with the ‘Mini Analysis’ 
software with the detection threshold set five times higher than the level of baseline noise. 
The holding current was measured during 10 ms segments preceding spontaneous events, 
to avoid contamination with phasic currents. The average holding current was calculated in 
recordings taken after chloride equilibration (baseline), ~200 sec after diazepam 
application, ~120 - 150 seconds after picrotoxin application (t1), and ~240 – 300 seconds 
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after picrotoxin application (t2). For each experiment, changes in holding current after drug 
application were statistically compared to baseline with paired Student’s t-test. Differences 
between genotypes were analyzed with one-way ANOVA and Bonferroni’s post-hoc 
multiple comparisons tests.  
Drugs 
Chemicals were purchased from Sigma/Fluka (Switzerland) or Tocris Inc. (ANAWA Inc, 
Switzerland), diazepam was provided by Hoffmann-La Roche Ltd (Switzerland). We tested 
DMSO alone at the appropriate concentrations on IPSCs to rule out direct effects when it 
was used as a solvent. 
 
Results 
GABAA receptors subtypes expressed in CA1 area 
The distribution of the four α subunit variants (α1, α2, α3, α5) contributing to diazepam-
sensitive GABAA receptors was analyzed in the hippocampal formation by 
immunoperoxidase staining in P21 wildtype mice, revealing clear-cut differences in 
staining intensity and regional distribution (Fig.1). Although staining intensity cannot be 
compared across antibodies, comparisons can be made relative to other brain regions. 
Thus, the α2 and α5 subunit exhibited the strongest immunoreactivity in the hippocampal 
formation, with α2 being more intense in the dentate gyrus than in CA1, whereas the α5 
subunit was strongest in CA1, especially in the pyramidal cell layer. Staining for both 
subunits was homogeneous across dendritic and cell body layers of the hippocampal 
formation, suggesting the presence of the corresponding receptors on the soma and 
dendrites of pyramidal cells. As reported previously (Brünig et al. 2002), the α1 subunit 
antibody strongly labelled a population of interneurons throughout the hippocampal 
formation and produced only a moderate staining in the dendritic layers of CA1, CA3, and 
the dentate gyrus, while the cell body layers appeared almost devoid of staining. The α3 
subunit was expressed at low levels in CA1, and was present in a few isolated interneurons, 
mainly found in the stratum oriens and in the hilus. The boundary between CA1 and 
subiculum was particularly evident for the α5 subunit, which is almost not detectable in the 
latter region. 
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Examination of sections from P21 and adult single and triple knock-in mice revealed no 
difference in regional distribution and relative staining intensity for the four subunits 
analyzed (not shown), as reported previously for the amygdala (Marowsky et al. 2004) and 
the cerebral cortex (Fagiolini et al. 2004). 
 
 
 
Figure 1. Differential distribution of α subunit variants contributing to diazepam-sensitive GABAA 
receptors in the hippocampal formation. Parasagittal sections from P21 wildtype mice were processed for 
immunoperoxidase staining with subunit-specific antibodies. The α1, α2, and α5 subunit have overlapping, but 
distinct distribution in CA1, CA3 and the dentate gyrus (DG). In contrast, staining for the α3 subunit is much 
weaker in the hippocampus than deep cortical layers (upper right corner) or superior colliculus (lower right 
corner). Both the α1 and α3 subunit label interneurons in various subfields. In subiculum (S), staining for the 
α1 and α2 subunit is prominent, whereas α3 is weakly stained and α5 absent, marking a sharp boundary with 
the CA1 subfield. Scale bar, 300 μm. 
 
 
Differential contribution of α1- and α2-GABAA receptors to evoked synaptic inhibition in 
CA1 pyramidal cells  
To assess the major GABAA receptor subtypes mediating phasic inhibition, the effects of 
diazepam on eIPSCs were compared in wildtype mice and five lines of mutant mice 
carrying diazepam-insensitive GABAA receptors (α1, α2, α3, α12, and α123 knock-in 
mice). Current pulses were delivered every 10 seconds through an extracellular stimulus 
electrode and their intensity adjusted to generate eIPSCs of similar amplitude in all 
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experiments (Table 1). There was no difference in rise time and decay time constants of 
eIPSCs in the different genotypes investigated (Table 1).  
Bath-application of diazepam (1 μM) invariably increased the amplitude of eIPSCs in 
wildtype mice (49 ± 5 %, n = 14) (Fig. 2A, left trace) indicating that GABAA receptors are 
not saturated in our recording conditions. The normalized effect of diazepam on eIPSC 
peak amplitude (46 ± 8%, n = 13) and decay time constant (29 ± 3%, n = 13) was not 
different in α3 knock-in mice compared to wildtype (Figure 2B, C), whereas in α12 and 
α123 knock-in mice it was abolished (amplitude: 6 ± 5 %, n = 7 and 6 ± 2%, n = 7) (Figure 
2A, right trace). In contrast, diazepam produced a significant increase in peak amplitude 
(α1: 33 ± 5%, n = 15 and α2: 27 ± 8%, n = 10) and decay time in recordings from α1 and 
α2 knock-in mice (Figure 2B, C). Therefore, no contribution of either α3- or α5-GABAA 
receptors to evoked phasic inhibition could be resolved in these mice, whereas both α1- 
and α2-GABAA receptors mediate the bulk of eIPSCs in CA1 pyramidal cells. 
To determine whether these two receptor subtypes are segregated between the soma and 
dendrites, the stimulus electrode was placed either in the stratum pyramidale (proximal 
stimulation) or at the border between stratum radiatum and stratum lacunosum-moleculare 
(distal stimulation) (Fig. 3). With proximal stimulation, diazepam application produced an 
increase in peak eIPSC amplitude in α1 knock-in mice similar to wildtype (50 ± 10%, 
n = 7; P < 0.02), whereas in α2 knock-in mice the increase was much smaller (8 ± 4%, 
n = 5; P < 0.002). The opposite effect was observed in recordings with distal stimulation 
(Figure 3): in α2 knock-in mice, the increase in amplitude after diazepam application (46 ± 
16%, n = 5, P < 0.002) was similar to wildtype mice whereas in α1 knock-in mice it was 
only 20 ± 5 % (n = 8, P < 0.02). Therefore, α2-GABAA receptors preferentially mediate 
phasic synaptic inhibition on the soma and α1-GABAA receptor on the dendrites of CA1 
pyramidal cells, in line with the subcellular distribution of these subunits (Fig. 1). The fact 
that the activation of distinct GABAA receptor subtypes can be resolved in these knock-in 
mice makes them a suitable tool for further investigation of GABAergic transmission in the 
hippocampal formation. 
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Figure 2. Effect of diazepam (1 μM) on evoked 
IPSCs in WT and knock-in mice. A: samples of 
averaged eIPSCs obtained before (baseline) and 
after diazepam application in WT and in α123 
knock-in mice; note the lack of contribution of α5-
GABAA receptors. B and C: normalized averaged 
diazepam effect on peak amplitude (B) and decay 
time constant (C) in the different genotypes tested: 
WT, α1, α2, and α3 knock-in mice showed a 
significant increase in amplitude and decay time 
after application of diazepam (* P < 0.05, paired 
Student’s t-test). ANOVA tests indicated a 
significant difference between genotypes 
(P < 0.001, n = 66) for both amplitude and decay 
time after diazepam. Post-hoc analysis with 
Bonferroni multiple comparisons tests revealed 
significantly larger responses in WT and α3 knock-
in mice than in α12 and α123 knock-in mice 
(P ≤ 0.001 for amplitude, and P ≤ 0.026 for decay 
time). Numbers of experiments per genotype are 
shown in table 1. 
 
 
 
TABLE 1. Baseline properties of eIPSCs recorded from CA1 pyramidal cells in wildtype 
(WT) and knock-in mice 
Genotype n Amplitude, pA Rise time, ms Decay time 
constant, ms 
WT 14 120 ± 10 4.2 ± 0.5 64.5 ± 6 
α3 13 110 ± 9 5.7 ± 0.9 64.7 ± 7.6 
α1 15 109 ± 12 5.5 ± 0.7 67.9 ± 5.3 
α2 10 125 ± 10 5.4 ± 0.6 74.0 ± 6.3 
α12 7 124 ± 28 3.7 ± 1.3 59.0 ± 8.2 
α123 7 107 ± 21 5.3 ± 1.0 63.1 ± 10.7 
Values are given as mean ± SE. eIPSC, evoked inhibitory postsynaptic current; WT, wildtype. 
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Figure 3. Effect of diazepam (1 µM) on 
eIPSCs reveals a genotype effect according 
to the area of stimulation. A: examples of 
averaged eIPSCs obtained before (baseline) and 
after diazepam application in 1 (left) and 2 
(right) knock-in mice according to the area of 
stimulation: either proximal (top) or distal 
(bottom) to the cell soma. B: in WT mice, 
diazepam-induced amplitude increase of 
eIPSCs was similar in proximal and distal 
evoked responses (n = 14, not significant). In   
1 knock-in mice, the diazepam-induced 
amplitude increase of eIPSCs was similar to 
WT in proximally evoked responses, but 
significantly reduced in distally evoked 
responses (P < 0.02, n = 15, unpaired Student’s 
t-test, equal variances assumed). In 2 knock-
in mice, diazepam application affected 
proximally evoked responses significantly 
more than distally evoked responses (P < 
0.002, n = 10, unpaired Student’s t-test, equal 
variances assumed). *Significant changes from 
baseline (P < 0.05, paired Student’s t-test). 
 
 
Distinct GABAA receptor subtypes mediate fast and slow sIPSCs 
GABAA, fast and GABAA, slow IPSCs represent two distinct modes of phasic synaptic 
inhibition in CA1 pyramidal cells, best distinguished in recordings of spontaneous events. 
GABAA, slow IPSCs have been suggested to involve a mixture of synaptic and perisynaptic 
or extrasynaptic receptors and to be mediated by a specialized, yet not identified, type of 
interneuron (Banks et al. 2000). Although α5-GABAA receptors do not appear to be much 
involved in eIPSCs (Fig. 2), a contribution to GABAA, slow IPSCs is conceivable. Therefore, 
to determine whether different GABAA receptors mediate GABAA, fast and GABAA, slow 
sIPSCs, the effects of diazepam were assessed in α123 knock-in and wildtype mice, using 
continuous whole-cell voltage-clamp recordings from CA1 and subicular pyramidal cells.  
Baseline properties of sIPSCs (peak amplitude, rise time and decay time constant) did not 
differ significantly between genotypes and hippocampal regions (CA1, subiculum) (Tables 
2 and 3). Examples of recordings from a CA1 pyramidal cell are shown in Fig. 4A, D. 
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sIPSCs were analyzed and subdivided into GABAA, slow (Fig. 4B, E) and GABAA, fast 
sIPSCs (Fig. 4C, F), as described in the methods section. 
After baseline recording, diazepam (1 μM) was bath-applied and recording was continued 
until enough GABAA, slow sIPSCs were detected for statistical analysis. diazepam 
significantly increased the mean amplitude of GABAA, slow sIPSCs in α123 knock-in mice 
from -83.5 ± 6.1 pA to -111.2 ± 9.8 pA (P < 0.01, n = 9) and in wildtype mice from -117.0 
± 17.4 pA to -229.3 ± 46.7 pA (P < 0.05, n = 7). In addition, a significant increase in decay 
time constant was observed in wildtype mice, from 40.7 ± 4.0 ms to 63.0 ± 9.6 ms after 
diazepam application (P < 0.05, n = 7), whereas the increase in decay time in α123 knock-
in mice just failed to reach significance. The rise time of GABAA, slow sIPSCs did not 
change significantly after diazepam application in either genotype. 
The effect of diazepam in α123 knock-in mice indicates that α5-GABAA receptors 
participate in GABAA, slow sIPSCs. However, the increase in GABAA, slow sIPSCs in CA1 
pyramidal cells was significantly larger in wildtype than in α123 knock-in mice (two- 
tailed, unpaired Student’s t-test, nWT = 7, nα123 = 8), suggesting that α1- and/or α2-GABAA 
receptors also contribute to GABAA, slow sIPSCs. In contrast, GABAA, fast sIPSCs were not 
affected by diazepam in α123 knock-in mice, unlike in wildtype (Fig. 4N, O). These 
findings are consistent with the observations made on eIPSCs and suggest that the 
contribution of α5-GABAA receptors to phasic inhibition is restricted to GABAA, slow 
IPSCs. 
 
TABLE 2. Baseline properties of GABAA, slow sIPSCs 
Genotype and 
Region 
n Amplitude, pA Rise time, ms Decay time 
constant, ms 
WT, CA1 7* -117.0 ± 17.4 20.6 ± 0.8 40.7 ± 4.0 
α123, CA1 9 -83.5 ± 6.1 18.2 ± 1.3 31.7 ± 3.3 
WT, Sub 6 -72.7 ± 12.0 11.6 ± 0.7 22.0 ± 0.7 
α23, Sub 7 -123.2 ± 22.8 17.1 ± 1.6 31.6 ± 3.1 
Values are means ± SE. * In 2 out of 9 cells the number of GABAA, slow sIPSCs was too low for statistical 
analysis. Sub, subiculum. For other abbreviations see Table 1. 
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TABLE 3. Baseline properties GABAA, fast sIPSCs 
Genotype and 
Region 
n Amplitude, pA Rise time, ms Decay time 
constant, ms 
WT, CA1 9 -44.2 ± 3.7 0.48 ± 0.04 16.3 ± 2.7 
α123, CA1 6 -44.5 ± 2.3 0.51 ± 0.06 18.7 ± 9.5 
WT, Sub 6 -40.6 ± 3.3 0.45 ± 0.03 7.7 ± 0.8 
α23, Sub 7 -62.8 ± 6.9 0.52 ± 0.07 11.9± 4.4 
Values are means ± SE. For abbreviations, see Tables 1 and 2. 
 
As shown in Fig. 4, α5 subunit immunoreactivity is almost undetectable in subiculum, just 
adjacent to the CA1 area, allowing to characterize GABAA, slow sIPSCs in neurons lacking 
α5-GABAA receptors and to validate the findings obtained in α123 knock-in mice. 
Experiments were performed applying the same protocol used for the CA1 area (Fig. 4G, 
K). GABAA, slow sIPSCs were observed in baseline recordings of subicular pyramidal cells, 
albeit at a lower frequency than in CA1. (fSubiculum = 0.039 ± 0.005 s-1 ; fCA1 = 0.099 ± 0.012 
s-1). Bath-application of diazepam (1 μM) increased the amplitude and decay time constant 
of both GABAA, slow and GABAA, fast sIPSCs, in cells from wildtype mice (Fig. 4H, J, N, 
and O), while in α123 knock-in mice these values remained unchanged (Fig. 4L, M, N, and 
O). In addition, application of the inverse agonist at the benzodiazepine binding site L-
655,708 (5 μM) only affected the amplitude of GABAA, slow in wildtype CA1 pyramidal 
cells (–74.1 ± 12.4 pA to –58.1 ± 9.5 pA, n=7, P<0.05), but not in subicular pyramidal cells 
(n = 5). Amplitude and kinetics of GABAA, fast sIPSCs in CA1 and subiculum (n=7 and n = 
5, respectively) remained unchanged. L-655,708 exhibits at least 50 times higher affinity 
for α5-GABAA receptors over GABAA receptors containing other α subunits (Quirk et al. 
1996). These results further confirmed that α5-GABAA receptors are absent in the 
subiculum and thus are not required for the generation of GABAA, slow and that these 
receptors do not contribute to GABAA, fast sIPSCs.  
Due to their slow time-course and sensitivity to GABA reuptake inhibitors, GABAA, slow 
IPSCs have been proposed to involve, at least in part, extrasynaptic receptors activated by 
GABA spillover (Banks et al. 2000). To compare the subunit profile of synaptic and 
extrasynaptic receptors contributing to GABAA, slow sIPSCs in CA1 pyramidal cells, we 
enhanced the spillover component using the selective GABA reuptake inhibitor NO711. 
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Recordings from CA1 pyramidal cells from wildtype and α123 knock-in mice (Fig. 5A, D) 
were obtained under baseline condition, then in presence of 2 μM NO711 (Table 4), and 
finally after application of diazepam (1 μM). To prevent tonic activation of GABAB 
receptors (Le Feuvre et al. 1997; Scanziani 2000) 1 μM of the GABAB antagonist 
CGP55845 was present throughout the experiment. 
Application of 2 μM NO711, greatly enhanced the amplitude and decay time constant of 
GABAA, slow sIPSCs in both genotypes (Fig. 5B, E). In α123 knock-in mice the average 
amplitude increased from -96.2 ± 8.6 pA to -175.0 ± 32.2 pA and the decay time constant 
changed from 27.85 ± 18.2 ms to 47.44 ± 2.26 ms (P < 0.05, n = 8). In wildtype mice, the 
average amplitude increased from -73.1 ± 6.2 pA to -121.0 ± 19.2 pA and the decay time 
constant changed from 21.43 ± 1.99 ms to 38.69 ± 2.50ms (P < 0.05, n = 10). There was 
also a significant increase in rise time in both genotypes. In contrast, NO711 had no effect 
on the amplitude and kinetics of GABAA, fast sIPSCs (Fig. 5C, F). Subsequent application 
of diazepam (1 μM) further enhanced amplitude, rise and decay time constant of GABAA, 
slow sIPSCs in both genotypes (Fig. 5B, E). As expected, diazepam also enhanced the 
amplitude and decay time constant of GABAA, fast sIPSCs in wildtype but not in α123 
knock-in mice (Fig. 5G, H). In the presence of NO711, no difference between the relative 
changes in GABAA, slow sIPSCs amplitudes in wildtype (1.67 ± 0.20, n = 10) and α123 
knock-in mice (1.49 ± 0.16, n = 8) could be observed after diazepam application.  
 
 
TABLE 4. Baseline properties GABAA sIPSCs in presence of 1μM CGP 55845 
Genotype and 
sIPSC type 
n Amplitude, pA Rise time, ms Decay time 
constant, ms 
WT, slow 10 -73.1 ± 6.2 15.9 ± 0.9 21.4 ± 2.0 
α123, slow 8 -96.2 ± 8.6 16.6 ± 0.6 27.8 ± 1.8 
WT, fast 10 -42.1 ± 2.4 0.55 ± 0.02 18.6 ± 1.7 
α23, fast 8 -38.8 ± 2.9 0.61 ± 0.03 14.7 ± 2.6 
Values given as means ± SE. For abbreviations, see Table 1. 
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Figure 4. In CA1, but not subicular, pyramidal cells α5-GABAA receptors (GABAA receptors) mediate 
slow spontaneous IPSCs (sIPSCs). Samples of continuous whole-cell voltage-clamp recordings from CA1 
(A and D) and subicular [sub] (G and K) pyramidal cells in slices obtained from WT (A and G) and α123 (D 
and K) knock-in mice. Baseline conditions in black; gray traces after bath application of 1 µM diazepam. 
GABAA,slow sIPSCs are marked with asterisks. Corresponding isolated and averaged GABAA,slow sIPSCs (B, 
E, H, and L) and GABAA,fast sIPSCs (C, F, J, and M) are shown below with baseline conditions drawn in 
black and sIPSCs after diazepam application in gray. GABAA,slow sIPSCs can be unambiguously detected in 
subicular pyramidal cells. In CA1 pyramidal cells, GABAA,slow sIPSC amplitude was increased in WT and 
α123 knock-in mice after diazepam. In contrast, diazepam had no significant effect on the amplitude of 
GABAA,slow sIPSCs in the subiculum in α123 knock-in mice, whereas it caused a significant increase in WT 
mice. N and O: average normalized effect on amplitudes and decay time constants of sIPSCs in 3 conditions: 
Diazepam in WT (black bars, nCA1 = 7, nsub = 6), diazepam in α123 knock-in mice (gray bars, nCA1 = 9, nsub = 
7), and the α5-GABAA receptors selective inverse agonist L-655,708 (5 µM) in WT mice (open bars, nCA1 = 
7, nsub = 5). *Significant changes from baseline (diazepam, P < 0.03; L-655,708, P < 0.05, paired Student’s t-
test). 
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Figure 5. GABA spillover enhances 
GABAA,slow currents and increases 
the contribution α5-GABAA 
receptors in the CA1 area. A–F: 
sample traces of recordings in the 
CA1 area in slices from α123 knock-
in (A) and WT (D) mouse in the 
presence of 1 µM CGP 55845. After 
baseline recording (black), 2 µM 
NO711 was added, and the recording 
was continued (light gray); finally 1 
µM diazepam was applied (dark 
gray). GABAA,slow sIPSCs are marked 
with an asterisk. Averaged sIPSCs 
from the α123 knock-in (B) and WT 
(E) mouse show typical responses of 
GABAA,slow sIPSCs to NO711 and the 
subsequent application of diazepam. 
Corresponding isolated and averaged 
GABAA,fast sIPSCs are depicted in C 
and F at an enlarged scale to reveal 
their kinetics. GABA reuptake 
inhibition increases the amplitude and 
alters the kinetics only of GABAA,slow 
sIPSCs. G and H: comparison of 
GABAA,slow sIPSCs mean amplitudes 
(G) and mean decay time constants 
(H) normalized to base-line 
conditions after addition of 2 µM 
NO711 (light gray) and 1 µM 
diazepam (dark gray). *Significant 
difference to preceding condition. 
Note that diazepam in the presence of 
NO711 now significantly affects 
decay time constant of GABAA,slow 
sIPSCs in α123 knock-in mice (n = 8 
cells from each genotype, paired 
Student’s t-test; P < 0.05). 
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Diazepam activated tonic inhibition in CA1 pyramidal cells is mediated by α5-GABAA 
receptors  
GABAA, slow sIPSCs share elements of tonic GABAergic transmission such as involving 
perisynaptic GABAA receptors. Therefore, we assessed which diazepam-sensitive GABAA 
receptor subtypes contribute to tonic inhibition in CA1 pyramidal cells. Whole-cell 
voltage-clamp recordings were made in slices from wildtype and α123 knock-in mice 
using a high chloride-containing intracellular solution. Using a perfusion rate of 1 ml/min, 
tonic inhibition was measured as the change in holding current after the application 
100 μM picrotoxin in the presence of the GABAB antagonist CGP 55845 (1 μM). No 
GABA reuptake inhibitor was used. Under these conditions, application of 100 μM 
picrotoxin produced an outward shift in the baseline current of 33 ± 4 pA (n = 7) at room 
temperature and 35 ± 9 pA (n = 5) at physiological temperature. The tonic conductance 
was mediated by GABAA receptors because it was also blocked by bicuculline (10 μM) 
(data not shown). Since it has been reported that low doses of picrotoxin selectively (e.g. 
more rapidly) block tonic inhibition (Semyanov et al. 2003), we performed the same 
experiments using 2 μM picrotoxin and measured the outward shift of the holding current 
during two distinct time windows: at 120 - 150 seconds (t1) and 240 - 300 seconds (t2) 
after picrotoxin application. The holding current at t1 changed by 22 ± 5 pA (n = 6) (Fig. 
6A, B middle trace, and C) and by 33 ± 4 pA at t2 (n = 6) (Fig. 6A, B right trace, and C). 
RMS noise decreased from 5.4 ± 0.27 pA to 4.4 ± 0.27 pA (P < 0.05) at t1 and to 3.9 ± 
0.18 pA, (n.s.) at t2. The amplitude of fast events remained constant at t1, whereas a 
tendency for smaller GABAslow amplitudes was observed at that time point. At time t2 both 
fast and slow events were significantly reduced in amplitude (–44.8 ± 1.1 to -28.6 ± 0.65 
pA, n=6, P < 0.01 in fast sIPSCs and –61.1 ± 7.5 to –34.4 ± 1.9 pA, n=6, P < 0.01 in slow 
sIPSCs ) (Fig. 6 D). At t1, the frequency and decay time constant of GABAA, fast sIPSCs 
were unaltered compared to baseline (3.8 ± 0.26 Hz to 4.0 ± 0.17 Hz, n=6; and 21.7 ± 0.7 
to 23.1 ± 0.9 ms, respectively) (Fig. 6E and 6F, left trace), whereas the frequency and 
decay time of GABAA, slow sIPSCs were significantly reduced (from 0.09 ± 0.01 Hz to 0.06 
± 0.01 Hz n = 6, P < 0.05 and from 27.6 ± 2.3 to 20.2 ± 2.8 ms, P < 0.05, respectively) 
(Fig. 6E and 6F, right trace). The selective change in decay time and frequency of GABAA, 
slow sIPSCs which correlated with the change in holding current, provides further indication 
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that slow events and tonic inhibition share a common pool of extrasynaptic and thus most 
likely α5-GABAA receptors (Caraiscos et al. 2004a).  
 
 
 
 
 
Figure 6. Effect of picrotoxin (PIC) on holding current and GABAA,fast and GABAA,slow sIPSCs. A: 
representative trace from a continuous voltage-clamp recording at room temperature from a CA1 pyramidal 
cell of a WT mouse. PIC (2 µM) application to bath solution resulted in a decrease in the inward holding 
current and a reduction in the frequency and decay time of sIPSCs. The arrows marked t1 and t2 represent the 
2 time windows during which holding current and spontaneous events were analyzed. B: magnified 1-s traces 
of baseline (left), t1 (middle), and t2 (right). GABAA,slow sIPSCs are marked with asterisks. C: average change 
in holding current measured at t1 and at t2; holding current was significantly reduced at t1 (*P < 0.05, n = 6, 
paired Student’s t-test). D: average peak amplitude in fast (left) and slow sIPSCs (right); amplitude of fast and 
slow events was significantly reduced at t2 (*P < 0.006, n = 6, paired Student’s t-test). E: averaged change in 
frequency of fast (left) and slow (right) sIPSCs. At t1, as the holding current was significantly reduced, fast 
sIPSC frequency was unaltered (left), whereas frequency of slow sIPSCs was significantly reduced (right; *P 
< 0.05, n = 6, paired Student’s t-test). ANOVA shows significant differences between baseline, t1, and t2 (n = 
6, P 0.01). F: averaged change in decay time of fast (left) and slow (i) sIPSCs. Changes follow the pattern 
seen in D and E. At t1, fast sIPSC decay time was unaltered (left), whereas decay time of slow sIPSCs was 
significantly reduced (right; *P < 0.05, n = 6, paired Student’s t-test). ANOVA reveals significant differences 
between baseline, t1, and t2 (n = 6, P 0.01). 
 
Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in 
hippocampal pyramidal neurons 
 
58 
 
Figure 7. Effect of diazepam and L-655,708 on tonic current from CA1 pyramidal cells. A: 
representative trace segments recorded in a CA1 pyramidal cell from WT mouse. Note the inward drift in the 
holding current after the application of 1 µM diazepam as well as the increase in amplitude and frequency 
from spontaneous events (middle). After 5 min of PIC (100 µM) application to bath solution, holding current 
had an outward drift equal to that observed with 2 µM PIC. B: representative traces from a recorded CA1 
pyramidal cell in 123 knock-in mouse. After application of 1 µM diazepam to the bath solution, holding 
current exhibited an inward drift, but frequency and amplitude of fast spontaneous events remained 
unchanged (middle). Outward drift in holding current after application of PIC (100 µM) was similar as in WT 
mice. C: average shift in holding current in percentage of baseline after drug applications: In WT mice, 
holding current increased after diazepam application by 12 ± 7 pA (n = 10), whereas in 123 knock-in mice, 
it increased by 7 ± 2 pA (n = 6). Increase in holding current after diazepam application showed no significant 
difference between WT and 123 knock-in mice (unpaired Student’s t-test, not significant). When using 5 
µM L-655,708 instead of diazepam, no effect on holding current from CA1 pyramidal cells was observed (n 
= 4). Subsequent application of PIC (100 µM) in these cells caused a change in holding current comparable 
with diazepam experiments. L-655,708 was not used on 123 knock-in mice. *Significant changes from 
baseline (P < 0.05, 2-tailed paired Student’s t-test). 
 
 
Supporting this hypothesis, application of diazepam caused an inward shift in baseline 
holding current recorded in wildtype mice (10 ± 4 pA, n = 7, Fig. 7A). In α123 knock-in 
mice, a similar inward shift in baseline holding current was also observed after the 
application of 1 μM diazepam (8 ± 2 pA, n = 5) (Fig. 7B, C), demonstrating that α5-
GABAA receptors mediate the diazepam-sensitive component of tonic inhibition in CA1 
pyramidal cells. The application of 5 μM L-655,708 instead of diazepam in on pyramidal 
cells of the CA1 area from wildtype mice did not significantly alter the holding current (n 
= 4) (Fig. 7C), indicating that diazepam application increased the affinity of previously 
silent α5-GABAA receptors to the point that they were activated by ambient GABA. As no 
reliable electrophysiological data on the affinity and activity of L-655,708 on GABAA 
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receptors carrying point mutated α-subunits is available we only used this substance in 
wildtype mice. 
 
Discussion 
The present results demonstrate clear task specificity for GABAA receptors subtypes 
distinguished by their α subunit composition in the hippocampal formation. In CA1 
pyramidal cells, fast synaptic inhibition is mediated selectively by α1- and α2- GABAA 
receptors, with a spatial segregation of the two different receptor subtypes in distal and 
proximal compartments, respectively. Slow phasic inhibition involves both synaptic and 
extrasynaptic receptors, the latter being principally α5-GABAA receptors. Finally, 
diazepam-sensitive tonic inhibition, which can be observed in the absence of GABA 
reuptake inhibitors, is mediated by α5-GABAA receptors. In subiculum, where the α5 
subunit is expressed at very low levels, GABAA, slow sIPSCs can be readily detected, 
indicating that these synaptic events do not depend on α5-GABAA receptors. Nevertheless, 
a mixture of synaptic and extrasynaptic receptors also mediates them. Altogether, these 
results indicate that the distinct modes of synaptic inhibition in hippocampal neurons 
involve different GABAA receptor subtypes, organized in a region-specific manner and 
precisely targeted to distinct synaptic, perisynaptic, and extrasynaptic sites. 
Technical considerations 
The conclusions of this study are derived from a pharmacological distinction of GABAA 
receptor subtypes in knock-in mutant mice. There are two major prerequisites to validate 
these conclusions. First, the point-mutation should not alter the organization and functional 
properties of GABAA receptors in mutant mice. Several lines of evidence indicate that this 
prerequisite is fulfilled: Animals containing one or more point-mutations develop 
normally, have no overt phenotype and the cellular and subcellular location of GABAA 
receptors is unchanged (Benke et al. 2004; Mohler et al. 2004; Rudolph et al. 1999, 2004; 
Yee et al. 2004). The functional properties of receptors containing mutated subunits are 
unaltered in vivo (Bacci et al. 2003; Fagiolini et al. 2004; Marowsky et al. 2004). The 
present results reveal no difference across genotypes in the kinetics of sIPSCs or eIPSCs, 
and in the stimulus strength required to evoke IPSCs of similar amplitude, confirming that 
functional properties of GABAA receptors are normal in mutant mice. Second, the effects 
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of diazepam on peak amplitude and/or decay time constant should be detectable on all 
sensitive GABAA receptor subtypes and should not be masked by agonist saturation. At 
least for the α1, α2, and α5-GABAA receptors these conditions were fulfilled, confirming 
that mouse CA1 pyramidal cells have an incomplete postsynaptic GABAA receptor 
occupancy at room temperature (Hajos et al. 2000; Perrais and Ropert 2000, 1999). Failure 
to detect a contribution of α3-GABAA receptors to eIPSCs likely reflects the low 
abundance of these receptors in CA1 pyramidal cells (Laurie et al. 1992) (Fig. 1). 
Therefore, with the knock-in strategy, the function of GABAA receptors containing specific 
αsubunits can be analyzed with great selectivity (Rudolph and Mohler 2004) and without 
inducing compensatory changes, as occurs in gene deletion experiments. To date, no drugs 
are available to discriminate between α1-, α2-, and α3-GABAA receptors in vivo with a 
comparable degree of selectivity. One obvious limitation of the approach lies in the fact 
that it is limited to diazepam-sensitive GABAA receptors. 
Somatic and dendritic inputs are mediated differentially by α2- and α1- GABAA receptors  
The results from the analysis of eIPSCs are largely in agreement with the known 
subcellular distribution of GABAA receptor subtypes in CA1 pyramidal cells. α2-GABAA 
receptors located predominantly on the axon-initial segment and on the soma, facing 
terminals from chandelier cells and from basket cells expressing cholecystokinin, 
respectively (Nusser et al. 1996; Nyiri et al. 2001). The α1-GABAA receptors on the soma 
are contacted by parvalbumin-positive basket cell terminals, and they predominate in the 
dendritic layers of CA1, as seen by immunohistochemistry (Fig. 1) (Brunig et al. 2002). 
This segregation of different GABAA receptors to different subcellular compartments is of 
functional relevance, as demonstrated in vivo with the contribution of distinct interneurons 
signaling through these receptors during specific behavioral states (Klausberger 2002, 
2003). Additionally, Pouille and Scanziani (2001, 2004) have recently demonstrated that 
feedforward and feedback inhibition are mediated predominantly by somatic and dendritic 
receptors respectively. The differential modulation by diazepam of IPSCs evoked by 
proximal and distal stimulation of inhibitory inputs in α1 and α2 knock-in mice confirms 
this functional segregation of α2- and α1-GABAA receptors, thereby validating the use of 
this knock-in model to pharmacologically isolate specific GABAA receptor subtypes. The 
agreement between the present results and the known segregation of α1- and α2-GABAA 
receptors in CA1 neurons makes it unlikely that the difference in the effects of diazepam 
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on amplitude of eIPSCs in α1 and α2 knock-in mice are due to differential occupancy of 
receptors located on the soma and dendrites. To explain the present results, the degree of 
occupancy of these receptors should be opposite on the soma and dendrites (α1 high on 
soma and low on dendrites, and vice-versa for α2), which appears rather unlikely. Finally, 
it is well established that α2-GABAA receptors deactivate more slowly than α1-GABAA 
receptors, as shown in recombinant systems (McClellan et al. 1999) and in vivo (Bosman et 
al. 2005; Goldstein et al. 2002; Vicini et al. 2001). This distinction was not apparent with 
eIPSCs, reflecting the detection of compound, non-synchronous events and the variable 
effects of dendritic filtering upon proximal and distal stimulation.  
GABAA, slow IPSCs involve activation of synaptic and perisynaptic receptors 
GABAA, slow IPSCs in CA1 pyramidal cells have been observed in evoked, spontaneous, 
and miniature IPSCs (Banks et al. 1998; Pearce 1993) GABAA, slow eIPSCs exhibit the 
same properties as GABAA, slow sIPSCs and probably emanate from the same synapse 
(Banks et al. 1998). Our data extend the previous findings by demonstrating the presence 
of GABAA, slow sIPSCs also in the subiculum. It was not possible to determine whether 
GABAA, slow IPSCs in CA1 and subicular pyramidal cells are produced by similar 
mechanisms. The question whether GABAA, slow IPSCs are produced by one specific cell 
type common to both brain areas therefore remains unresolved. 
Slow events have been proposed to involve phasic activation of perisynaptic or even 
extrasynaptic GABAA receptors upon GABA spillover from the synaptic cleft (Banks et al. 
1998). The sensitivity of GABAA, slow to diazepam in α123 knock-in mice and their 
depression by L-655,708 in wildtype mice demonstrate that α5-GABAA receptors 
contribute to GABAA, slow sIPSCs. More importantly, this contribution is amplified and 
likely dominates the current in conditions of enhanced spillover, since the diazepam 
induced increase in GABAA, slow currents became indistinguishable between wildtype and 
α123 knock-in mice in presence of a GABA uptake inhibitor. An enhanced diffusion 
volume covered by the neurotransmitter and the prolonged gating kinetics of the receptors 
by the elevated concentration of GABA can explain the change in rise and decay time 
constant of GABAA, slow in the presence of a GABA uptake inhibitor. Which particular 
mechanism prevails would most likely be determined by the amount of spilled out GABA. 
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Our results clearly show that the spillover component of slow phasic currents is mediated 
by α5-GABAA receptors and nicely agree with the predominantly extrasynaptic 
distribution of α5-GABAA receptors (Brunig et al. 2002; Caraiscos et al. 2004a,b; Crestani 
et al. 2002). Interestingly, however, GABAA, slow sIPSCs also occurred in subiculum where 
the α5 subunit is virtually absent. The potentiation by diazepam in wildtype mice provides 
direct evidence that GABAA, slow sIPSCs there are also mediated by other diazepam-
sensitive GABAA receptor subtypes. These IPSCs are otherwise indistinguishable from 
those recorded in CA1, suggesting that the function of α5-GABAA receptors is taken over 
by other GABAA receptors with similar peri- and extrasynaptic localization in subicular 
neurons.  
The stronger effect of diazepam on GABAA, slow sIPSCs in wildtype compared to α123 
knock-in mice in CA1 pyramidal cells and the partial effect of L-655,708 (Fig 4) implicate 
the involvement of additional GABAA receptor subtypes in slow currents, with α1-GABAA 
receptors as likely co-participants, as this subunit has been demonstrated sometimes to co-
localize with the α5 subunit in the same clusters (Hutcheon et al. 2004). The lack of 
diazepam effect on GABAA, fast sIPSCs in α123 knock-in mice (Fig. 4) indicates that α5-
GABAA receptors do not participate in fast phasic inhibition. We did not detect any 
spillover component in fast GABAergic sIPSCs in the CA1 region and even the 
combination of NO711 and diazepam on cells from α123 mice revealed no contribution of 
α5-GABAA receptors to GABAA, fast. Therefore, these GABAA receptors are targeted 
selectively to sites mediating GABAA, slow sIPSCs in CA1 pyramidal cells, where they are 
probably located both in the synaptic cleft and perisynaptically. Using paired intracellular 
recordings; Thomson et al. (2000) provided indirect pharmacological evidence for the 
existence of α5-GABAA receptors mediating fast phasic inhibition from bistratified cells, 
which innervate distal pyramidal cell dendrites. The failure to detect these receptors in 
point-mutated mice might reflect the minor contribution of these events to the overall 
number of sIPSCs received by pyramidal cells. Banks et al. (1998) provided evidence for 
blockade of GABAA, fast sIPSCs by furosemide, suggesting a contribution of α4-GABAA 
receptors to these events. We did not assess the contribution of α4-GABAA receptors, 
which are diazepam-insensitive, but their low expression level in CA1 area (Pirker et al. 
2000) makes it unlikely that they play a major role in mediating GABAA, fast sIPSCs.  
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Our findings emphasize the proposed role of α5-GABAA receptors as detectors for 
extrasynaptic GABA (Caraiscos et al. 2004a; Glykys and Mody, 2006), and reveal their 
dual assignment to the generation of slow GABAergic events and the mediation of 
diazepam-sensitive tonic inhibition. In both cases GABA is not confined to synaptic clefts 
and the extent to which the neurotransmitter release underlying GABAA, slow sIPSCs 
contributes to ambient GABA remains to be examined. 
Tonic inhibition 
So far we have shown that in the CA1 area, GABAA, slow events partially arise from the 
activation of α5-GABAA receptors that are predominantly located extrasynaptically. Since 
GABAA, slow sIPSCs are rare, their early block by the activity-dependent antagonist 
picrotoxin, which parallels the early decrease of tonic GABAergic currents, most likely 
reflects crosstalk between the receptor populations mediating these two types of 
GABAergic currents. The pronounced sensitivity of tonic inhibition and GABAA, slow for 
picrotoxin is in line with a higher opening probability of tonically activated, extrasynaptic 
receptors.  
The increase in holding current after application of diazepam in both wildtype and α123 
knock-in mice confirms that α5-GABAA receptors can generate both tonic inhibition and 
slow events in CA1 pyramidal cells. Several lines of evidence indicate that most 
α5-GABAA receptors contain the β3 subunit in pyramidal neurons and β3-GABAA 
receptors are present in extrasynaptic regions (Pirker et al. 2000). It would be of major 
interest to know whether these receptors have the required high affinity for GABA. The 
fact that in our experiments the inverse agonist L-655,708 in contrast to diazepam, failed to 
exert any effect on the holding current of CA1 pyramidal cells raises questions about the 
role of α5-GABAA receptors detecting ambient GABA concentrations in the absence of 
diazepam. Diazepam increases the probability of GABAA receptors to be activated after 
GABA binding. This can lead to tonic opening of receptors under low ambient GABA 
concentration. Consequently, an inverse agonist fails to produce any effect on previously 
not activated receptors. Scimemi et al. (2005) have been the first to address the dependency 
of α5-GABAA receptors activation on GABA concentrations. The authors found that L-
655,708 decreases the holding current only when ambient GABA concentrations are 
elevated. Under physiological conditions, synchronous neural network activity might lead 
to such heightened ambient GABA concentration and subsequent activation of 
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extracellular α5-GABAA receptors (Towers et al. 2004). Nevertheless our findings are 
relevant to explain the physiological effects of diazepam, as this drug experiences 
widespread pharmaceutical use.  
Significance of the work 
We have shown that the subunit composition of GABAA receptors not only affects their 
subcellular distribution but also dictates their functional role. The clear segregation of 
GABAA receptor subtypes demonstrated here shows the complex organization of the 
inhibitory system at the molecular level and provides a compelling explanation for the 
specific effects of different GABAA receptors in distinct behaviorally significant signaling 
pathways. 
 
Acknowledgments 
We thank Corinne Sidler and Franziska Parpan for their excellent technical assistance. 
 
Grants 
G.A. Prenosil, E. M. Schneider Gasser and K.E. Vogt are supported by  
grant # 631-066012 of the Swiss National Science Foundation. 
 
References 
Bacci A, Rudolph U, Huguenard JR, and Prince DA. Major differences in inhibitory      
synaptic transmission onto two neocortical interneuron subclasses. J Neurosci 23: 9664-
9674, 2003. 
Banks MI, Hardie JB, and Pearce RA. Development of GABAA receptor-mediated 
inhibitory postsynaptic currents in hippocampus. J Neurophysiol 88: 3097-3107, 2002. 
Banks MI, Li TB, and Pearce RA. The synaptic basis of GABAA,slow. J Neurosci 18: 
1305-1317, 1998. 
Banks MI and Pearce RA. Kinetic differences between synaptic and extrasynaptic GABAA 
receptors in CA1 pyramidal cells. J Neurosci 20: 937-948, 2000. 
Banks MI, White JA, and Pearce RA. Interactions between distinct GABAA circuits in 
hippocampus. Neuron 25: 449-457, 2000. 
Results
 
65 
Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, 
Bateson AN, and Langer SZ. International Union of Pharmacology. XV. Subtypes of 
GABAA receptors: classification on the basis of subunit structure and receptor function. 
Pharmacol Rev 50: 291-313, 1998. 
Benke D, Fakitsas P, Roggenmoser C, Michel C, Rudolph U, and Mohler H. Analysis of 
the presence and abundance of GABAA receptors containing two different types of α 
subunits in murine brain using point-mutated α subunits. J Biol Chem 279: 43654-
43660, 2004. 
Benson JA, Low K, Keist R, Mohler H, and Rudolph U. Pharmacology of recombinant 
GABAA receptors rendered diazepam-insensitive by point-mutated α-subunits. FEBS 
Lett 431: 400-404, 1998. 
Bosman LW, Heinen K, Spijker S, and Brussaard AB. Mice lacking the major adult 
GABAA receptor subtype have normal number of synapses, but retain juvenile IPSC 
kinetics until adulthood. J Neurophysiol 94: 338-346, 2005. 
Bosman LW, Rosahl TW, and Brussaard AB. Neonatal development of the rat visual 
cortex: synaptic function of GABAA receptor α subunits. J Physiol 545: 169-181, 2002. 
Brickley SG, Cull-Candy SG, and Farrant M. Development of a tonic form of synaptic 
inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA 
receptors. J Physiol 497: 753-759, 1996. 
Brunig I, Scotti E, Sidler C, and Fritschy JM. Intact sorting, targeting, and clustering of γ-
aminobutyric acid A receptor subtypes in hippocampal neurons in vitro. J Comp Neurol 
443: 43-55, 2002. 
Caraiscos VB, Elliott EM, You-Ten KE, Cheng VY, Belelli D, Newell JG, Jackson MF, 
Lambert JJ, Rosahl TW, Wafford KA, MacDonald JF, and Orser BA. Tonic inhibition 
in mouse hippocampal CA1 pyramidal neurons is mediated by α5 subunit-containing γ-
aminobutyric acid type A receptors. Proc Natl Acad Sci U S A 101: 3662-3667, 2004a. 
Caraiscos VB, Newell JG, You-Ten KE, Elliott EM, Rosahl TW, Wafford KA, MacDonald 
JF, and Orser BA. Selective enhancement of tonic GABAergic inhibition in murine 
hippocampal neurons by low concentrations of the volatile anesthetic isoflurane. J 
Neurosci 24: 8454-8458, 2004b. 
Cope DW, Hughes SW, Crunelli V. GABAA receptor-mediated tonic inhibition in thalamic 
neurons. J Neurosci 25:11553-11563, 2005.  
Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in 
hippocampal pyramidal neurons 
 
66 
Crestani F, Keist R, Fritschy JM, Benke D, Vogt K, Prut L, Bluthmann H, Mohler H, and 
Rudolph U. Trace fear conditioning involves hippocampal α5-GABAA receptors. Proc 
Natl Acad Sci U S A 99: 8980-8985, 2002. 
Drasbek KR, Jensen K. THIP, a hypnotic and antinociceptive drug, enhances an 
extrasynaptic GABAA receptor-mediated conductance in mouse neocortex. Cereb 
Cortex Oct 12, 2005; 10.1093/cercor/bhj055 
Fagiolini M, Fritschy JM, Low K, Mohler H, Rudolph U, and Hensch TK. Specific 
GABAA circuits for visual cortical plasticity. Science 303: 1681-1683, 2004. 
Farrant M and Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of 
GABAA receptors. Nat Rev Neurosci 6: 215-229, 2005. 
Freund TF and Buzsaki G. Interneurons of the hippocampus. Hippocampus 6: 347-470, 
1996. 
Fritschy JM and Mohler H. GABAA-receptor heterogeneity in the adult rat brain: 
differential regional and cellular distribution of seven major subunits. J Comp Neurol 
359: 154-194, 1995. 
Fritschy JM, Weinmann O, Wenzel A, and Benke D. Synapse-specific localization of 
NMDA and GABAA receptor subunits revealed by antigen-retrieval 
immunohistochemistry. J Comp Neurol 390: 194-210, 1998. 
Glykys J, Mody I. Hippocampal network hyperactivity following selective reduction of 
tonic inhibition in GABAA receptor α5 subunit deficient mice, J Neurophysiol Feb 1, 
2006; 10.1152/jn.01122.2005. 
Goldstein PA, Elsen FP, Ying SW, Ferguson C, Homanics GE, and Harrison NL. 
Prolongation of hippocampal miniature inhibitory postsynaptic currents in mice lacking 
the GABAA receptor α1 subunit. J Neurophysiol 88: 3208-3217, 2002. 
Hajos N, Nusser Z, Rancz EA, Freund TF, and Mody I. Cell-type- and synapse-specific 
variability in synaptic GABAA receptor occupancy. Eur J Neurosci 12: 810-818, 2000. 
Hutcheon B, Fritschy JM, and Poulter MO. Organization of GABAA receptor α-subunit 
clustering in the developing rat neocortex and hippocampus. Eur J Neurosci 19: 2475-
2487, 2004. 
Hutcheon B, Morley P, and Poulter MO. Developmental change in GABAA receptor 
desensitization kinetics and its role in synapse function in rat cortical neurons. J Physiol 
522: 3-17, 2000. 
Results
 
67 
Klausberger T. Brain-state- and cell type-specific firing of hippocampal interneurons in 
vivo. Nature 421: 844-848, 2003. 
Klausberger T, Roberts JD, and Somogyi P. Cell type- and input-specific differences in the 
number and subtypes of synaptic GABAA receptors in the hippocampus. J Neurosci 22: 
2513-2521, 2002. 
Knoflach F, Rhyner T, Villa M, Kellenberger S, Drescher U, Malherbe P, Sigel E, and 
Mohler H. The γ3-subunit of the GABAA-receptor confers sensitivity to benzodiazepine 
receptor ligands. FEBS Lett 293: 191-194, 1991. 
Laurie DJ, Wisden W, and Seeburg PH. The distribution of thirteen GABAA receptor 
subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 
12: 4151-4172, 1992. 
Le Feuvre Y, Fricker D, and Leresche N. GABAA receptor-mediated IPSCs in rat thalamic 
sensory nuclei: patterns of discharge and tonic modulation by GABAB autoreceptors. J 
Physiol 502: 91-104, 1997. 
Low K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, 
Bluethmann H, Mohler H, and Rudolph U. Molecular and neuronal substrate for the 
selective attenuation of anxiety. Science 290: 131-134, 2000. 
Marowsky A, Fritschy JM, and Vogt KE. Functional mapping of GABAA receptor 
subtypes in the amygdala. Eur J Neurosci 20: 1281-1289, 2004. 
McClellan AM, and Twyman RE. Receptor system response kinetics reveal functional 
subtypes of native murine and recombinant human GABAA receptors. J Physiol 515: 
711-727, 1999. 
McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, Farrar S, Myers 
J, Cook G, Ferris P, Garrett L, Bristow L, Marshall G, Macaulay A, Brown N, Howell 
O, Moore KW, Carling RW, Street LJ, Castro JL, Ragan CI, Dawson GR, and Whiting 
PJ. Sedative but not anxiolytic properties of benzodiazepines are mediated by the 
GABAA receptor α1 subtype. Nat Neurosci 3: 587-592, 2000. 
McKernan RM and Whiting PJ. Which GABAA-receptor subtypes really occur in the 
brain? Trends Neurosci 19: 139-143, 1996. 
Mtchedlishvili Z, Kapur J. High-affinity, slowly desensitizing GABAA receptors mediate 
tonic inhibition in hippocampal dentate granule cells. Mol Pharmacol 69:564-575, 
2006.  
Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in 
hippocampal pyramidal neurons 
 
68 
Mody I and Pearce RA. Diversity of inhibitory neurotransmission through GABAA 
receptors. Trends Neurosci 27: 569-575, 2004. 
Mohler H, Fritschy JM, Crestani F, Hensch T, and Rudolph U. Specific GABAA circuits in 
brain development and therapy. Biochem Pharmacol 68: 1685-1690, 2004. 
Mohler H, Fritschy JM, and Rudolph U. A new benzodiazepine pharmacology. J 
Pharmacol Exp Ther 300: 2-8, 2002. 
Nusser Z and Mody I. Selective modulation of tonic and phasic inhibitions in dentate gyrus 
granule cells. J Neurophysiol 87: 2624-2628, 2002. 
Nusser Z, Sieghart W, Benke D, Fritschy JM, and Somogyi P. Differential synaptic 
localization of two major GABAA receptor α subunits on hippocampal pyramidal cells. 
Proc Natl Acad Sci U S A 93: 11939-11944, 1996. 
Nyiri G, Freund TF, and Somogyi P. Input-dependent synaptic targeting of α2-subunit-
containing GABAA receptors in synapses of hippocampal pyramidal cells of the rat. 
Eur J Neurosci 13: 428-442, 2001. 
Pearce RA. Physiological evidence for two distinct GABAA responses in rat hippocampus. 
Neuron 10: 189-200, 1993. 
Perrais D and Ropert N. Altering the concentration of GABA in the synaptic cleft 
potentiates miniature IPSCs in rat occipital cortex. Eur J Neurosci 12: 400-404, 2000. 
Perrais D and Ropert N. Effect of zolpidem on miniature IPSCs and occupancy of 
postsynaptic GABAA receptors in central synapses. J Neurosci 19: 578-588, 1999. 
Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, and Sperk G. GABAA receptors: 
immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 
101: 815-850, 2000. 
Porcello DM, Huntsman MM, Mihalek RM, Homanics GE, and Huguenard JR. Intact 
synaptic GABAergic inhibition and altered neurosteroid modulation of thalamic relay 
neurons in mice lacking δ subunit. J Neurophysiol 89: 1378-1386, 2003. 
Pouille F and Scanziani M. Enforcement of temporal fidelity in pyramidal cells by somatic 
feed-forward inhibition. Science 293: 1159-1163, 2001. 
Pouille F and Scanziani M. Routing of spike series by dynamic circuits in the 
hippocampus. Nature 429: 717-723, 2004. 
Price CJ, Cauli B, Kovacs ER, Kulik A, Lambolez B, Shigemoto R, and Capogna M. 
Neurogliaform neurons form a novel inhibitory network in the hippocampal CA1 area. 
J Neurosci 25: 6775-6786, 2005. 
Results
 
69 
Pritchett DB, Sontheimer H, Shivers BD, Ymer S, Kettenmann H, Schofield PR, and 
Seeburg PH. Importance of a novel GABAA receptor subunit for benzodiazepine 
pharmacology. Nature 338: 582-585, 1989. 
Quirk K, Blurton P, Fletcher S, Leeson P, Tang F, Mellilo D, Ragan CI, McKernan RM. 
[3H]L-655,708, a novel ligand selective for the benzodiazepine site of GABAA 
receptors which contain the α5 subunit. Neuropharmacology 35: 1331-1335, 1996 
Rudolph U, Crestani F, Benke D, Brunig I, Benson JA, Fritschy JM, Martin JR, 
Bluethmann H, and Mohler H. Benzodiazepine actions mediated by specific GABAA 
receptor subtypes. Nature 401: 796-800, 1999. 
Rudolph U and Mohler H. Analysis of GABAA receptor function and dissection of the 
pharmacology of benzodiazepines and general anesthetics through mouse genetics. 
Annu Rev Pharmacol Toxicol 44: 475-498, 2004. 
Scanziani M. GABA spillover activates postsynaptic GABAB receptors to control rhythmic 
hippocampal activity. Neuron 25: 673-681, 2000. 
Scholze P, Ebert V, and Sieghart W. Affinity of various ligands for GABAA receptors 
containing α4β3γ2, α4γ2, or α1β3γ2 subunits. Eur J Pharmacol 304: 155-162, 1996. 
Scimemi A, Semyanov A, Sperk G, Kullmann DM, and Walker MC. Multiple and plastic 
receptors mediate tonic GABAA receptor currents in the hippocampus. J Neurosci 25: 
10016-10024, 2005. 
Semyanov A, Walker MC, and Kullmann DM. GABA uptake regulates cortical excitability 
via cell type-specific tonic inhibition. Nat Neurosci 6: 484-490, 2003. 
Semyanov A, Walker MC, Kullmann DM, and Silver RA. Tonically active GABAA 
receptors: modulating gain and maintaining the tone. Trends Neurosci 27: 262-269, 
2004. 
Sieghart W and Sperk G. Subunit composition, distribution and function of GABAA 
receptor subtypes. Curr Top Med Chem 2: 795-816, 2002. 
Smith AJ, Alder L, Silk J, Adkins C, Fletcher AE, Scales T, Kerby J, Marshall G, Wafford 
KA, McKernan RM, and Atack JR. Effect of α subunit on allosteric modulation of ion 
channel function in stably expressed human recombinant GABAA receptors determined 
using 36Cl ion flux. Mol Pharmacol 59: 1108-1118, 2001. 
Stell BM, Brickley SG, Tang CY, Farrant M, and Mody I. Neuroactive steroids reduce 
neuronal excitability by selectively enhancing tonic inhibition mediated by δ subunit-
containing GABAA receptors. Proc Natl Acad Sci U S A 100: 14439-14444, 2003. 
Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in 
hippocampal pyramidal neurons 
 
70 
Sun C, Sieghart W, and Kapur J. Distribution of α1, α4, γ2, and δ subunits of GABAA 
receptors in hippocampal granule cells. Brain Res 1029: 207-216, 2004. 
Thomson AM, Bannister AP, Hughes DI, and Pawelzik H. Differential sensitivity to 
Zolpidem of IPSPs activated by morphologically identified CA1 interneurons in slices 
of rat hippocampus. Eur J Neurosci 12: 425-436, 2000. 
Towers SK, Gloveli T, Traub RD, Driver JE, Engel D, Fradley R, Rosahl TW, Maubach K, 
Buhl EH, and Whittington MA. α5 subunit-containing GABAA receptors affect the 
dynamic range of mouse hippocampal kainate-induced γ frequency oscillations in vitro. 
J Physiol 559: 721-728, 2004. 
Vicini S, Ferguson C, Prybylowski K, Kralic J, Morrow AL, and Homanics GE. GABAA 
receptor α1 subunit deletion prevents developmental changes of inhibitory synaptic 
currents in cerebellar neurons. J Neurosci 21: 3009-3016, 2001. 
White JA, Banks MI, Pearce RA, and Kopell NJ. Networks of interneurons with fast and 
slow γ-aminobutyric acid type A (GABAA) kinetics provide substrate for mixed γ-τ 
rhythm. Proc Natl Acad Sci U S A 97: 8128-8133, 2000. 
Wieland HA, Luddens H, and Seeburg PH. A single histidine in GABAA receptors is 
essential for benzodiazepine agonist binding. J Biol Chem 267: 1426-1429, 1992. 
Yee BK, Hauser J, Dolgov VV, Keist R, Mohler H, Rudolph U, and Feldon J. GABA 
receptors containing the α5 subunit mediate the trace effect in aversive and appetitive 
conditioning and extinction of conditioned fear. Eur J Neurosci 20: 1928-1936, 2004. 
 2. Interneurons in the hippocampal CA1 area exhibit region-specific 
tonic inhibition mostly mediated by α1-GABAA receptors  
Edith M. Schneider Gasser, Jean-Marc Fritschy & Kaspar Vogt 
 
Publication in preparation  
 
 
Abstract 
Using patch-clamp recordings of acute hippocampal slices, we show that, under intact 
GABA uptake, interneurons of the CA1 area differ markedly in the extent of their tonic 
inhibitory conductance. Tonic inhibition was consistently higher in stratum oriens than in 
stratum radiatum interneurons. In stratum lacunosum-moleculare, we identified a group of 
interneurons lacking tonic inhibition. As tonic conductance in hippocampal interneurons is 
diazepam-sensitive, we examined whether distinct GABAA receptor subtypes mediate 
these currents by using mice with a knock-in point mutation that renders individual 
GABAA receptor subtypes insensitive to this modulator. By comparing the effects of 
diazepam in interneurons from single, double and triple mutant mice, we could determine 
the contribution of α1, α2, α3 or α5-GABAA receptors to tonic inhibition. Triple-point 
mutated mice for the α1, α2 and α3 subunits, no increase in tonic inhibition after the 
application of diazepam occurred, whereas in double-mutant mice for the α2 and α3 
subunits, tonic inhibition increased after diazepam application in 80% of stratum oriens 
and 70% of stratum radiatum interneurons. In α1 point-mutated mice, only 20% of the 
stratum oriens and 30% of the stratum radiatum interneurons exhibited increased tonic 
inhibition after diazepam application. Our results show that in the CA1 area of the 
hippocampus, tonic inhibition is mostly mediated by α1-GABAA receptors and in a subset 
of interneurons by α2-GABAA receptors. The higher amount of tonic inhibition in stratum 
oriens compared to stratum radiatum suggests regional differences in extracellular GABA 
concentration. 
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Introduction 
GABAA receptors can be activated via a brief (phasic) exposure of postsynaptic receptors 
to a high concentration of GABA released from presynaptic vesicles, or by a continuous 
(tonic) exposure to ambient GABA binding to extrasynaptic receptors (Brickley et al., 
1996; Nusser and Mody, 2002; Semyanov et al., 2004; Farrant and Nusser, 2005). Tonic 
activation of receptors depends on the ambient concentration of GABA in the extracellular 
space, which is controlled by a balance between GABA release and uptake. Tonic 
GABAA-mediated inhibition regulates neuronal input resistance and, hence, excitability 
(Brickley et al., 2001; Semyanov et al., 2003), resulting in a decrease in the probability that 
a neuron reaches its threshold for firing an action potential.  
Separate populations of GABAA receptors mediate the two forms of inhibitory 
conductance with different molecular assemblies and different affinities for GABA (Stell 
and Mody, 2002). GABAA receptors mediating phasic currents are typically composed of 
2α/2β/γ subunits (Tretter et al., 1997; Barnard et al., 1998; Sieghart and Sperk, 2002). The 
γ2 subunit confers diazepam sensitivity to the receptors if expressed together with either 
α1, α2, α3 or α5 subunits (Mohler et al., 2002; Mohler, 2006), and is necessary for their 
aggregation at postsynaptic sites (Essrich et al., 1998; Nusser et al., 1998; Fritschy and 
Brunig, 2003). 
Receptors containing the α4 or α6 subunit are frequently associated with the δ subunit and 
constitute major subtypes underlying tonic inhibition in dentate gyrus, ventrobasal complex 
of the thalamus, and cerebellar granule cell layer (Brickley et al., 2001; Belelli et al., 2002; 
Nusser and Mody, 2002; Stell et al., 2003; Jia et al., 2005; Belelli et al., 2006). These 
receptors are diazepam-insensitive, with high affinity for GABA, high sensitivity to 
neurosteroids and slow rates of desensitization (Brickley et al., 1999; Yeung et al., 2003; 
Belelli et al., 2006; Chandra et al., 2006). They do not form postsynaptic aggregates and 
are mainly located extrasynaptically. Finally, there are various types of GABAA receptors 
that mediate either tonic or phasic inhibition, depending on their cellular and subcellular 
location. In the CA1 area of the hippocampus, for example, diazepam-sensitive receptors 
are responsible for tonic inhibition under elevated ambient GABA concentrations, whereas 
at low concentrations, diazepam-insensitive, δ subunit-containing receptors are 
predominantly active (Semyanov et al., 2003; Caraiscos et al., 2004b; Scimemi et al., 
2005). The former are GABAA receptors containing the α5 subunit that are localized in 
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pyramidal cells (Brunig et al., 2002; Crestani et al., 2002; Prenosil et al., 2006). In 
subiculum, expression of the α5 subunit is very low and tonic inhibition is likely mediated 
by α1-GABAA receptors (Prenosil et al., 2006). Hippocampal interneurons exhibit 
prominent tonic zolpidem-sensitive currents (Semyanov et al., 2003), but the GABAA 
receptor subtypes involved have not yet been identified. Therefore, the aim of the present 
study was to address this issue by analyzing the contribution to tonic inhibition of each α-
subunit variant forming diazepam-sensitive GABAA receptors in interneurons.  
Using in vitro patch-clamp electrophysiology, we recorded GABAA receptor-mediated 
currents in interneurons located in stratum oriens, radiatum and lacunosum-moleculare to 
determine whether tonic inhibition is layer- and/or cell type-specific. Interneurons were 
classified according to their spiking properties and were filled with biocytin for 
morphological characterization. The contribution of different diazepam-sensitive GABAA 
receptor subtypes to tonic inhibition was assessed using knock-in mice carrying an H101R 
point mutation in the α1, α2, α3 or α5 subunit that rendered the corresponding GABAA 
receptor insensitive to diazepam. The effect of diazepam on the holding current was 
compared between the different genotypes. 
 
Methods 
Mutant mice breeding 
Experiments were performed in 129/SvJ knock-in mice carrying diazepam-insensitive 
GABAA receptor subtypes obtained by a histidine-to-arginine point-mutation in the α1, α2, 
α3 or α5 subunit gene [α1(H101R), α2(H101R) and α3(H126R), α5(H105R)] (Benson et 
al., 1998; Rudolph et al., 1999; Low et al., 2000) introduced by homologous recombination 
in embryonic stem cells. Mice carrying a point mutation in two (α12, α23) and even three 
(α123) α-subunit variants were obtained by intercrossing single mutant mice (Prenosil et 
al., 2006). All experiments were approved by the cantonal Veterinary Office of Zurich and 
were performed in accordance with the European Community Council Directive 
(86/609/EEC). 
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Slice preparation 
Mice of both sexes (P18-24) were anaesthetized with inhaled isoflurane and decapitated. 
The brains were removed quickly and placed in ice-cold artificial cerebrospinal fluid 
(ACSF, composition in mM: NaCl 125, NaHCO3 26, NaH2PO4 1.25, KCl 2.5, MgCl2 1, 
CaCl2 2.5, glucose 11, oxygenated with 95% O2/5% CO2). The brain was affixed to a 
vibratome stage (Microm HM 650 V, Microm International AG, Volketswil, Switzerland) 
with cyanoacrylate and kept in the ice-cold ACSF for slicing. Parasagittal 400 μm thick 
hippocampal slices were prepared and incubated at 33°C for 20 min, prior to being stored 
at room temperature (25°C) in oxygenated ACSF.  
Electrophysiological recordings  
Slices were visualized with a CCD camera (PCO Vx45; Till Photonics, Germany) mounted 
on an upright microscope (BX51WI; Olympus, Switzerland), equipped with a long 
working-distance water-immersion objective (Xlumplan FI 20X, 0.95 numerical aperture), 
a fourfold magnification changer, Nomarski-type differential interference contrast and 
infrared illumination. Patch electrodes were pulled from borosilicate glass (GC150TC; 
Clark Instruments, UK) and had an open tip resistance of 3-4 MΩ when filled with the 
internal solution.  
Whole-cell voltage-clamp recordings in wildtype mice and different α-subunit mutants 
were made at room temperature (unless indicated) with a continuous perfusion (1 ml/min) 
of ACSF, at a holding potential of –60 mV with a high chloride-containing internal 
solution (composition in mM: CsCl 100, MgCl2 2, EGTA 1, MgATP 2, GTP 0.3, HEPES 
40, pH 7,2, 300 mOsm) or at –50 mV with a low chloride-containing internal solution 
(composition in mM: KGlu 130, EGTA 1, HEPES 10, MgATP 5, NaGTP 0.5, NaCl 5, pH 
7.3, 295 mOsm). Tonic inhibition was determined by the change in holding current after 
application of the GABAA receptor antagonist picrotoxin (2 or 100 μM, dissolved in 
DMSO). Bicuculline (10 μM) was also applied in some experiments to confirm GABAA 
receptor selectivity of the antagonists. Excitatory synaptic transmission was blocked with 2 
mM kynurenic acid, and GABAB receptors were blocked with the antagonist CGP 55845 
(1 μM, dissolved in DMSO). The sensitivity to diazepam (1 μM, dissolved in DMSO) was 
measured by applying the drug to the bath solution. In some experiments DMSO alone was 
applied to the bath solution to rule out any effect of the solvent on tonic inhibition. 
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Recorded interneurons were filled with biocytin 1% for later morphological identification. 
Recordings were made using a Multiclamp 700A patch-clamp amplifier (Axon 
Instruments, Inc., USA), low-pass filtered at 5 kHz, digitized at 20 kHz (PCI 6035; 
National Instruments, USA), stored and analyzed off-line using IGOR Pro software (Wave 
Metrics, Lake Oswego, USA). Access resistance was monitored throughout the 
experiments using a –5 mV voltage step every 10 seconds. The access was <20 MΩ, and 
results were discarded if they changed by more than 20% during the recording. The current 
decay after the voltage step was used to calculate the capacitance of the neurons.  
Data analysis 
Tonic current was analyzed with a custom-written macro running under IGOR Pro. Seal 
tests were deleted from the continuous recordings. Each 10-second baseline current period 
was represented as one point for all histogram plots. The average baseline holding current 
was calculated after intracellular chloride equilibration and 3-4 minutes after diazepam and 
picrotoxin application. The magnitude of the tonic current was obtained by subtracting the 
current recorded in the presence of picrotoxin or bicuculline from the baseline current. For 
each experiment, changes in holding current after drug application were statistically 
compared to baseline with paired Student’s t-test. Differences between genotypes were 
analyzed with one-way ANOVA and Bonferroni’s post-hoc multiple comparisons tests.  
Morphological characterization 
Patch pipettes were carefully removed from the recorded cells to avoid biocytin leakage 
and slices were fixed for 1 day in 4% paraformaldehyde dissolved in 0.1 M phosphate 
buffer (PB) (pH 7.3). Slices were then washed in 0.1 M PB and embedded overnight in 
30% sucrose solution diluted in 0.1 M PB for cryopreservation. Slices were then frozen at 
–40°C in dimethylbutane and stored at –20°C until revelation Biocytin-filled cells were 
visualized by incubating the sections in avidin-biotin-horseradish peroxidase (HRP) 
complex (ABC 1:100 in PB 0.1 M) (Vectastain Elite Kite, Vector Laboratories, 
Burlingame, CA, USA) for 3 hours. To reveal the HRP staining, the reaction product was 
processed with diaminobenzidine tetrahydrochloride (DAB; Sigma, St. Louis, MO, USA) 
as chromogen. Sections were then mounted onto gelatin-coated slides, air-dried, 
dehydrated in ethanol, cleared in xylene, and coverslipped with Eukitt (Erne Chemie, 
Dällikon, Switzerland). Cells were examined with a light microscope (Nikon E-400) 
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equipped with a camera lucida and drawings of labeled interneurons lacking tonic 
inhibition were made from serial sections using a 20× (N.A. 0.75) objective. 
Drugs 
Chemicals were purchased from Sigma/Fluka (Switzerland) or Tocris Inc. (ANAWA Inc, 
Switzerland). Diazepam was provided by Hoffmann-La Roche Ltd (Switzerland). We 
tested DMSO alone at the appropriate concentrations on IPSCs to rule out any direct 
effects when it was used as a solvent. 
 
Results 
Tonic GABAA receptor-mediated inhibition in mouse hippocampal CA1 stratum oriens and 
stratum radiatum interneurons  
We recorded spontaneous activity in whole-cell voltage-clamp mode from stratum oriens 
and stratum radiatum interneurons in wildtype mouse hippocampal slices. The internal 
solution contained a high cesium chloride concentration so that GABAA receptor-mediated 
currents were inward at –60 mV. GABAB receptors were blocked in all recordings. 
Application of 100 μM picrotoxin caused an outward drift in the holding current in all 
recorded interneurons from stratum oriens (e.g. Fig. 1A, n = 8) and stratum radiatum (e.g. 
Fig 1B, n = 10). eIPSCs and sIPSCs were completely abolished by picrotoxin as verified 
by extracellular stimulation (data not shown).  
The effect of picrotoxin on the holding current was significantly different between stratum 
oriens and stratum radiatum interneurons. After application of picrotoxin, a double drift in 
the holding current was observed in all recorded stratum oriens interneurons (n = 21) 
compared to the drift in stratum radiatum interneurons (n = 25) (Fig. 1, Table 1). 
Application of a low concentration of picrotoxin (2 μM), which is reported to preferentially 
block GABA-bound GABAA receptors rather than unbound ones (Newland and Cull-
Candy, 1992; Semyanov et al., 2003), produced a change in the holding current similar to 
that registered with high picrotoxin concentrations, but no significant reduction in the peak 
amplitude of the sIPSCs was observed (Prenosil et al., 2006). These results suggest the 
participation of GABAA receptors with different affinities for GABA in phasic and tonic 
forms of inhibition, as well as a higher affinity for GABA in tonically active GABAA 
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receptors. Because picrotoxin also antagonizes glycine receptors, we applied another 
GABAA receptor antagonist, bicuculline (10 μM). Bicuculline similarly abolished sIPSCs 
and reduced the holding current as picrotoxin in stratum radiatum interneurons (n = 4) but 
to a lesser extent in stratum oriens interneurons (n = 5), indicating either a higher GABA 
concentration or the possible involvement of glycine-mediated tonic inhibition in the 
stratum oriens. Tonic inhibition was also present in interneurons recorded at physiological 
temperature (32°C), indicating that the results obtained at room temperature are not due to 
an impaired GABA uptake leading to more GABA accumulation. Application of the 
selective GABA uptake inhibitor NO711 (2 μM) at room temperature increased the amount 
of tonic current (Fig. 1D, n = 7), providing a second line of evidence for an unaltered 
uptake machinery. The total drift in holding current after application of different 
antagonists and the number of experiments per genotype are shown in Table 1.  
 
 
TABLE 1. Effects of GABAA receptor antagonists on holding current in CA1 
hippocampal interneurons 
 ΔI hold, pA (n) 
Interneurons in stratum oriens  
Picrotoxin 2 μM (25°C) 
Picrotoxin 100 μM (25°C) 
Picrotoxin 2 μM (32°C) 
Picrotoxin 100 μM (32°C) 
Bicuculline 10 μM (25°C) 
30 ± 11 (4) 
27 ± 5 (8) 
34 ± 14 (5) 
34 + 10 (4) 
18 + 6 (5) 
Interneurons in stratum radiatum 
Picrotoxin 2 μM (25°C) 
Picrotoxin 100 μM (25°C) 
Picrotoxin 2 μM (32°C) 
Picrotoxin 100 μM (32°C) 
Bicuculline 10 μM (25°C) 
12 ± 5 (5)* 
12 ± 4 (10)* 
22 ± 3 (5)* 
20 + 4 (5)* 
14 + 6 (4)* 
* Significant (P<0.05) difference between stratum oriens and stratum radiatum interneurons (Student’s t-test, 
see also graphs in figure 1). 
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Figure 1. Interneurons in stratum oriens and radiatum express a tonic GABAA receptor mediated 
conductance being significantly higher in stratum oriens interneurons. A, B: Representative traces from 
stratum oriens (A) and stratum radiatum (B) interneurons showing the change in holding current after 
application of 100 μM picrotoxin. White dashed lines show the change in the holding current. Picrotoxin (100 
μM) abolished spontaneous IPSCs. C: Absolute changes in holding current following application of the 
GABAA antagonist picrotoxin (PIC) in low or high concentrations (2 μM and 100 μM) and bicuculline (10 μM 
BIC). In stratum oriens interneurons bicuculline (10 μM) had a reduced effect compared to picrotoxin. D: 
Representative traces from stratum oriens interneuron showing the change in holding current after application 
of the GABA uptake blocker NO711 (2 μM). SO= stratum oriens, SR= stratum radiatum. Error bars (C) 
indicate standard deviation. *P < 0.05, Student's t-test. Numbers of experiments are shown in Table 1. 
 
 
Different amounts of tonic current in stratum oriens and stratum radiatum interneurons 
suggest regional differences in extracellular GABA concentration 
To determine the cause of the difference in tonic conductance between stratum oriens and 
stratum radiatum interneurons, we first determined whether interneurons in stratum oriens 
are larger than in stratum radiatum by measuring the capacitance of all recorded cells at 
room temperature. No correlation between capacitance and total leak current was observed 
in either layer (Fig. 2A). Moreover, although interneurons in stratum radiatum showed on 
average a significantly larger capacitance than interneurons in stratum oriens (Fig. 2B), 
their leak current was significantly smaller (Fig. 2C) and their input resistance slightly 
higher (Fig. 2D). As shown below, the characterization of the GABAA receptor subtypes 
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involved in tonic inhibition showed that α1-GABAA receptors are involved in most 
interneurons, thereby ruling out the possibility that the larger currents seen in stratum 
oriens are mediated by a different GABAA receptor subtype than in stratum radiatum. 
Therefore, extracellular GABA concentration may differ between the two layers in the 
CA1 area. The small leak current and large capacitance consistently recorded from 
different interneuron types in stratum radiatum further support the conclusion that the 
difference in tonic conductance results from a relatively low GABA content in this layer. 
 
 
 
Figure 2. Difference in leakage between stratum oriens and stratum radiatum interneurons is not 
correlated with the capacitance of the cells. A: Correlation plot between capacitance and leakage shows no 
correlation between these parameters. Note that even cells with big capacitance are less leaky in stratum 
radiatum than in stratum oriens. B: Bar graphs representing average values from capacitance. C: Bar graphs 
representing average values from leakage. D: Bar graphs representing average values from input resistance in 
stratum oriens (SO) and stratum radiatum (SR) interneurons. n = 11 for SO and n = 16 for SR. Error bars B 
and C indicate standard error. *P < 0.05, Student's t-test. 
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Interneurons in stratum oriens and stratum radiatum with diverse firing patterns exhibit 
diazepam-sensitive GABAA receptor mediated tonic inhibition  
Application of diazepam when recording from CA1 interneurons in wildtype mice 
increased the holding current in all interneurons from stratum oriens (n = 7) and stratum 
radiatum (n = 8) (Fig. 3A1-C1). This result confirms a previous report (Semyanov et al., 
2003) that tonic inhibition in interneurons from the CA1 area is mediated by zolpidem-
sensitive GABAA receptors in contrast to the diazepam-insensitive GABAA receptors seen 
in granule cells (Nusser et al., 1998). In order to classify the recorded interneurons, we 
determined their spiking patterns at the beginning of each experiment. Spike discharge was 
generated by 1-second 250 pA depolarizing pulses. Whole-cell current-clamp recordings 
with a low-chloride internal solution revealed three distinct patterns of inhibitory 
discharge: regular, irregular and clustered. Most interneurons in stratum oriens and stratum 
radiatum exhibited a regular firing pattern with weak accommodation (Fig. 3A and C, n = 
13). Irregular spiking patterns were registered only in one stratum oriens and one stratum 
radiatum interneuron (Fig. 3B). Among the regular-spiking interneurons, five in stratum 
oriens and two in stratum radiatum showed fast-frequency (40-60 Hz) spiking patterns 
(Fig. 3A), whereas five interneurons in stratum radiatum and one in stratum oriens showed 
a spiking-pattern frequency between 10 and 20 Hz (Fig. 3C). The higher tonic conductance 
registered in stratum oriens could also be due to the type of interneuron present. Fast-
frequency spiking interneurons are more common in stratum oriens and release more 
GABA, which could spill out of the synaptic cleft. 
When threshold current injection (10-40 pA according to cell type) was applied in the 
presence of 2 μM picrotoxin, there was a marked increase in the number of action 
potentials were evoked in the interneurons (data not shown), confirming that blockade of 
tonic inhibition enhances their excitability.  
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Figure 3. Spiking patterns from stratum oriens and stratum radiatum interneurons showing diazepam-
sensitive tonic inhibition. A-C: Current-clamp traces showing the different spike trains after a one second 
250 pA depolarizing current step. A: Fast spiking interneuron (30 – 60 Hz) (50%). B: Irregular spiking 
interneuron (10%). C: Regular spiking interneurons (10 - 20 Hz) with modest accommodation (40%). The 
percent values represent the frequency with which this sort of spiking pattern interneurons was registered. 
A1-C1: Change in holding current after the application of diazepam (outward drift) and picrotoxin (inward 
drift). Holding current values after picrotoxin application were aligned to 0 pA for easier comparison. All 
recorded interneurons had an increase in holding current after application of diazepam indicating the 
involvement of diazepam-sensitive GABAA receptors in tonic inhibition. 
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A subset of interneurons in stratum lacunosum-moleculare lack tonic inhibition 
A subgroup of interneurons (n = 6) with the soma located at the border between stratum 
radiatum and stratum lacunosum-moleculare showed no drift in holding current after the 
application of either picrotoxin or bicuculline. Diazepam application also did not increase 
the holding current in these cells (Fig. 4C). Camera lucida reconstruction of biocytin-filled 
cells showed that they possess a characteristically round and small soma and aspiny 
dendrites (Fig. 4A1) oriented along the border of stratum lacunosum-moleculare and 
stratum radiatum (Fig. 4A). All recorded cells lacking tonic inhibition had the same 
location and morphology. The spiking patterns of these interneurons varied, showing either 
fast spiking (40-70 Hz), slightly accommodating action potentials (Fig. 4B1, n = 3) or 
clustered firing patterns (Fig. 4B2, n = 3). Unfortunately, further immunocytochemical 
characterization of these cells was not possible. 
 
 
TABLE 2. Effect of 1 μM diazepam on holding current in different knock-in mice 
interneurons 
ΔI hold, pA (n) 
Mice type Interneurons in stratum oriens (SO) Interneurons in stratum radiatum (SR) 
Wild type 14 ± 4 (8) 10 ± 2 (10) 
α5 11 ± 4 (5) 8 ± 3 (6) 
α123 -3 + 4 (5)* 0 + 1 (6)* 
α12 0 ± 3 (4)* -2 ± 2 (7)* 
α1 -2 ± 2 (5)* 2 ± 3 (7)* 
α23 8 ± 4 (7) 4 ± 2 (11) 
*Significant (P<0.05) difference between WT and knock-in values (Student’s t-test, see also graphs in Figure 
5). 
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Figure 4. Spiking patterns of stratum lacunosum-moleculare interneurons not showing tonic inhibition. 
A: Camera lucida reconstruction of dendrites (thick line) and axonal (fine line) arborization of biocytin-filled 
CA1 interneuron with soma in the stratum lacunosum-moleculare. A1: Micrograph showing detail of 
dendrites and axonal (arrowhead) processed from the reconstructed cell. Axonal processed typically show 
varicosities. B: Current-clamp traces showing the spike trains after a one second 250 pA depolarizing current 
step. B1: Weak accommodating high frequency (40 - 70 Hz) spike train and B2: clustered spike trains are 
observed in these types of interneurons. C: Holding current shows no change after the application of 
diazepam and picrotoxin. SP = stratu pyramidale; SR = stratum radiatum; SLM = stratum lacunosum-
moleculare.  
 
Tonic inhibition in interneurons in stratum oriens and stratum radiatum is mostly mediated 
by α1 subunit-containing GABAA receptors  
The increase in holding current after application of diazepam implies that tonic inhibition 
in CA1 interneurons is mediated, at least in part, by receptors containing the γ2 subunit 
and/or lacking the α4 subunit. In pyramidal cells, α5-GABAA receptors mediate tonic 
Interneurons in the hippocampal CA1 area exhibit region-specific tonic inhibition mostly 
mediated by α1-GABAA receptors 
 
84 
inhibition (Caraiscos et al., 2004b; Prenosil et al., 2006) but in interneurons this subunit is 
normally absent (Brunig et al., 2002). We investigated the involvement of different 
diazepam-sensitive GABAA receptor subtypes that mediate tonic inhibition in interneurons 
by whole-cell voltage-clamp recordings from knock-in mice carrying diazepam-insensitive 
GABAA receptor subtypes. Figure 5 shows the drift in the holding current after the 
application of diazepam and picrotoxin in wildtype mice (Fig. 5A-B); α123-mice, in which 
only α5-GABAA receptors remain diazepam-sensitive (Fig. 5C-D); α1-mice, in which α5-, 
α3- and α2-GABAA receptors remain diazepam-sensitive (Fig. 5E-F) and α23-mice in 
which α1- and α5-GABAA receptors remain diazepam-sensitive (Fig. 5G-H). Recordings 
in α5- and α12- mice were also made (not shown). The average change in holding current 
after application of 1 μM diazepam to the various genotypes, and the number of recorded 
cells, is summarized in Table 2. In α123-mice, the effect of diazepam was completely 
abolished, confirming the absence of α5-GABAA receptors in interneurons (Fig. 5C-D). In 
α12-mice, only one cell out of twelve with the soma located close to the alveus showed a 
slight change in holding current after diazepam application, consistent with the presence of 
a specific population of interneurons carrying α3-GABAA receptors at this location and in 
the hilus (Brünig et al., 2002; Schneider Gasser et al., 2007). 
 
 
Figure 5. Holding current changes in stratum oriens and stratum radiatum interneurons from 
wildtype and different α-subunit knock-in mice after the application of diazepam and picrotoxin. Left 
graphs (A, C, E, G) represent examples of stratum oriens interneurons and right graphs (B, D, F, H) of 
stratum radiatum interneurons. A, B: Change in holding current in wildtype (WT) mice. C, D: Change in 
holding current in α1, α2 and α3 knock-in mice (α123) showing no activation of α5-containing receptors in 
tonic inhibition. E, F: Change in holding current in α1 knock-in mice (α1) showing no activation of α2, α3 
and α5-containing receptors in tonic inhibition. G, H: Change in holding current in α2 and α3 knock-in mice 
(α23) showing the involvement of α1-GABAA receptors in tonic inhibition. I: Percentage of interneurons in 
stratum oriens (SO) and radiatum (SR) showing increase in holding current after the application of diazepam 
in α12, α23 and α1 knock-in mice. Error bars represent S.E. J: Summary data plotted from average values of 
each recorded genotype showing the increase in holding current after application of diazepam. α5 = α5 
knock-in mice and α12 = α1 and α2 knock-in mice. See also table 2. Error bars represent SD. 
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 In α1-mice, only 20% of interneurons in stratum oriens and 30% in stratum radiatum were 
sensitive to diazepam (Fig. 5E-F), suggesting that α2-GABAA receptors contribute to tonic 
inhibition in a subgroup of interneurons. In contrast, in α23-mice, diazepam increased 
holding currents in 80% of stratum oriens and 70% of stratum radiatum interneurons, 
confirming the predominant role of α1-GABAA receptors in tonic inhibition in CA1 
interneurons. 
 
 
Discussion 
Our study reveals layer-specific differences in the amplitude of tonic inhibition mediated 
by CA1 interneurons. In most cells, these currents are carried by α1-GABAA receptors, 
although a contribution of α2- and α3-GABAA receptors was also found in a minority of 
interneurons. A specific cell type identified in stratum lacunosum-moleculare was devoid 
of tonic inhibition. Altogether, these findings suggest that the density of extrasynaptic 
GABAA receptors and/or extracellular GABA concentrations may differ according to strata 
and cell type to control neuronal and network excitability. 
The present data show that tonic GABAA receptor-mediated inhibition is present in CA1 
interneurons from mice recorded in acute slices in the absence of GABA uptake inhibitors.  
The amplitude of tonic inhibition was similar at room and at physiological temperature, 
indicating that the uptake machinery is functional under both conditions. Application of the 
selective GABA-uptake inhibitor NO711 at room temperature increased the amount of 
tonic current, suggesting that the measured tonic current does not result from an altered 
GABA uptake. Unexpectedly, we observed that tonic conductance is mostly a function of 
the laminar position of the interneurons, rather than the physiological properties used here 
to define separate cell types. Interneurons in stratum oriens have a significantly and 
consistently larger tonic conductance than interneurons in stratum radiatum/lacunosum-
moleculare independent of the type of GABAA receptor involved in mediating the tonic 
conductance. 
 
Differences in extracellular GABA content according to strata may exist in the CA1 area. 
Engel et al. (1998) reported a laminar difference in GABA uptake and GABA transporter 
(GAT-1) expression in the rat CA1 area, and interneurons in stratum oriens were shown to 
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express less GAT-1 than interneurons in stratum radiatum/lacunosum-moleculare, so the 
regulation of GABA uptake seems to differ between layers, and most probably the lower 
expression of GAT-1 indicates a higher accumulation of extracellular GABA and therefore 
a higher tonic conductance. These results are also supported by the fact that tiagabine, a 
GABA-uptake blocker specific for the neuronal transporter GAT-1 (Borden et al., 1994), 
caused a marked prolongation of IPSCs that was significantly larger in stratum radiatum 
than in stratum oriens (Engel et al., 1998). Transporters can also undergo rapid 
redistribution between surface and intracellular compartments, and their function can be 
altered by phosphorylation (Quick et al., 2004) or intermolecular interactions (Hansra et 
al., 2004). So even when GABA release is unchanged, ambient GABA concentration, and 
thereby tonic inhibition, can be modulated by changes in uptake. Local GABA 
concentrations cannot be estimated, since they are also dependent on local differences in 
GABA release.  
The firing patterns of hippocampal interneurons did not show a correlation with the amount 
of tonic conductance. Cells with the same spiking pattern in stratum oriens and stratum 
radiatum exhibited different amounts of tonic inhibition according to their location, 
whereas cells with different spiking patterns in the same layer had similar tonic activation. 
Therefore, the difference in tonic inhibition depends primarily on the location rather than 
on the subtype of interneuron. In stratum lacunosum-moleculare some cells exhibit tonic 
inhibition of the same amplitude as in stratum radiatum, which might reflect a lower 
extracellular GABA concentration compared to stratum oriens. Remarkably, a specific 
group of cells located along the border of the stratum radiatum and stratum lacunosum-
moleculare with two types of spiking patterns and a similar dendritic morphology, lack 
tonic inhibition. The stratum lacunosum-moleculare is the main site of termination of 
axons from layer III of the entorhinal cortex. These axons form a direct excitatory pathway 
onto CA1 pyramidal cells (Gloveli et al., 1997), but also produce inhibition of pyramidal 
cells through activation of feedforward GABAergic interneurons whose dendrites are 
located in the stratum lacunosum-moleculare (Remondes and Schuman, 2002). It is quite 
possible that the interneurons involved in feedforward inhibition of CA1 pyramidal 
neurons are those described here as being devoid of tonic inhibition.  
Low and high picrotoxin concentrations were shown to have the same effect on holding 
currents in our recordings, whereas sIPSCs were only abolished with high concentrations. 
The difference in blockade of tonic and phasic receptors by low picrotoxin concentration 
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does not imply differences in affinity of the receptors for picrotoxin, but implies a 
difference in affinity of the receptors for GABA, and therefore a difference in their 
activation. Thus, extrasynaptic GABAA receptors, which have a higher affinity for GABA, 
are blocked early, and by a low dose of picrotoxin (Prenosil et al., 2006). Bicuculline 
abolished sIPSCs in a similar way to picrotoxin but had a smaller effect on tonic inhibition 
in stratum oriens interneurons. The proportion of tonic current not blocked by bicuculline 
could be attributed to the fact that, as a competitive antagonist, it may be displaced from 
high GABA-affinity receptors when GABA concentrations rise. Other possible causes 
could be the presence of bicuculline-insensitive GABAC receptors, which are mostly 
extrasynaptically located and activated by spillover of synaptically released GABA 
(Alakuijala et al., 2006), or the presence of glycinergic tonic inhibition. 
Differences in subunit composition between synaptic and extra- or perisynaptic receptors 
are reflected in the differential modulation of phasic and tonic inhibition by benzodiazepine 
site ligands. In dentate gyrus, tonic conductance is mediated by diazepam-insensitive α4βδ 
receptors (Nusser and Mody, 2002) and in cerebellar granule cells by diazepam-insensitive 
α6βδ receptors (Hamann et al., 2002), whereas in hippocampal pyramidal cells, tonic 
activation is mediated by α5β3γ2 receptors (Caraiscos et al., 2004a; Prenosil et al., 2006). In 
contrast, we show here that the tonic conductance in CA1 interneurons is mediated mainly 
by α1-GABAA receptors. It should be noted that enhanced tonic conductance in the 
presence of a positive allosteric modulator is not as straightforward to interpret as the lack 
of an effect, because any drug-induced increase in receptor affinity might recruit additional 
receptor populations (including synaptic receptors) that are not ordinarily activated by the 
low ambient GABA concentration. 
Our study reveals layer-specific differences in the amplitude of tonic inhibition mediated 
by CA1 interneurons. In most cells, these currents are carried by α1-GABAA receptors, 
although a contribution of α2- and α3-GABAA receptors was also found in a minority of 
interneurons. A specific cell type identified in stratum lacunosum-moleculare was devoid 
of tonic inhibition. Altogether, these findings suggest that the density of extrasynaptic 
GABAA receptors and/or extracellular GABA concentrations may differ according to strata 
and cell type to control neuronal and network excitability.  
 
Results
 
89 
References 
Alakuijala A, Alakuijala J, Pasternack M (2006) Evidence for a functional role of GABA 
receptors in the rat mature hippocampus. Eur J Neurosci 23:514-520. 
Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, 
Bateson AN, Langer SZ (1998) International Union of Pharmacology. XV. Subtypes of 
GABAA receptors: classification on the basis of subunit structure and receptor function. 
Pharmacol Rev 50:291-313. 
Belelli D, Casula A, Ling A, Lambert JJ (2002) The influence of subunit composition on 
the interaction of neurosteroids with GABAA receptors. Neuropharmacology 43:651-
661. 
Belelli D, Herd MB, Mitchell EA, Peden DR, Vardy AW, Gentet L, Lambert JJ (2006) 
Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and 
physiological relevance. Neuroscience 138:821-829. 
Benson JA, Low K, Keist R, Mohler H, Rudolph U (1998) Pharmacology of recombinant 
GABAA receptors rendered diazepam-insensitive by point-mutated α-subunits. FEBS 
Lett 431:400-404. 
Borden LA, Murali Dhar TG, Smith KE, Weinshank RL, Branchek TA, Gluchowski C 
(1994) Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned 
GABA transporter GAT-1. Eur J Pharmacol 269:219-224. 
Brickley SG, Cull-Candy SG, Farrant M (1996) Development of a tonic form of synaptic 
inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA 
receptors. J Physiol 497 ( Pt 3):753-759. 
Brickley SG, Cull-Candy SG, Farrant M (1999) Single-channel properties of synaptic and 
extrasynaptic GABAA receptors suggest differential targeting of receptor subtypes. J 
Neurosci 19:2960-2973. 
Brickley SG, Revilla V, Cull-Candy SG, Wisden W, Farrant M (2001) Adaptive regulation 
of neuronal excitability by a voltage-independent potassium conductance. Nature 
409:88-92. 
Brunig I, Scotti E, Sidler C, Fritschy JM (2002) Intact sorting, targeting, and clustering of 
GABAA receptor subtypes in hippocampal neurons in vitro. J Comp Neurol 443:43-55. 
Caraiscos VB, Newell JG, You-Ten KE, Elliott EM, Rosahl TW, Wafford KA, MacDonald 
JF, Orser BA (2004a) Selective enhancement of tonic GABAergic inhibition in murine 
Interneurons in the hippocampal CA1 area exhibit region-specific tonic inhibition mostly 
mediated by α1-GABAA receptors 
 
90 
hippocampal neurons by low concentrations of the volatile anesthetic isoflurane. J 
Neurosci 24:8454-8458. 
Caraiscos VB, Elliott EM, You-Ten KE, Cheng VY, Belelli D, Newell JG, Jackson MF, 
Lambert JJ, Rosahl TW, Wafford KA, MacDonald JF, Orser BA (2004b) Tonic 
inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by α5 subunit-
containing GABAA receptors. Proc Natl Acad Sci U S A 101:3662-3667. 
Chandra D, Jia F, Liang J, Peng Z, Suryanarayanan A, Werner DF, Spigelman I, Houser 
CR, Olsen RW, Harrison NL, Homanics GE (2006) GABAA receptor α4 subunits 
mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of 
gaboxadol. Proc Natl Acad Sci U S A 103:15230-15235. 
Crestani F, Keist R, Fritschy JM, Benke D, Vogt K, Prut L, Bluthmann H, Mohler H, 
Rudolph U (2002) Trace fear conditioning involves hippocampal α5-GABAA receptors. 
Proc Natl Acad Sci U S A 99:8980-8985. 
Engel D, Schmitz D, Gloveli T, Frahm C, Heinemann U, Draguhn A (1998) Laminar 
difference in GABA uptake and GAT-1 expression in rat CA1. J Physiol 512 ( Pt 
3):643-649. 
Essrich C, Lorez M, Benson JA, Fritschy JM, Luscher B (1998) Postsynaptic clustering of 
major GABAA receptor subtypes requires the γ2 subunit and gephyrin. Nat Neurosci 
1:563-571. 
Farrant M, Nusser Z (2005) Variations on an inhibitory theme: phasic and tonic activation 
of GABAA receptors. Nat Rev Neurosci 6:215-229. 
Fritschy JM, Brunig I (2003) Formation and plasticity of GABAergic synapses: 
physiological mechanisms and pathophysiological implications. Pharmacol Ther 
98:299-323. 
Gloveli T, Schmitz D, Empson RM, Dugladze T, Heinemann U (1997) Morphological and 
electrophysiological characterization of layer III cells of the medial entorhinal cortex of 
the rat. Neuroscience 77:629-648. 
Hamann M, Rossi DJ, Attwell D (2002) Tonic and spillover inhibition of granule cells 
control information flow through cerebellar cortex. Neuron 33:625-633. 
Hansra N, Arya S, Quick MW (2004) Intracellular domains of a rat brain GABA transporter 
that govern transport. J Neurosci 24:4082-4087. 
Results
 
91 
Jia F, Pignataro L, Schofield CM, Yue M, Harrison NL, Goldstein PA (2005) An 
extrasynaptic GABAA receptor mediates tonic inhibition in thalamic VB neurons. J 
Neurophysiol 94:4491-4501. 
Low K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, 
Bluethmann H, Mohler H, Rudolph U (2000) Molecular and neuronal substrate for the 
selective attenuation of anxiety. Science 290:131-134. 
Mohler H (2006) GABAA receptor diversity and pharmacology. Cell Tissue Res 326:505-
516. 
Mohler H, Fritschy JM, Rudolph U (2002) A new benzodiazepine pharmacology. J 
Pharmacol Exp Ther 300:2-8. 
Newland CF, Cull-Candy SG (1992) On the mechanism of action of picrotoxin on GABA 
receptor channels in dissociated sympathetic neurones of the rat. J Physiol 447:191-
213. 
Nusser Z, Mody I (2002) Selective modulation of tonic and phasic inhibitions in dentate 
gyrus granule cells. J Neurophysiol 87:2624-2628. 
Nusser Z, Sieghart W, Somogyi P (1998) Segregation of different GABAA receptors to 
synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci 18:1693-
1703. 
Prenosil GA, Schneider Gasser EM, Rudolph U, Keist R, Fritschy JM, Vogt KE (2006) 
Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in 
hippocampal pyramidal neurons. J Neurophysiol 96:846-857. 
Quick MW, Hu J, Wang D, Zhang HY (2004) Regulation of a GABA transporter by 
reciprocal tyrosine and serine phosphorylation. J Biol Chem 279:15961-15967. 
Remondes M, Schuman EM (2002) Direct cortical input modulates plasticity and spiking in 
CA1 pyramidal neurons. Nature 416:736-740. 
Rudolph U, Crestani F, Benke D, Brunig I, Benson JA, Fritschy JM, Martin JR, 
Bluethmann H, Mohler H (1999) Benzodiazepine actions mediated by specific GABAA 
receptor subtypes. Nature 401:796-800. 
Scimemi A, Semyanov A, Sperk G, Kullmann DM, Walker MC (2005) Multiple and plastic 
receptors mediate tonic GABAA receptor currents in the hippocampus. J Neurosci 
25:10016-10024. 
Semyanov A, Walker MC, Kullmann DM (2003) GABA uptake regulates cortical 
excitability via cell type-specific tonic inhibition. Nat Neurosci 6:484-490. 
Interneurons in the hippocampal CA1 area exhibit region-specific tonic inhibition mostly 
mediated by α1-GABAA receptors 
 
92 
Semyanov A, Walker MC, Kullmann DM, Silver RA (2004) Tonically active GABAA 
receptors: modulating gain and maintaining the tone. Trends Neurosci 27:262-269. 
Sieghart W, Sperk G (2002) Subunit composition, distribution and function of GABAA 
receptor subtypes. Curr Top Med Chem 2:795-816. 
Stell BM, Mody I (2002) Receptors with different affinities mediate phasic and tonic 
GABAA conductances in hippocampal neurons. J Neurosci 22:RC223. 
Stell BM, Brickley SG, Tang CY, Farrant M, Mody I (2003) Neuroactive steroids reduce 
neuronal excitability by selectively enhancing tonic inhibition mediated by δ subunit-
containing GABAA receptors. Proc Natl Acad Sci U S A 100:14439-14444. 
Tretter V, Ehya N, Fuchs K, Sieghart W (1997) Stoichiometry and assembly of a 
recombinant GABAA receptor subtype. J Neurosci 17:2728-2737. 
Yeung JY, Canning KJ, Zhu G, Pennefather P, MacDonald JF, Orser BA (2003) Tonically 
activated GABAA receptors in hippocampal neurons are high-affinity, low-conductance 
sensors for extracellular GABA. Mol Pharmacol 63:2-8. 
 
 3. Immunofluorescence in brain sections: simultaneous detection of 
presynaptic and postsynaptic proteins in identified neurons  
Edith M. Schneider Gasser1, Carolin J. Straub1, Patrizia Panzanelli2, Oliver 
Weinmann3, Marco Sassoè-Pognetto2,4, Jean-Marc Fritschy 
1 Equal contribution 
 
2Department of Anatomy, Pharmacology, and Forensic Medicine, University of Turin, Corso Massimo 
d’Azeglio 52, I – 10126 Torino, Italy 
3 Brain Research Institute, University of Zurich, Winterthurerstrasse 190, CH – 8057 Zurich, Switzerland  
4 Rita Levi Montalcini Center for Brain Repair, University of Turin, Italy 
 
Published in: Nature Protocols 1: 1887 - 1897, 2006 
 
 
Abstract 
Elucidating the molecular organization of synapses is essential for understanding brain 
function and plasticity. Immunofluorescence, combined with various fluorescent probes, is 
a sensitive and versatile method for morphological studies. However, analysis of synaptic 
proteins in situ is limited by epitope masking upon tissue fixation. Furthermore, 
postsynaptic proteins (ionotropic receptors, scaffolding proteins) often require weaker 
fixation for optimal detection than most cell type and presynaptic markers, thereby 
hindering simultaneous visualization of these molecules. Here, we present an alternative to 
perfusion-fixation overcoming these restrictions. Brief tissue fixation shortly after 
interruption of vital functions preserves both morphology and antigenicity. Using markers 
of inhibitory synapses in rodent brain, selective detection of GABAA receptors and the 
scaffolding protein gephyrin in relation to identified presynaptic terminals is feasible by 
confocal laser scanning microscopy in neurochemically defined neurons. The most 
sophisticated of these protocols can be combined with electrophysiology for correlative 
morphofunctional studies of synapses in CNS. Tissue preparation and immunofluorescence 
staining require 2-3 consecutive days for completion. 
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Introduction 
The function of synapses crucially depends on proper alignment of pre- and postsynaptic 
specializations and on targeting and anchoring of the neurotransmitter release machinery 
and postsynaptic density proteins to appropriate sites. Immunoelectron microscopy studies 
have demonstrated the existence of membrane microdomains, either pre- or 
postsynaptically, in which specific molecules are clustered with high density (e.g., 1-9; 
reviewed in 10). While allowing determination of the precise ultrastructural localization of 
antigen(s) of interest, immunoelectron microscopy typically is limited to a small sample 
and cannot readily be combined with complementary functional analyses in living tissue. 
Furthermore, some antigens are washed out during dehydration and become undetectable 
upon conventional tissue preparation for electron microscopy. Added sensitivity can be 
achieved by plunge freezing and low temperature Lowicryl embedding 11, 12 or freeze-
fracture replica labeling 13-16. However, these methods are not routinely established in most 
laboratories and are technically challenging.  
Although ultrastructural analysis is a prerequisite for studying the morphology of synapses, 
the resolution of epifluorescence, in particular when combined with confocal laser 
scanning microscopy, is sufficient for clearly distinguishing pre- and postsynaptic 
compartments in tissue sections 17, 18. Furthermore, a vast array of fluorescent probes can 
be investigated in combination with immunofluorescence. Therefore, this approach is in 
principle suitable to analyze the distribution of synaptic proteins in CNS tissue with the 
added advantages that several molecules can be co-visualized using multiple fluorescence 
labeling. 
Histology and immunohistochemistry, in particular, require appropriate fixation for the 
morphological preservation of the structures to be analyzed. Current chemical fixatives 
include aldehydes or organic solvents, such as methanol or acetone. Aldehyde fixation is a 
prerequisite for immunohistochemical detection of soluble proteins, including 
neurotransmitters, neuropeptides, calcium-binding proteins, and reporter proteins such as 
GFP, to avoid diffusion out of damaged cells during the staining procedure. However, loss 
of antigenicity and/or epitope masking due to tissue fixation is a major limitation of 
immunohistochemistry, notably for the detection of postsynaptic proteins 19-21. Aldehyde 
fixation may alter antigenic sites by cross-linking tissue proteins and appears to limit the 
penetration of antibodies into the postsynaptic density and into the synaptic cleft, a narrow 
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space separating the pre- and postsynaptic elements and filled with extracellular matrix 
molecules. Accordingly, classical fixation of brain tissue by intravascular perfusion with an 
aldehyde solution (or merely by immersion in the fixative) leads to a reduced detection of 
postsynaptic proteins. In contrast, immunohistochemical staining of vesicle-associated 
presynaptic proteins, such as vesicular transporters, usually requires excellent tissue 
preservation, hence a strong fixation, and therefore the simultaneous detection of pre- and 
postsynaptic markers by immunofluorescence is challenging 22. Accordingly, there are only 
a few studies in which satisfactory detection of cell type markers or neutrotransmitters was 
combined successfully with immunofluorescence of postsynaptic proteins. While it appears 
of prime importance to understand the chemical neuroanatomy of neurons and synapses, 
these technical limitations have greatly hampered progress in this field. 
A number of solutions have been proposed to resolve this issue, including various antigen-
retrieval procedures 19, digestion of the fixed tissue with proteolytic enzymes 23, 24, 
inhibition of proteolysis during fixation 22, and short-fixation techniques to achieve a 
compromise between labeling efficiency and morphological preservation 20. In our studies, 
we have focused on the latter approach, attempting to reconcile the opposite fixation 
requirements of pre- and postsynaptic proteins for optimal immunohistochemical detection. 
By rapidly freezing tissue prior to immersion-fixation or by briefly fixing tissue slices as 
soon as possible after interruption of vital functions, it is possible to avoid loss of soluble 
proteins by proteolysis or diffusion. Our experience is mainly derived from the study of 
inhibitory synapses. Such synapses are characterized by GABAA and/or glycine receptors, 
which are heterooligomeric ligand-gated channels assembled from a large family of 
subunits 25-28. These receptors are clustered at postsynaptic sites with gephyrin 29, a 
scaffolding molecule which is selectively located in all but a few types of inhibitory 
synapses 30, and therefore is a reliable marker of such synapses. Our specific aim is to 
correlate expression of specific neuronal markers in defined synaptic circuits with distinct 
GABAA (or glycine) receptor subtypes, distinguished by their subunit composition. 
Here, we describe a protocol allowing the detection of postsynaptic clusters of GABAA 
receptors and gephyrin by immunofluorescence. Three alternative methods of tissue 
preparation are presented (Fig. 1), in order to visualize these postsynaptic proteins together 
with markers of identified cell types or presynaptic terminals. These procedures use freshly 
resected brain tissue rather than perfusion-fixed tissue. They have been tested extensively 
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in mouse and rat brain tissue (see Table 2) but should be suitable for other small 
vertebrates with minimal adjustments. 
• Option 1A (Fig. 1) allows detection of GABAA receptors and gephyrin with the 
highest efficiency. Staining of presynaptic vesicles (e.g., vesicular transporters) and 
cytoplasmic proteins is rather poor; likewise, staining of juvenile tissue is limited 
due to a very weak fixation. However, this procedure is fast and allows cutting 
entire brain sections for rapid screening of regional distribution patterns.  
• Option 1B (Fig. 1) provides a good compromise between sensitivity and 
morphological preservation. In addition to GABAA receptor subunits and gephyrin, 
it also allows visualization of cytoplasmic cell markers in the soma and dendrites 
and of some presynaptic molecules, notably those associated with presynaptic 
vesicles. Detection of GFP transgenically expressed as reporter protein is poor. This 
protocol is best suited for brain regions that can readily be isolated (e.g., olfactory 
bulb) and that usually are not adequately preserved with option 1A (retina; juvenile 
tissue). 
• Option 1C (Fig. 1) provides, in addition to option 1B, a better preservation of cell 
morphology and detection of soluble cell markers, including GFP, 
neurotransmitters, calcium binding proteins, etc. Here, brain slices are prepared 
first using the same protocol as for electrophysiological recordings; therefore, both 
methods can be combined on the same animal (or even the same slices). Another 
advantage of option 1C is that selected slices can be processed further for electron 
microscopy. It is the most time-consuming of the three options and does not allow 
parallel processing of multiple animals.  
As a word of caution, it should be emphasized that this protocol is not aimed at replacing 
perfusion-fixation, which is a convenient and reliable method for adequate tissue 
preservation and suitable for most Immunohistochemical applications. However, since 
epitope-masking of postsynaptic proteins often occurs in perfusion-fixed tissue, the 
protocols presented here provide a way to circumvent this limitation for studies of the 
subcellular distribution of synaptic proteins. Furthermore, by avoiding perfusion-fixation, 
this protocol can be combined with functional or biochemical analyses performed on the 
same animals. 
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Figure 1: A flow chart of the experimental procedure for the three options of tissue preparation. Each 
day is indicated by a distinct color, with overnight (O.N.) incubation being shown in black. 
 
 
 
Materials 
REAGENTS 
- Volatile anesthetic (e.g., isoflurane, Abbott; Methophan®, Janssen GmbH)  
! CAUTION Harmful if inhalated. Work in a ventilated hood. 
- Powdered dry ice. 
- NaOH (Fluka, Sigma) ! CAUTION Corrosive. Wear gloves and work in a 
ventilated hood. 
- Sodium phosphate buffer (Fluka, Sigma) 
- Phosphate buffered saline (Fluka, Sigma) 
- Salts for ACSF preparation (Fluka, Sigma) 
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- Sucrose (Fluka, Sigma) 
- Methanol puriss. (Fluka, Sigma) 
- Paraformaldehyde (EM grade, Nr. 19208; Electron Microscopy Sciences) 
 ! CAUTION Harmful if inhalated. To be used only in a ventilated hood 
- Embedding medium for frozen sectioning (e.g., M1 embedding matrix, #1310; 
Thermo Shandon, Pittsburgh, PA 15275) 
- Parafilm (Pechiney Plastic Packaging, Chicago, IL 60631) 
- Cyanoacrilate glue 
- Coated microscope slides (gelatin-coated or “Superfrost” slides) 
- Coverslips for microscopy (Karl Hecht Assistent Gmbh) 
- Mounting medium for fluorescent sections (Mowiol, Dako Fluorescent Mounting 
Medium) 
- Primary antibodies against cell markers (see Table 1) 
- Primary antibodies against presynaptic proteins (see Table 1) 
- Primary antibodies against GABAA receptor subunits (see Table 1) 
- Secondary antibodies coupled to distinct fluorochromes emitting around 500, 600, 
and 700 nm (Jackson Immunoresearch, Molecular Probes) 
- Normal serum of the host species of the secondary antibodies (Serotec) 
- Triton X-100 (Fluka) 
 
EQUIPMENT 
- Laser scanning confocal microscope 
- Cryostat 
- Gas tank (95% O2/5% CO2) (option C) 
- Vibratome (option C) 
- Water repellent slide marker (Pap-Pen or equivalent) 
 
REAGENT SETUP 
Fixative 
Dissolve paraformaldehyde in warm dH2O (up to 60ºC); add 2 drops NaOH 1 N /100 ml; 
make final dilution in 0.1 M sodium phosphate buffer (0.1%, 2%, or 4%), allow cooling at 
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room temperature, adjust the pH to 7.4 and filter. ▲CRITICAL Make up fresh on day of 
experiment; the solution can be aliquoted and frozen for future use.  
Artificial cerebrospinal fluid (ACSF) 10X 
This stock solution is made by diluting 125 mM (73.05 g/l) NaCl, 26 mM (21.84 g/l) 
NaHCO3, 1.25 mM (1.73 g/l NaH2PO4 monohydrate), 2.5 mM (3.72 g/l) KCl and 1 mM 
MgCl2 (corresponding to 2.04 ml from a 4.9 M stock solution) in dH2O. Store at 4°C up to 
several weeks. 
ACSF 1X  
To make one liter, dilute 100 ml of 10X ACSF in 900 ml dH2O and add 2 g glucose (11 
mM final concentration) and 6.6 ml CaCl2 (1 Osm Stock; final concentration 2.5 mM). The 
osmolarity should be around 320 mOsm, pH 7.4; adjust with glucose or dH2O as necessary. 
▲CRITICAL Make up fresh on day of experiment.  
Cryoprotectant 
Dissolve 30% sucrose (w/v) in 0.1 M sodium phosphate buffer, pH 7.4, and refrigerate to 
4ºC. ▲CRITICAL Make up fresh on day of experiment. 
Blocking solution 
Dilute 10% normal serum of the host species of the secondary antibodies (typically goat or 
donkey) and 0.2 % Triton X-100 in phosphate buffered saline (PBS). ▲CRITICAL Make 
up fresh on day of experiment.  
Primary antibodies  
This protocol requires primary antibodies raised in different species (e.g. mouse, rabbit, 
guinea pig) and secondary antibodies devoid of cross-reactivity and all raised in the same 
species. They are diluted at the appropriate concentration (to be determined by the end-
user) in phosphate buffered saline (PBS) that contains 10% normal serum of the species in 
which the secondary antibodies were raised and 0.2% Triton X-100. ▲CRITICAL Make 
up fresh on day of experiment. 
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Secondary antibodies 
Secondary antibodies coupled to a large variety of fluorochromes are available, which 
provide satisfactory quantum yield and limited bleaching. Carbocyanine dyes (Cy2, Cy3, 
Cy5) and Alexa fluorochromes (e.g. Alexa-Fluor 488, 543, etc) are largely comparable and 
suitable for these applications. For confocal laser scanning microscopy, typical 
fluorochromes have maximal excitation spectrum around 480, 540, and 630 nm. These 
emission spectra can be separated without any overlap using sequential detection of each 
fluorochrome with appropriate band pass filters. 
Dilute secondary antibodies at the appropriate concentration (to be determined by the end-
user) in PBS that contains 10% normal serum of the host species. ▲CRITICAL Make up 
fresh on day of experiment. 
 
Procedure 
Tissue preparation 
1. There are two basic preparation methods (Fig. 1). Use option A for preparing sections 
from fresh frozen brain, and options B and C for preparing sections from dissected tissue 
slabs and from living tissue slices, respectively.  
(A) Sections from fresh frozen brain 
(i)  Anesthetize a mouse with a volatile anesthetic and decapitate it with a sharp 
scissor. 
! CAUTION Cervical dislocation often damages caudal brain structures. 
(ii) Rapidly excise the brain and place it on a cold surface (Petri dish placed on ice). 
(iii) Dissect the region of interest with a scalpel, mount it on a piece of cork (2 x 2 x 0.2 
cm) using a drop of PBS, and freeze with powdered dry ice. 
(iv) After 3 min wrap the frozen block air-tight in aluminum foil and store it at −80ºC. 
! CAUTION The tissue should be used within a few weeks, due to dehydration in 
the freezer. 
(v) Set the temperature of the cryostat chamber to -20ºC and that of the knife to -22ºC. 
(vi)  Place the frozen tissue in the chamber of the cryostat and allow the temperature to 
equilibrate (for at least 30 min). 
(vii) Mount the cork on the specimen holder and orient for cutting. 
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(viii) Cut 12-16 μm-thick cryosections, mount them onto gelatin-coated slides (kept at 
room temperature) and allow to air dry for exactly 30 sec at room temperature. Use 
a slide marker to draw a hydrophobic ring around the sections and store at –20°C in 
the cryostat until cutting is completed.  
▲CRITICAL STEP Best results are obtained when the tissue can be further 
processed immediately after cutting; if necessary, sections can be stored up to a few 
days at –20°C. ? TROUBLESHOOTING: see Table 2. 
(ix) Fix samples using methods described in Box 1. 
(x)  After fixation and rising are complete, continue immediately with the 
immunofluorescence staining starting from Step 2. 
 
 
BOX 1. Fixation methods 
 
For fixation, there are three possible methods (option A1, A2, or A3). Option A1 provides the 
weakest fixation and should be used for antigens highly sensitive to fixation; Option A2 is well 
suited for most purposes; option A3 is optimal for tissue from young animals.  
 
A1 Microwave-assisted fixation with paraformaldehyde 
1. Place 3-4 slices in a Petri dish of 14cm diameter and add 50ml fixative (containing 0.1% 
paraformaldehyde) 
2. Irradiate for 30 sec in a microwave oven (600 – 900 W) 
3. Rinse and store the slides with PBS 
 
A2 Fixation with paraformaldehyde 
1. Dip the slides in fixative containing 2% paraformaldehyde (4 ºC) for 90 sec 
2. Rinse the slides with PBS and store in PBS 
 
A3 Brief fixation with methanol 
1. Dip the slides in cold methanol (-20ºC) for 30 sec 
2. Rinse the slides with PBS and store in PBS 
 
(B) Dissected tissue slabs 
● TIMING This procedure requires 2 consecutive days (Fig. 1). On day 1, preparation, 
fixation and cryoprotection of tissue slabs occurs; on day 2, sectioning occurs. 
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(i) Anesthetize a mouse with a volatile anesthetic and decapitate it with a sharp 
scissor. 
! CAUTION Cervical dislocation often damages caudal brain structures. 
(ii) Rapidly excise the brain and place it on a cold surface (a Petri dish placed on ice) 
(iii) Dissect the regions of interest, cut tissue slabs of 1-2 mm thickness with a sharp 
scalpel and rinse briefly in ice-cold PBS (alternatively, a tissue chopper can be 
used) 
▲CRITICAL STEP This procedure should be completed as fast as possible. 
(iv) Dip the tissue slabs in ice-cold fixative (2-4% paraformaldehyde; 5-10 ml per slab) 
and fix for 10-45 min; the fixation time depends on the type of tissue and primary 
antibodies used.  
(v) Rinse extensively (3 times 5 min, with agitation) with ice-cold PBS. 
(vi) Transfer to cryoprotectant (10 ml per slab) and store overnight at 4ºC. 
■ PAUSE POINT The tissue should not be stored in cryoprotectant longer than 
overnight. 
(vii) Section samples according to the method described in Box 2. 
■ PAUSE POINT Sections from option B can be stored for up to 2 weeks at -20 °C. 
(viii) Proceed to Step 2. 
 (C) Living tissue slices 
● TIMING This procedure requires 2 consecutive days (Fig. 1). On day 1, preparation of 
living tissue slices, fixation and cryoprotection occurs; on day 2, sectioning occurs. 
 (i) Pour about 100 ml ACSF in a glass beaker placed on ice and about 100 ml in 
another beaker placed in a water bath pre-warmed to 33°C; oxygenate both with 
95% O2/5% CO2. 
(ii)  Anesthetize a mouse with a volatile anesthetic and decapitate it with a sharp 
scissor. 
! CAUTION Cervical dislocation often damages caudal brain structures. 
(iii) Rapidly excise the brain and place it in ice-cold ACSF oxygenated with 95% 
O2/5% CO2 for 2 min. 
▲CRITICAL STEP Speed is crucial for optimal results; all instruments should be 
ice-cold. 
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(iv) Block the brain in desired orientation and mount on the vibratome stage with 
cyanoacrylate glue; keep submerged with ice-cold ACSF oxygenated with 95% 
O2/5% CO2 for slicing. 
(v)  Cut 300 μm-thick slices in the desired plane with the vibratome (at a high 
frequency and low speed) and let them recover for about 20 min in oxygenated 
ACSF at 33°C. 
▲CRITICAL STEP Living tissue should be used immediately after sectioning. 
(vi) Transfer the slices into fixative (3 ml per slice) and fix for 10-20 min (the duration 
depends on primary antibodies and region of interest). 
(vii) Rinse extensively (3 times for 20 min, with low agitation) in PBS. 
(viii) Transfer to cryoprotectant (3 ml per slice) and store overnight at 4°C 
■ PAUSE POINT The tissue should not be stored in cryoprotectant longer than 
overnight. 
 
BOX 2. Tissue slice sectioning 
1. Set the temperature of the cryostat chamber to –20°C and the knife temperature to −22°C 
2. Place a large drop of embedding medium onto a metal specimen holder 
3. Once the embedding medium is frozen, cut the surface to make it flat  
4. Wrap a glass slide with parafilm and place the slab on this surface after rinsing it shortly in ice-
cold  PBS 
5. Immediately transfer the slab onto the frozen embedding medium flat surface and let it freeze 
6. Cover with aluminum foil and allow temperature equilibration for at least 30 min 
7. Cut 12-16 μm-thick cryosections, mount them onto gelatin-coated slides (kept at room 
temperature) and allow to air dry for 30-60 sec at room temperature. Use a Pap-pen to draw a 
hydrophobic ring around the sections and store at –20°C in the cryostat until cutting is 
completed.  
 
▲CRITICAL STEP Even better results can be obtained with delicate tissue (e.g., retina, young 
animals) by mounting the sections on cold slides (kept inside the cryostat). In this case, the tissue 
should be equilibrated with cryoprotectant and mounting medium (1:1; 30 min) before freezing 
and should be covered with mounting medium before cutting. 
 
? TROUBLESHOOTING: see Table 2. 
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(ix) Section samples according to the method described in Box 2.  
▲CRITICAL STEP Sections from option C are best processed immediately for 
immunofluorescence staining. 
 (x) Proceed to step 2. 
 
Immunofluorescence staining: Incubation in primary antibodies 
2. Pipet 100-300 μl blocking solution on each slide and incubate for 60 min.  
  ! CAUTION The sections should never dry during the entire procedure. 
3. In the mean time, prepare primary antibody solutions (see Reagents setup) 
4. Discard the blocking solution and carefully dry the glass slides outside of the repellent 
ring. 
5. Pipet 100-300 μl primary antibody solution inside of the water repellent ring, making 
sure to cover all sections on the glass slide 
6. Place all slides into a humid chamber and incubate overnight at 4ºC with gentle 
agitation; shorter incubation at room temperature (e.g., 3 h) is also possible but the 
penetration of antibodies into the sections might be reduced. 
■ PAUSE POINT The incubation in primary antibodies should not last longer than 
overnight. 
 
Immunofluorescence staining: Incubation in secondary antibodies 
7. Rinse the slides with PBS (3 x 10 min with gentle agitation). 
8. In the mean time, prepare secondary antibody solutions (see Reagents setup). 
9. Carefully dry the glass slides outside of the repellent ring. 
10. Pipet 200 - 400 μl secondary antibody solution over the sections. 
11. Incubate for 60 min at room temperature. 
12. Rinse the slides with PBS (at least 3 x 10 min with agitation). 
13. Discard excess buffer (without drying the sections) and cover with appropriate 
mounting medium using coverslips calibrated for microscopy. 
 
■ PAUSE POINT The staining procedure is now complete. Store the slides at 4ºC, in the 
dark, for up to 2 weeks. Allow for the mounting medium to polymerize (overnight at 4ºC) 
before examination at the microscope. 
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TABLE 1. Comparing subcellular distribution patterns of selected presynaptic and 
postsynaptic proteins 
Target 
protein 
Antibody Perfusion-
fixed 
 
Option A: 
Fresh-frozen 
brain 
Option B: 
Dissected 
tissue slabs 
Option C: 
Living tissue 
slices 
 
GABAA 
receptor 
subunits 
 
 
Custom-made 
guinea pig sera 
against α1, α2, 
α3, α5, and γ2 
subunits31 
 
 
Uniform cell-
surface staining 
 
Clustered,  
postsynaptic 
staining 19
 
Clustered, 
postsynaptic 
staining 32, 36
 
Clustered, 
postsynaptic 
staining 
GABAB 
receptor 
B
subunits 
Rabbit anti-
GABABR1 
subunit 
(Chemicon 
International) 
 
Uniform cell-
surface staining 
Uniform cell 
surface staining 
Uniform cell-
surface staining 
Not tested 
NMDA 
receptor 
subunits 
Custom-made 
guinea pig 
antibodies NR2A 
and NR2B19; 
rabbit anti-
NMDAR1 
subunit 
(Chemicon 
Internacional) 
 
Intracellular 
staining, most 
prominent in 
soma 
Clustered, 
postsynaptic 
staining 19
Not tested Not tested 
AMPA 
receptor 
subunits 
Rabbit anti-
GluR1 and 
GluR2,3 
antibodies 
(Chemicon 
Internacional) 
 
Mainly 
intracellular 
staining 
Mainly 
intracellular 
staining 
(unpublished) 
Mainly 
intracellular 
staining 
(unpublished) 
Not tested 
Gephyrin Mouse 
monoclonal 
antibody 
(Synaptic 
Systems) 
Partially 
clustered at 
postsynaptic 
sites; high 
background in 
forebrain 
 
Clustered, 
postsynaptic 
staining 36
Clustered, 
postsynaptic 
staining 
Clustered, 
postsynaptic 
staining 
PSD-95 Mouse 
monoclonal 
antibody 
(Chemicon, 
Internacional) 
 
Diffuse 
intracellular 
staining 
Not tested Clustered, 
postsynaptic 
staining 
Not tested 
Bassoon Mouse 
monoclonal 
antibody (AMS 
Biotechnology) 
Punctate 
staining of 
synaptic 
terminals 
Non-specific 
staining 
Partial staining 
of synaptic 
terminals 
Not tested 
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Synapsin 1 Rabbit anti-
synapsin 1 
(Molecular 
Probes) 
Punctate 
staining of 
synaptic 
terminals 
 
Non-specific 
staining 
Partial staining 
of synaptic 
terminals 
Not tested 
Vesicular 
GABA 
transporter 
Rabbit anti-
vGAT (Synaptic 
Systems) 
Punctate 
staining of 
synaptic 
terminals 
 
Partial staining 
of synaptic 
terminals 
Partial staining 
of synaptic 
terminals 
Punctate 
staining of 
synaptic 
terminals 
Parvalbumin Mouse 
monoclonal 
antibody 
(SWant); 
Rabbit anti-
parvalbumin 
(Immunostar) 
Prominent 
intracellular 
staining of 
somata, 
dendrites and 
axons 
 
Detectable only 
in isolated 
neurons 
Labeling of 
somata and 
dendrites 
Prominent 
intracellular 
staining of 
somata, 
dendrites and 
axons 
Calbindin Mouse 
monoclonal 
antibody 
(SWant) 
Rabbit anti-
calbindin 
(Immunostar) 
Prominent 
intracellular 
staining of 
somata and 
dendrites 
Not detectable Labeling of 
somata and 
dendrites 
Prominent 
intracellular 
staining of 
somata, 
dendrites and 
axons 
 
Tyrosine 
hydroxylase 
Rabbit anti-
tyrosine 
hydroxylase 
(Chemicon 
International) 
Staining of 
somata, 
dendrites and 
axons 
Not detectable Labeling of 
somata and 
dendrites 
Prominent 
intracellular 
staining of 
somata, 
dendrites and 
axons 
 
Serotonin Rabbit anti-
serotonin 
(Immunostar) 
Staining of 
somata, 
dendrites and 
axons 
Not detectable Not tested Prominent 
intracellular 
staining of 
somata, 
dendrites and 
axons 
 
eGFP GAD67-eGFP 
transgene and 
GlyT2-eGFP 
transgene 
Staining of 
somata, 
dendrites and 
axons 
Not detectable Weak staining 
of somata and 
dendrites; 
moderate 
background 
Prominent 
intracellular 
staining of 
somata, 
dendrites and 
axons 
 
 
Microscopy and image analysis 
14. Evaluation of immunofluorescence staining patterns can be done by epifluorescence 
microscopy. Imaging of synaptic structures is best achieved by confocal laser scanning 
microscopy. There is no instrument-specific requirement for analyzing tissue sections 
prepared according to these three protocols. For dual and triple labeling experiment, the 
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microscope has to be equipped with the corresponding lasers and fluorescence filter sets. A 
high resolution objective (numerical aperture >1.3) is necessary for optimal resolution. 
Acquisition of multiple labeling has to be done sequentially with appropriate band pass 
filters to avoid cross talk between fluorochromes. Figures 2 and 3 were prepared using a 
confocal microscope LSM 510 Meta (Zeiss AG) and the image analysis software Imaris 
(Bitplane). Background was subtracted and a low pass filter (‘edge preserving’ filter) was 
applied. All images are shown by superposition of the different color channels using the 
maximal intensity projection mode (stack of 5-30 confocal images spaced by 0.25 – 0.5 
μm).  
? TROUBLESHOOTING: see Table 2. 
 
Timing 
Option A 
Tissue preparation (1A, i –iv), 10 min per mouse 
Sectioning (1A, v-viii), 60-90 min per brain 
Fixation (1A ix; Box 1, A1), 30 min for 20 slides 
Fixation (1A ix; Box 1, A2), 20 min for 20 slides 
Fixation (1A, ix; Box 1, A3), 20 min for 20 slides 
Option B 
Tissue preparation (1B, i-iii), 10 min per mouse 
Fixation and cryoprotection (1B, iv-vi), 30-60 min depending on the duration of fixation 
Sectioning (Box 2) 60-90 min per tissue slice 
Option C 
Tissue preparation (1C, i-v), 60-90 min per mouse 
Fixation and cryoprotection (1C, vi-viii), 90 - 120 min 
Sectioning (Box 2) 60-90 min per tissue slice 
Incubation in primary antibodies (i-v), 90 min and overnight incubation 
Incubation in secondary antibodies (vi-xii), 150 min 
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TABLE 2. Troubleshooting table 
Step Problem Possible solution 
A (viii) or 
Box 2 
 
The sections are wrinkled 
or rolled during cutting 
 
( i ) Perfectly align the glass plate with the knife 
(ii) Change the thickness of the section 
 
14 
 
The sections do not 
adhere to the slides 
( i ) The slide is too cold 
(ii) Embed tissue with mounting medium prior to cutting 
(iii) Store the sections overnight at -20ºC prior to staining 
(iv) Make sure that the gelatin coating of the slides is uniform 
(v) If possible, prepare larger tissue slabs or slices surrounding  
     the region of interest (large sections adhere better) 
 
14 The level of background 
fluorescence is too high 
 
( i ) The quality of frozen sections is suboptimal 
(ii) Make sure that the tissue remains humid during the entire 
     staining procedure 
(iii) The tissue might have been stored for too long in the freezer 
(iv) The fixative was not appropriate 
 
14 The distribution of 
presynaptic or 
postsynaptic markers is 
not clustered 
( i ) Shorten the duration of brain dissection 
(ii) Fixative has to be freshly prepared 
(iii) Avoid storing sections for longer than a few weeks at -20ºC 
(iv) Adjust the duration of fixation to the primary antibodies used 
(v) Reduce the concentration of primary antibodies 
(vi) Increase the number and duration of washing steps during the 
      immunostaining procedure 
 
 
 
? TROUBLESHOOTING  
General comments  
These procedures require a good practice in preparing cryostat sections and in performing 
and evaluating immunofluorescence experiments. The specificity of primary antibodies has 
to be well established; conventional immunohistochemical staining of perfusion-fixed 
tissue can be used for this purpose; option A is also well suited for a general screening. The 
use of mouse monoclonal antibodies on mice tissue sections may result in background 
from the secondary antibodies (e.g. non-specific labeling of cell nuclei or blood vessels). 
Cross-reactivity between secondary antibodies can be limited by using affinity-purified 
secondary antibodies when necessary. In mice, lipofucsin pigments, which are strongly 
Results
 
109 
fluorescent over a broad spectrum of excitation, are formed in neurons at a younger age 
than in rats and are potentially confounded with “clustered” immunolabeling; if possible, 
use animals younger than 12 weeks. Further troubleshooting advice can be found in 
Table 2. 
 
Anticipated results 
These protocols were developed for immunofluorescence in CNS tissue with four specific 
goals: (i) overcome the limited detection of postsynaptic proteins caused by tissue fixation 
while maintaining a good morphological preservation; (ii) distinguish pre- and 
postsynaptic compartments by apposition of immunofluorescent clusters of pre- and 
postsynaptic molecules; (iii) investigate the distribution of identified presynaptic terminals 
and postsynaptic markers in neurochemically defined neurons; (iv) combining high 
resolution immunofluorescence imaging with biochemical or functional analyses 
performed on the same animal or tissue slices. The procedures were optimized for 
inhibitory synapses, but previous results indicated that at least options A and B are also 
suitable for studying other neurotransmitter systems, including glutamatergic synapses 19 
(Table 1).  
It should be emphasized that epitopes differ widely in their sensitivity to fixation and that 
all proteins mentioned here are readily detected in perfusion-fixed tissue (Table 1). 
However, epitope-masking in specific subcellular compartments, notably in the 
postsynaptic density, can occur in perfusion-fixed tissue. This effect is illustrated in Fig. 
2a-b, which compares the subcellular distribution of the GABAA receptor α1 subunit in 
mitral cells of the olfactory bulb in perfusion-fixed tissue31 and in tissue processed 
according to option B. In both cases, a prominent immunofluorescence, reflecting the high 
density of this protein in mitral cells, is evident. However, the clustered distribution of α1-
GABAA receptors at postsynaptic sites is detectable only in weakly fixed tissue32,33. Such a 
dramatic difference is not predictable and does not occur for all postsynaptic membrane 
proteins. For instance, staining of receptors present at low density at synaptic sites, such as 
GABAB receptors, is not improved using option 1A compared to perfusion-fixed tissue 
(Table 1). These unpredictable effects of fixation strength on the apparent subcellular 
distribution of synaptic proteins make it difficult to ascertain that a given staining pattern 
corresponds to the native distribution of these proteins. Additional information, notably 
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ultrastructural evidence, should be used to evaluate staining results. For instance, the 
selective distribution of gephyrin in symmetric (i.e. inhibitory) synapses seen by electron 
microscopy 33-36 provides indirect evidence for the postsynaptic localization of proteins 
colocalized with gephyrin in immunofluorescence experiments.  
Each of the three options yields a distinctive immunofluorescence staining of GABAA 
receptor subunits and gephyrin in sections from rodent brain tissue, as illustrated in Fig. 
2b-g and Fig. 3a-e, g-i. Option A provides a highly sensitive detection of GABAA receptors 
and gephyrin and allows the investigation of multiple brain regions or animals in a single 
experiment, because of the relative ease and speed of tissue preparation (Fig. 1). The 
discrete nature of clusters makes them readily amenable for quantification in two- or three-
dimensional images. This protocol has been applied extensively to study GABAA and 
glycine receptors 32, 36-40, NMDA receptors 19, as well as postsynaptic proteins of the 
dystrophin glycoprotein complex 41, 42. Its value is limited for the detection of presynaptic 
markers 37, because the immunofluorescence signal is generally blurred or almost 
undetectable (Table 1). 
Option B provides a good signal-to-noise ratio for the detection of several postsynaptic 
proteins (Fig. 2f), although the optimal fixation time may vary for different antibodies to 
be used in multiple labeling experiments. This protocol also allows detection of cell 
markers and presynaptic molecules (e.g., synapsin 1, vGAT), as illustrated in Fig. 2g. 
However, this observation cannot be generalized and needs to be tested for different brain 
regions and markers (Table 1). Because tissue slices are fixed by immersion, there may be 
variability among different cryostat sections obtained from the same slice. However, in our 
common practice this has never been a major impediment. If required, the use of three 
dimensional reconstruction from stacks of confocal images provides unequivocal evidence 
for spatial apposition between GABAA receptor clusters and dendrites immunopositive for 
a neuronal markers such as calbindin (Fig. 2f), despite the limited resolution of confocal 
laser scanning microscopy along the z-axis.  
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Figure 2. Examples of double immunofluorescence staining of mouse and rat brain tissue with options 
A and B compared to perfusion-fixed tissue. Panels a and b show a comparison of GABAA receptor α1-
subunit immunofluorescence in mitral cells of the mouse olfactory bulb in perfusion-fixed tissue (a) and in 
tissue processed according to option B (b) (guinea pig antiserum against an N-terminal peptide31, diluted 
1:5000 and 1:40’000, respectively). The strong fixation that is produced with perfusion results in a uniform 
surface labeling of the soma and dendrites (many of them are transversally cut in panel a), without any 
evidence for postsynaptic aggregation. By contrast, staining of weakly fixed tissue results in a clustered 
pattern corresponding to postsynaptic aggregates. EPL, external plexiform layer; CGL, granule cell layer; 
ML, mitral cell layer. Panels c-e show double-labeling for gephyrin (geph; green, diluted 1:700) and the 
GABAA receptor α3-subunit (red; guinea pig antiserum against an N-terminal peptide31, diluted 1:3’000) in 
the CA1 region of the mouse hippocampus (stratum oriens), using option A. Panel c illustrates the clustered 
distribution of gephyrin, which is selectively localized in the postsynaptic density of GABAergic synapses. 
The α3 subunit is present in a subset of interneurons and is most concentrated in clusters on their soma and 
proximal dendrites (d). Superposition of both panels (e) demonstrates the postsynaptic localization of α3-
GABAA receptor clusters by their precise colocalization with gephyrin. Panel f shows the distribution of 
GABAA receptor α2-subunit clusters (red; affinity-purified guinea pig antiserum against an N-terminal 
peptide31, diluted 1:1000) on the dendrites of a calbindin- (CB)-positive periglomerular cell (blue; rabbit 
antibody, diluted 1:3’000) in the rat olfactory bulb (option B). The stack of confocal sections was projected in 
three orthogonal planes at the level of the lines. Note the reduced resolution along the z-axis, resulting in an 
ovoid cluster shape. Most α2-GABAA receptor clusters in this image are located on the labeled dendrites 
(arrowheads). Panel g shows the close apposition of vGAT-positive GABAergic terminals (green) with 
gephyrin clusters (red) in the molecular layer of the mouse cerebellum (option B); note that the two markers 
are not colocalized but closely apposed, reflecting the spatial separation of presynaptic and postsynaptic 
elements. Scale bars for all panels, 10 μm. 
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Option C provides an excellent preservation of soluble proteins, such as eGFP, 
neurotransmitters, and presynaptic markers, while retaining the strong and highly sensitive 
staining of postsynaptic proteins (Fig. 3; table 1). So, the distribution of synapses can be 
analyzed and quantified on identified neurons, as shown for interneurons expressing 
parvalbumin (Fig. 3a,h-i), serotonin (Fig. 3b), tyrosine hydroxylase (a marker of 
catecholaminergic neurons; Fig. 3c-e), GAD67-eGFP (a marker of GABAergic neurons; 
Fig. 3f), and GlyT2-eGFP (glycine transporter type 2, a marker of glycinergic neurons; Fig. 
3g, i). The preservation of small neurotransmitter molecules, such as serotonin, is excellent 
and comparable to that seen in perfusion-fixed tissue. In contrast, there is a reduction in the 
intensity of eGFP compared to perfusion-fixed tissue, but, as illustrated in Fig. 3f-i, the 
remaining signal is sufficient for unambiguous detection of axons and synaptic terminals.  
 
 
Figure 3. Examples of double and triple immunofluorescence staining of mouse brain tissue with 
option C. Panel a shows clusters of gephyrin (red; diluted 1:700) in relation to parvalbumin- (PV)-positive 
dendrites (green; mouse monoclonal, diluted 1:10’000) in the CA1 stratum radiatum. A projection in three 
orthogonal planes at the level of the thin lines is shown. Arrowheads point to gephyrin clusters on dendrites, 
representing presumptive GABAergic postsynaptic sites. Many gephyrin clusters are not associated with PV-
positive profiles (arrows). Panel b shows clusters of GABAA receptor α3-subunits (red; guinea pig antiserum 
against an N-terminal peptide31, diluted 1:3’000) in relation to a serotonin- (5HT)-positive neuron (green; 
rabbit antibody, diluted 1:5’000) in the nucleus raphe magnus; only few, small clusters are located on this cell 
(arrowhead), whereas larger clusters are found in the surrounding neuropil (arrows). Note that 5HT-positive 
axons (crossed arrows) are not associated with α3-GABAA receptors, as expected. The yellow color of the 
cell body results from intracellular staining of the α3 subunit. Panels c-e show GABAergic terminals, stained 
for vGAT (blue; rabbit affinity-purified antibody, Synaptic Systems, diluted 1:3’000) apposed to α3-GABAA 
receptor clusters (red) on tyrosine hydroxylase (TH)-positive cells (green; rabbit antibody, diluted 1:10’000) 
in the substantia nigra (arrowheads). The boxed area is enlarged in panel e to highlight the spatial separation 
between pre- and postsynaptic markers (arrows). Note the higher density of synapses on dendrites compared 
to the soma of dopaminergic cells. Expression of the α3 subunit by these dopaminergic neurons is also 
evident in the soma, which appears yellow in the overlay (panel d). Panel f shows the eGFP labeling of 
GABAergic interneurons and axons in the CA1 region of the hippocampus (under control of the GAD67 
promoter); note that eGFP is well preserved in fine structures (arrowheads), even without amplification by 
immunofluorescence. Panels g-i show heterogeneity of presynaptic input onto α3-GABAA receptors (red) in 
a neuron of the pontine reticular formation visualized by triple staining with GlyT2-eGFP (green) and PV. 
Panel g illustrates GlyT2-eGFP positive terminals, representing glycinergic synapses, terminating onto α3 
subunit clusters (arrows); panel h shows that the postsynaptic cell expresses PV and receives a prominent 
innervation from PV-positive terminals; panel i illustrates that individual α3 subunit clusters are either alone 
(star) or associated with single (arrows) or double-labeled (crossed arrows) terminals. Scale bars for all 
panels represent 10 μm. 
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The difference between a neurotransmitter and eGFP probably stems from the fact that the 
latter is present as a soluble protein in the cytoplasm, without any compartmentalization, 
for example in synaptic vesicles. eGFP-fusion proteins, or membrane-anchored eGFP-
reporter genes, would not be affected by rapid outward diffusion in weakly fixed tissue.  
The high signal-to-noise ratio obtained in tissue sections processed with option C allows a 
clear and unambiguous spatial separation of pre- and postsynaptic markers (Fig. 3e, i), as 
well as a distinction between different populations of presynaptic terminals innervating a 
particular cell compartment. In the example shown in Fig. 3g-i, at least four types of 
GABAergic synapses containing the α3 subunit can be distinguished based on markers of 
presynaptic terminals (GlyT2-eGFP, representing glycinergic terminals; parvalbumin; both 
markers together; no marker). The major limitations of option C are that only a few 
animals at a time can be processed and the results can be quite variable because they 
depend critically on the speed of the brain dissection and the quality of the cryostat 
sections. 
The use of confocal laser scanning microscopy provides spatial segmentation of images 
and three-dimensional reconstruction, facilitating the quantification of structures in space. 
Quantifying the number of presumptive presynaptic or postsynaptic sites of individual 
neurons identified by the expression of a selective marker is therefore feasible. 
Furthermore, slices prepared according to option C can be utilized first for 
electrophysiological analysis; using an intracellular dye to label the recorded neuron(s), 
correlative microscopy is then readily available. Likewise, correlative light and electron 
microscopy is possible using alternate slices for immunofluorescence and immunogold 
electron microscopy. Option C can therefore be expected to help overcome barriers among 
disciplines and provide detailed morphological parameters of functionally characterized 
neurons. 
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Abstract 
A majority of hippocampal interneurons strongly express GABAA receptors containing the 
α1 subunit, suggesting that inhibitory control of interneurons is important for proper 
function of hippocampal circuits. Here, we investigated with immunohistochemical and 
electrophysiological techniques how these GABAA receptors are replaced in mice carrying 
a targeted deletion of the α1 subunit gene (α10/0). Using markers of five major populations 
of CA1 interneurons (parvalbumin, calretinin, calbindin, neuropeptide Y and somatostatin), 
we show that these interneurons remain unaffected in α10/0 mice. In triple 
immunofluorescence staining experiments combining these markers with the GABAA 
receptor α1, α2 or α3 subunit and gephyrin, we demonstrate a strong increase in α3- and 
α2-GABAA receptors clustered at postsynaptic sites along with gephyrin in most CA1 
interneurons in α10/0 mice. The changes were cell type-specific and resulted in an increased 
number of GABAergic synapses on interneurons. These adjustments were mirrored 
functionally by retention of spontaneous IPSCs with prolonged decay kinetics, as shown by 
whole-cell patch clamp recordings of CA1 interneurons. However, a significant decrease in 
frequency and amplitude of miniature IPSCs was evident, suggesting reduced affinity of 
postsynaptic receptors and/or impaired vesicular GABA release. Finally, to assess whether 
these compensatory changes are sufficient to protect against a pathological challenge, we 
tested the susceptibility of α10/0 mice against kainic acid-induced excitotoxicity. No 
genotype difference was observed in the effects of kainic acid, indicating that the absence 
of a major GABAA receptor subtype is functionally compensated for in hippocampal 
interneurons by a reorganization of inhibitory circuits. 
 119
Reorganization of GABAergic circuits maintains GABAA receptor-mediated transmission 
onto CA1 interneurons in α1 subunit-null mice 
 
120 
Introduction 
GABAA receptors are ligand-gated chloride ion channels contributing to fast inhibitory 
transmission in the CNS. They form heteropentameric channels assembled from a large 
family of subunits encoded by distinct genes (α1-6, β1-3, γ1-3, δ, ε, θ, π) (Barnard, 2001; 
Sieghart & Ernst, 2005). Around 50% GABAA receptors in the brain contain the α1 
subunit, along with β2 and γ2 (Benke et al., 1994), and mediate the sedative, amnesic and 
anticonvulsant action of diazepam (Rudolph et al., 1999, 2001; McKernan et al., 2000; 
Mohler et al., 2002). α1-GABAA receptors have fast decay kinetics and their expression 
increases during postnatal development, rendering inhibitory synaptic transmission faster 
(Hutcheon et al., 2000; Vicini et al., 2001; Bosman et al., 2002).  
In the hippocampal formation, all α subunit variants except α6 are expressed (Persohn et 
al., 1992; Wisden et al., 1992), contributing to multiple GABAA receptor subtypes with 
specific cellular and subcellular distribution patterns (Fritschy & Mohler, 1995; Nusser et 
al., 1996; Brünig et al., 2002). α1-GABAA receptors are expressed in pyramidal cells, but 
are especially abundant in specific populations of interneurons, notably parvalbumin-
positive cells (Gao & Fritschy, 1994). These form a major population of fast-spiking 
interneurons and mainly comprise axo-axonic and a subset of basket cells (Bartos et al., 
2002; Klausberger et al., 2005; Baude et al., 2006). Other interneurons, notably those 
expressing calbindin, are apparently devoid of α1-GABAA receptors (Gao & Fritschy, 
1994), but the type of receptor they carry has not been identified. It is widely assumed that 
the α2, α4 and α5 subunit, which are abundant in pyramidal cells, are largely absent from 
hippocampal interneurons (Fritschy & Mohler, 1995; Pirker et al., 2000). Finally the α3 
subunit, which is expressed at low levels in the hippocampus (Prenosil et al., 2006), is 
selectively present in a subset of interneurons in CA1-CA3 stratum oriens and the hilus 
(Brünig et al., 2002), which innervate other hippocampal interneurons and project to the 
septum (Gulyas et al., 2003; Fritschy and Gulyas, unpublished observations). 
Deletion of the α1 subunit gene by homologous recombination results in a viable 
phenotype (Sur et al., 2001; Vicini et al., 2001), due in part to compensatory alterations in 
the GABAergic system (Kralic et al., 2002, 2006; Ogris et al., 2006). In particular, a 
pronounced upregulation of other GABAA receptor subtypes occurs in regions depleted of 
α1-GABAA receptors, without change in their regional or subcellular distribution (Kralic et 
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al., 2006). However, while synaptic inhibition is retained in neocortex, hippocampal 
formation, olfactory bulb and cerebellar granule cells of α10/0 mice, the kinetics of IPSCs 
are slower (Vicini et al., 2001; Goldstein et al., 2002; Barberis et al., 2005; Bosman et al., 
2005; Lagier et al., 2007), suggesting that such compensatory changes cannot fully restore 
the function of α1-GABAA receptors. Furthermore, a complete loss of GABAA-mediated 
transmission can occur in specific neurons of α10/0 mice, as shown for cerebellar Purkinje 
cells, for example (Kralic et al., 2005a; Fritschy et al., 2006). Therefore, rather than 
substitution of the α1 subunit by another isoform, structural reorganization of inhibitory 
networks contributes to retain synaptic inhibition in the brain of α10/0 mice. 
To better understand the nature of compensatory changes occurring in interneurons and 
their functional consequences in vivo, we investigated here by immunohistochemistry and 
whole-cell patch clamp recordings the properties of GABAA receptors expressed by 
hippocampal interneurons of α10/0 mice. We focused on major populations of CA1 
interneurons identified by expression of specific markers (parvalbumin (PV), calretinin 
(CR), calbindin (CB), neuropeptide Y (NPY) and somatostatin (SOM)) (Matyas et al., 
2004). First, we investigated whether the regional distribution of these interneurons and the 
expression of these markers are affected in mutant mice. Subsequently, changes in GABAA 
receptor subunit expression were examined at the subcellular level, using gephyrin as a 
marker of GABAergic postsynaptic sites (Sassoè-Pognetto & Fritschy, 2000; Lagier et al., 
2007). These results indicated a substitution of the α1 subunit by the α2 or the α3 subunit, 
as well as an increase in the number of postsynaptic sites, on most identified interneurons. 
To determine the functional correlate of these changes, spontaneous IPSCs (sIPSCs) and 
miniature IPSCs (mIPSCs) were recorded from interneurons in CA1 stratum oriens, along 
with tonic inhibition mediated by GABAA receptors. Unexpectedly, these results pointed to 
a decreased frequency and amplitude of mIPSCs, suggesting that the prominent 
morphological rearrangements seen by immunofluorescence do not fully restore 
GABAergic transmission on interneurons. Finally, to assess the strength of the 
compensatory changes occurring in the absence of α1-GABAA receptors against a 
pathological challenge, we tested the susceptibility of α10/0 mice against kainic acid-
induced seizures in a mouse model of temporal lobe epilepsy (Bouilleret et al., 1999). 
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Methods 
Animals 
Wildtype and homozygous GABAA receptor α1 subunit knock-out (α10/0) mice were 
generated on a mixed C57BL/6J-129Sv/SvJ background (see Vicini et al. (2001) for 
characterization). Wildtype and α10/0 mice used for experiments were obtained by 
intercrossing heterozygous mutants (α1+/0) or homozygous mice from first-generation 
heterozygous intercrosses. GAD67-GFP Δneo mice (Tamamaki et al., 2003) were provided 
by Y. Yanagawa (Gunma University Graduate School of Medicine) and maintained on a 
C57Bl6/J heterozygous background. Experiments were approved by the cantonal veterinary 
office of Zurich and performed in accordance with international guidelines on animal use 
and care (European Community Council Directive 86/609/EEC). All efforts were made to 
minimize animal suffering and the number of experimental animals used. 
Kainic acid injection 
Under isoflurane general anesthesia, wildtype and α10/0 mice (n=6 per genotype) received 
a unilateral stereotaxic injection of 50 nl of a 20 mM solution of kainic acid (Calbiochem; 
San Diego, CA) in saline (i.e., 1 nmol kainic acid) into the right CA1 area of the dorsal 
hippocampus [coordinates with bregma as reference: anteroposterior = -1.7, mediolateral = 
-1.6, dorsoventral = -1.9 mm] as described (Kralic et al., 2005b). The effects of kainic acid 
on the cytoarchitecture of the hippocampus and survival of interneurons were determined 
14 days after treatment using Nissl staining and immunohistochemistry. 
Immunohistochemistry 
Primary antibodies used in this study are listed in Table 1. All antibodies have been 
extensively characterized for their specificity in previous studies (references in Table 1), 
using Western blotting, immunoprecipitation, as well as immunohistochemical staining of 
mice with targeted gene deletions (GABA  receptor α1, α3, and α5 subunit), and 
comparison with published studies (for the GABA  receptor α4 subunit, gephyrin, 
calcium-binding proteins and neuropeptides). 
A
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Tissue preparation  
Perfusion-fixed tissue was prepared for immunoperoxidase and immunofluorescence 
staining in wildtype, GAD67-GFP, α1  mice, and kainic acid-treated mice to analyze the 
regional distribution of either GABA  receptor subunits 
0/0
A (α1, α2, α3, α4, α5) or 
interneuron markers (PV, CR, CB, NPY, SOM) (Matyas et al., 2004). Adult mice were 
deeply anesthetized with Nembutal (50 mg/kg, i.p.) and perfused through the ascending 
aorta with 4% paraformaldehyde in 0.15 M phosphate buffer (pH 7.4) containing 15% of a 
saturated picric acid solution. Brains were postfixed for 3 hours, cryoprotected in sucrose, 
frozen, and cut transversally at 40 μm with a sliding microtome. Sections were collected in 
PBS and stored in an antifreeze solution (15% glucose and 30% ethylene glycol in 50 mM 
phosphate buffer, pH 7.4) prior to use. 
The subcellular distribution of the α1, α2 and α3 subunits in CA1 interneurons from 
wildtype and α10/0 mice was investigated by triple immunofluorescence staining in 
combination with gephyrin and a neurochemical marker. Optimal detection of 
neuropeptides and calcium-binding proteins usually is achieved in perfusion fixed tissue, 
whereas gephyrin and GABAA receptors are best detected in weakly fixed tissue (Fritschy 
et al., 1998). For combined labeling, a novel protocol was developed (see Schneider Gasser 
et al. (2006) for details), which ensures preservation of soluble cytoplasmic proteins in 
weakly fixed tissue. In brief, brain slices were prepared as described below for 
electrophysiology. They were fixed by immersion for 10 min in 4% paraformaldehyde in 
0.15 M phosphate buffer, washed with PBS, cryoprotected overnight in 30% sucrose in 
PBS and frozen on a flat surface in the cryostat. Parasagittal sections were cut at a 
thickness of 16 μm, mounted onto gelatin-coated glass slides, air-dried at room 
temperature for 30 seconds, and stored at -20°C for at least one hour. 
Immunoperoxidase staining 
Free-floating sections were incubated overnight at 4°C with primary antibodies (Table 1) 
diluted in Tris buffer containing 2% normal goat serum and 0.2% Triton X-100. Sections 
were then washed and incubated for 30 minutes at room temperature in biotinylated 
secondary antibodies (1:300; Jackson Immunoresearch, West Grove, PA) diluted 1:300 in 
Tris buffer containing 2% normal goat serum. After three washes, sections were incubated 
in the ABC complex (1:100 in Tris buffer) for 20 minutes (Vectastain Elite Kit; Vector 
Reorganization of GABAergic circuits maintains GABAA receptor-mediated transmission 
onto CA1 interneurons in α1 subunit-null mice 
 
124 
Laboratories, Burlingame, CA), washed again and reacted with diaminobenzidine 
tetrahydrochloride (DAB; Sigma, St. Louis, MO) in Tris buffer (pH 7.7) containing 
0.015% hydrogen peroxide. The color reaction was stopped after 5-15 minutes with ice-
cold PBS. Sections were then mounted on gelatin-coated slides and air-dried. Finally, they 
were dehydrated with an ascending series of ethanol, cleared in xylene, and coverslipped 
with Eukitt (Erne Chemie, Dällikon, Switzerland). Sections from wildtype and mutant 
mice were processed in parallel under identical conditions to minimize variability in 
staining intensity.  
Immunofluorescence staining  
This technique was used to quantify interneuron markers in perfusion-fixed tissue and to 
analyze the subcellular distribution of GABAA receptor subunits and gephyrin in identified 
neurons. Sections were preincubated for one hour at room temperature in PBS containing 
10% normal donkey serum and 0.2% Triton X-100, followed by overnight incubation at 
4°C with one or a mixture of primary antibodies raised in different species (Table 1) 
diluted in the same solution. Sections were then washed extensively in PBS and incubated 
for 30 minutes at room temperature in corresponding affinity-purified donkey IgGs 
coupled to Cy3 (1:300), Cy2 (1:200) or Cy5 (1:200) (Jackson Immunoresearch). Sections 
were washed again, and coverslipped with aqueous mounting medium (Dako, Carpinteria, 
CA). 
Image analysis  
Sections processed for immunoperoxidase staining were analyzed with bright field 
microscopy (Axioskop; Zeiss, Jena, Germany). Differences in staining intensity and 
distribution were assessed visually in four animals per group. Digital photographs were 
taken with a high-resolution color camera (Axiocam; Zeiss). Identical acquisition 
parameters were used for wildtype and α10/0 mice. Minimal adjustments of contrast and 
brightness were made to entire images if necessary. Sections processed for 
immunofluorescence staining for quantification of interneurons were visualized by 
epifluorescence microscopy (Zeiss Imager equipped with an Apotome module). The 
number of interneurons immunoreactive for PV, CR, CB, SOM or NPY in wildtype and 
α10/0 mice was counted in the CA1 area bilaterally in four sections per mouse (n=3 per 
genotype). Using GAD67-GFP mice, the fraction of GAD67-positive interneurons in the 
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CA1 region that were double-labeled for the α1 subunit was assessed in a random sample 
of 100 interneurons from 3 sections per mouse (n = 3). 
Triple immunofluorescence staining of GABAA receptor subunits and gephyrin in 
identified interneurons was visualized by confocal laser scanning microscopy (LSM-510 
Meta; Zeiss) with a X100 Plan-Acromat objective (N.A. 1.4) and sequential acquisition of 
separate color channels. Image acquisition settings were adjusted to cover the entire 
dynamic range of the photomultipliers. The pinhole size was set to 1.0 Airy unit for each 
channel, and stacks of 10 consecutive sections (512 x 512) spaced by 0.3 μm were acquired 
at a magnification of 0.1 μm/pixel. For display, images were processed with the image-
analysis program Imaris (Bitplane, Zurich, Switzerland). Images from three channels were 
overlaid and background was subtracted. The density of gephyrin- and GABAA receptor α 
subunit clusters was quantified from reconstructed volumes from 10 confocal images using 
the module “surpass”. Individual clusters were identified as isolated objects by threshold 
segmentation and counted automatically. These data were averaged from ten images per 
animal (n = 3-6 mice per genotype). Statistical comparison was done using a non-
parametric test. 
 
Electrophysiology 
Slice preparation 
Mice from both sexes (P21-30) were anesthetized with isoflurane and decapitated. The 
brain was quickly removed and placed in ice-cold artificial cerebrospinal fluid (ACSF, 
composition in mM: 125 NaCl, 26 NaHCO3, 1.25 NaH2PO4, 2.5 KCl, 1 MgCl2, 2.5 CaCl2, 
11 glucose, oxygenated with 95% O2 - 5% CO2). The brain was affixed to a vibratome 
stage with cyanoacrylate and kept in the ice-cold ACSF for slicing. Parasagittal 300 to 350 
µm-thick slices containing the hippocampus were prepared and incubated at 33°C for 20 
min before being stored at room temperature (25°C) in oxygenated ACSF. 
Electrophysiological recordings and analysis 
Slices were transferred to a recording chamber and visualized with a CCD camera (PCO 
Vx45; Till Photonics, Munich, Germany) mounted on an upright microscope (BX51WI; 
Olympus, Tokyo, Japan), equipped with a long working distance water-immersion 
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objective (Xlumplan FI 20X, N.A. 0.95), a fourfold magnification changer, Nomarski-type 
differential interference contrast, and infrared illumination. Patch electrodes were pulled 
from borosilicate glass (GC150TC; Clark Instruments, Wilts, UK) and had an open tip 
resistance of 3–4 M  when filled with the internal solution. Kynurenic acid (2 mM) was 
added to the external ACSF solution to block excitatory synaptic transmission and CGP 
55845 (1 µM, dissolved in DMSO) to block GABAB receptors. Recordings were made 
using a Multiclamp 700A patch-clamp amplifier (Axon Instruments, Molecular Devices, 
Sunnyvale, CA), filtered at 4 kHz for spontaneous events and 2 kHz for miniature events, 
digitized at 20 kHz, stored, and analyzed using IGOR Pro software (Wavemetrics, Lake 
Oswego, OR). Access resistance was monitored for all experiments, and cells were 
excluded from further analysis if it changed by >20% during the recording. 
Whole-cell voltage-clamp recordings of sIPSCs from wildtype and α10/0 stratum oriens 
interneurons were obtained at room temperature with a holding potential of –60 mV and a 
high chloride containing internal solution (in mM: 100 CsCl, 2 MgCl2, 1 EGTA, 2 ATP, 
0.3 GTP, and 40 HEPES, pH 7,2, 300 mOsm). Continuous recordings started after the 
holding current had stabilized and lasted 10-15 min for baseline period and for the same 
length of time in the presence of each applied drug. Diazepam (1 μM) was applied to test 
the affinity and degree of saturation of the receptors to benzodiazepine agonists in wildtype 
and α10/0 mice. The amplitude of tonic current was assessed by applying picrotoxin (100 
μM) to the bath. mIPSCs were recorded in the presence of TTX (0.5 μM). Inhibitory 
events were recorded five minutes after the application of each drug. 
sIPSCs and mIPSCs were detected off-line automatically with the ‘Mini Analysis’ software 
(Synaptosoft; Decatur, GA) with the detection threshold set 5 times higher than the 
baseline noise level for spontaneous events and 3 times higher for miniature events. All 
detected events were counted for analysis of frequency. 200 events were randomly selected 
for each recorded cell. For analysis of kinetics and amplitude double events were rejected. 
All accepted IPSCs were aligned on the point of rise and the decay time constant was 
calculated by monoexponential fitting from 10 to 90% of the curve. For each condition at 
least five individual animals were used. Plots of cumulative probability were made for 
inter-interval event duration, amplitude and decay time constants of IPSCs from wildtype 
and α10/0 mice. Statistical significance was assessed using unpaired Student’s t-test from 
averaged values. 
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TABLE 1: List of primary antibodies used in the present study 
Target 
protein 
Antigen Species Dilution 
Fixed 
tissue 
Dilution 
slices 
Source References 
GABAA 
receptor α1 
rat N-terminal 
peptide 1-16 
guinea pig 
serum 
1:10000 1:50000 in house (Fritschy & 
Mohler, 1995; 
Kralic et al., 2006) 
 
GABAA 
receptor α2 
rat N-terminal 
peptide 1-9 
guinea pig, 
affinity 
purified 
1:1000 1:3000 in house (Marksitzer et al., 
1993; Fritschy & 
Mohler, 1995) 
 
GABAA 
receptor α3 
rat N-terminal 
peptide 1-15 
guinea pig 
serum 
1:3000 1:5000 in house (Fritschy & 
Mohler, 1995; 
Studer et al., 
2006) 
 
GABAA 
receptor α4 
rat N-terminal 
peptide 1-14 
rabbit, 
affinity-
purified 
1:1000 - Dr. W. 
Sieghart, 
Vienna 
(Bencsits et al., 
1999; Ogris et al., 
2006) 
 
GABAA 
receptor α5 
rat N-terminal 
peptide 1-10 
guinea pig 
serum 
1:2500 - in house (Fritschy & 
Mohler, 1995; 
Fritschy et al., 
1997) 
 
gephyrin affinity-
purified rat 
glycine 
receptors 
mouse 
monoclonal 
antibody 7a 
- 1:1000 Synaptic 
Systems, 
Göttingen, 
Germany; No. 
147011 
(Pfeiffer et al., 
1984; Sassoè-
Pognetto et al., 
2000) 
PV purified bovine 
parvalbumin
  
rabbit IgG  1:10000 1:5000 Immunostar, 
Hudson WI; 
No. 24428 
(Bouilleret et al., 
2000b) 
 
 
CR recombinant 
human 
calretinin 
rabbit serum 1:5000 1:5000 Swant, Cat. 
No. 7699/4 
(Schwaller et al., 
1993) 
 
 
CB bovine 
calbindin D28k 
rabbit IgG  1:5000 1:5000 Immunostar; 
No. 24427 
(Bouilleret et al., 
2000b) 
 
NPY synthetic 
porcine NPY  
rabbit serum 1:3000 1:3000 Immunostar; 
No. 22940 
(Bouilleret et al., 
2000b) 
 
SOM somatostatin 28 
(Tyr1-14)  
rabbit serum 1:3000 1:3000 Immunostar; 
No. 20089 
(Bouilleret et al., 
2000b) 
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Results 
GABAA receptor α2, α3 and α4 subunits are upregulated in dorsal hippocampus of adult 
α10/0mice  
Deletion of the α1 subunit gene resulted in a complete loss of α1 subunit-
immunoreactivity (-IR), except in the layer of pyramidal cells and in the cell body of some 
interneurons (Fig. 1A-A1), where the residual staining might reflect the presence of an N-
terminal protein fragment recognized by the antibody. As reported previously (Kralic et al., 
2006), staining for the α2, α3 and α4 subunit was increased in the hippocampal formation 
of α10/0 mice, notably in CA1 compared to wildtype littermates (Fig. 1B-D1), whereas α5 
subunit-IR remained unchanged (not shown). For the α2 subunit, no change in regional or 
cellular distribution was evident despite the enhanced IR, suggesting a global increase in 
protein abundance (Fig. 1B, E). The α3 subunit-IR, which faintly labels the CA1 area and a 
scattered subpopulation of interneuron somata in wildtype tissue (Fig. 1C, E1) was 
increased in interneurons and became prominent also in their dendrites in sections from 
mutant mice (Fig. 1C1, E2), apparently replacing the missing α1 subunit in these cells. 
Altogether, these observations suggest that the absence of α1-GABAA receptors from 
pyramidal cells and interneurons in the hippocampal formation is compensated for by 
increased density of other receptors contributing to both phasic (α2, α3) and tonic (α4) 
inhibition. This compensation is subunit-specific and occurs in both pyramidal cells and 
interneurons.  
 
Figure 1. Comparative distribution of GABAA receptor subunits α1 (A, A1, E), α2 (B, B1), α3 (C, C1, E1, 
E2) and α4 (D, D1) in dorsal hippocampus of wildtype (WT) (A-E, E1) and α10/0 mice (A1-D1, E2), 
visualized by immunoperoxidase staining in transverse sections. The dashed lines in panel A1 delineate the 
borders of the region in CA1 where cells were sampled for quantification throughout this study. A-A1: The 
α1 subunit-IR disappears in the mutant mouse section, although a weak staining remains in the pyramidal cell 
layers and, mainly in interneurons, possibly denoting the presence of an N-terminal protein fragment 
recognized by the antibody. B-D1: Global increase in α2, α3 and α4 subunit staining in α10/0 mice, most 
prominent in the CA1 area. E-E2: Higher magnification photomicrographs illustrating the α1 subunit-IR in 
CA1 interneurons in wildtype mice and their weak labeling for the α3 subunit; arrowheads point to positive 
interneurons. In mutant, the α3 subunit-IR becomes very prominent in a subset of interneurons, apparently 
replacing the α1 subunit. DG: dentate gyrus; so: stratum oriens; sp: stratum pyramidale; sr: stratum radiatum; 
slm: stratum lacunosum-moleculare. Scale bar = 240 μm (applies to A-D) and 60 μm (applies to E).  
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Unaltered distribution of interneurons in dorsal hippocampus of α10/0 mice 
Given the prominent expression of the α1 subunit in distinct subpopulations of 
interneurons, notably PV- and NPY-positive interneurons (Gao & Fritschy, 1994), we 
determined whether the neurochemical phenotype of five major interneuron subtypes was 
altered in the CA1 area of adult α10/0 mice. Four of these markers (PV, CR, NPY, and 
SOM) are present in various proportions of α1-subunit-positive interneurons in rat CA1 
area (Gao & Fritschy, 1994) and have a similar distribution in mice (Matyas et al., 2004). 
The fifth marker, CB, is present in interneurons apparently devoid of α1 subunit-IR (Gao 
& Fritschy, 1994) and was selected as a negative control. It should be noted that although 
these five markers allow an unambiguous identification of interneurons by 
immunofluorescence staining, none of them defines a single functional cell class (e.g., 
chandelier cell, OLM-cell) (Toledo-Rodriguez et al., 2005; Baude et al., 2006).  
As illustrated in Figure 2, the staining pattern, regional and laminar distribution, and 
dendritic morphology of interneurons identified with these five markers was not altered in 
the hippocampal formation of α10/0 mice. Each marker exhibited the typical distribution 
seen in wildtype mice from different strains (see Bouilleret et al. (2000b) and Matyas et al. 
(2004) for comparison). Except CB, which labels dentate gyrus granule cells and CA1 
pyramidal cells in addition to interneurons, all these markers were selectively detected in 
interneurons. A quantitative analysis revealed no difference the number of interneuron 
profiles in the CA1 area between wildtype and mutant mice for any of these markers (Fig. 
2F; mean ± SD; n=3 per mice per genotype). These results indicate that deletion of the α1 
subunit gene had no apparent effect on the expression of neurochemical markers or the 
distribution and morphology of interneurons in the hippocampal formation. 
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Figure 2. Distribution of PV- (A), CR- (B), CB- (C), NPY- (D) and SOM- (E) IR in dorsal hippocampus of 
α10/0 mice, visualized by immunoperoxidase staining in transverse sections. Each of this marker exhibits a 
similar distribution pattern corresponding to that described in wildtype mice (Matyas et al., 2004). In the CA1 
area, PV-positive interneurons (A) are mostly located in stratum oriens (so) and stratum pyramidale (sp); CR- 
(B) and CB-positive interneurons (C) are located in all layers including stratum lacunosum-moleculare (slm); 
NPY-positive cells (D) are seen in the sp, so and stratum radiatum (sr) and SOM-positive cells (E) are only 
abundant in the so. F: The number of interneurons positive for each of these five markers remains unchanged 
between wildtype and α10/0 mice (mean±SD; Student’s t-test; n=3 mice/genotype). Scale bar = 240 μm.  
 
 
Compensatory changes in GABAA receptor subunit-immunoreactivity in CA1 interneurons 
of α10/0mice 
First, to determine which fraction of interneurons express the α1 subunit in mouse CA1 
area, immunofluorescence staining was performed in sections from GAD67-GFP mice 
(Tamamaki et al., 2003), in which all interneurons are labeled with GFP. Random 
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sampling of CA1 interneurons in the dorsal hippocampus in three mice revealed 58-65% 
GFP-positive interneurons double-labeled for the α1 subunit, which outlined their soma 
and proximal dendrites. Most double-labeled cells were located in the stratum oriens, 
stratum pyramidale and lower half of stratum radiatum (data not shown).  
Next, to determine whether the increased α2 and α3 subunit-IR in the CA1 region of α10/0 
mice contributes to compensate for the lack of α1-GABAA receptors in GABAergic 
synapses on interneurons, we performed a high resolution analysis of the distribution of the 
α1-α3 subunits along with gephyrin on the soma and proximal dendrites of interneurons 
identified by one of these five markers, using triple immunofluorescence staining. 
Gephyrin is selectively localized in the postsynaptic density of GABAergic synapses, as 
determined by pre- and postembedding immunoelectron microscopy (Sassoè-Pognetto et 
al., 2000; Panzanelli et al., 2004; Lagier et al., 2007), and was taken here as a bona fide 
marker of GABAergic synapses. The present experiments were done in weakly fixed 
sections prepared from living slices to optimize the combined staining of the 
neurochemical marker with GABAA receptor subunit and gephyrin clusters at postsynaptic 
sites (Schneider Gasser et al., 2006).  
In wildtype mice, the α1 subunit-IR was detected in all subtypes of interneurons 
investigated, ranging from 100% in PV-positive cells to 33% CB-positive non-pyramidal 
cells (Table 2). In PV-, CR-, NPY- and SOM-immunoreactive cells, staining for the α1 
subunit was mostly diffused around the soma (extrasynaptic) but a fraction was also 
clustered and colocalized with gephyrin, presumably representing synaptic receptors (Figs. 
3A, 4A, 6A and 6E). CB-positive cells immunoreactive for the α1 subunit had only a small 
number of clusters double-labeled for the α1 subunit and gephyrin (Fig. 5A). Likewise, the 
majority of interneurons had a small number of α2 subunit-positive clusters, mainly on 
their dendrites, as seen by high resolution imaging in sections from wildtype mice (Fig. 3C, 
4D, 5C-D; Table 2). An increase in α2-subunit-IR was detected in selected interneurons of 
α10/0 mice, as detailed in the next section, although the proportion of interneurons carrying 
α2 subunit-positive clusters did not change significantly (Table 2). Finally, the α3 subunit-
IR was undetectable by immunofluorescence in most CA1 interneurons from wildtype 
mice, except for a subpopulation located deep in the stratum oriens, representing a subset 
of PV-, NPY-, and SOM-positive cells (Table 2). In striking contrast, most interneurons 
from α10/0 mice were positive for the α3 subunit, some of them having numerous clusters 
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around soma and dendrites. The genotype difference was significant in the five types of 
interneurons analyzed, and the proportion of α3 subunit-positive interneurons in α10/0 mice 
in each subpopulation became highly similar to that seen for the α1 subunit in wildtype 
mice (Table 2). Therefore, GABAA-mediated inhibition in CA1 interneurons is likely 
retained following α1 subunit gene deletion owing to upregulation of α3- and, to a lesser 
extent, α2-GABAA receptors. In contrast, the α4 and α5 subunit were not detectable in 
hippocampal interneurons from either wildtype or α10/0 mice (not shown). 
 
TABLE 2. Percentage of identified CA1 interneurons immunopositive for a given α 
subunit variant in wildtype (WT) and α10/0 mice 
α1 α2 α3 Interneuron 
marker 
N (per 
genotype) WT α10/0 WT α10/0 WT α10/0
PV 6 100 0 96 ± 4 100 5 ± 4 98 ± 2** 
CR 5 53 ± 5 0 69 ± 19 100 8 ± 8 52 ± 3** 
CB 3 33 ± 8 0 83 ± 16 81 ± 19  2 ± 2 34 ± 9* 
NPY 3 57 ± 4 0 58 ± 37 77 ± 20 7 ± 7 84 ± 8* 
SOM 3 64 ± 6 0 68 ± 15 79 ± 15 12 ± 10 87±11* 
Significant differences between average values in wildtype (WT)  and α10/0 mice are indicated (Mann-
Whitney test, 2-tailed; *P<0.05; ** P<0.01). 
 
 
Heterogeneity in cellular adaptation to the α1 subunit gene deletion 
To further determine whether the compensatory changes occurring in α10/0 mice affect the 
number of GABAergic postsynaptic sites and the subcellular distribution of GABAA 
receptors, the number of gephyrin and α subunit clusters located on labeled interneurons in 
wildtype and mutant mice was quantified in reconstructed volumes (51 x 51 x 3 μm) 
comprising the soma. The fraction of gephyrin clusters co-localizing with each α subunit 
was determined (Table 3), along with the ratio of gephyrin, α2 and α3 subunit clusters per 
cell between genotypes (Table 4). These data provide a quantitative assessment of the 
reorganization of inhibitory synapses on interneurons in response to the α1 subunit gene 
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deletion and demonstrate the dramatic upregulation of the α3 subunit in interneurons of 
mutant mice. 
 
TABLE 3. Percentage of gephyrin clusters colocalized with α subunits in CA1 
interneurons from wildtype (WT) and α10/0 mice 
gephyrin/α1 gephyrin/α2 gephyrin/α3 Interneuron 
marker 
N (per 
genotype) WT α10/0 WT α10/0 WT α10/0
PV 6 83 ± 3 0 14 ± 2 30 ± 10  3 ± 1 70 ± 8** 
CR 5 49 ± 12 0 34 ± 11 40 ± 15 17 ± 5 60 ± 7** 
CB 3 36 ± 10 0 60 ± 24 58 ± 14 4 ± 1 42 ± 9* 
NPY 3 66 ± 4 0 31 ± 18 30 ± 10 3 ± 2 70 ± 5* 
SOM 3 70 ± 11 0 15 ± 3 13 ± 6 15 ± 5 67±22* 
See Figures 3-6 for absolute values; Significant differences between average values in WT and α10/0 mice are 
indicated (Mann-Whitney test, 2-tailed; *P<0.05; ** P<0.01). 
 
 
TABLE 4: Ratio of postsynaptic cluster number in CA1 interneurons of α10/0 and 
wildtype mice  
Interneuron type gephyrin α2 α3 
PV 1.43* 4.56* 24.77** 
CR 2.18* 1.81* 7.19** 
CB 1.23 2.31* 39.94** 
NPY 1.82* 1.07 38.39** 
SOM 1.13 1.33 5.99** 
See bar graphs in Figs. 3-6 for mean values (±SD). Significant differences between average values in WT and 
α10/0 mice are indicated (Mann-Whitney test, 2-tailed; *P<0.05; ** P<0.01). 
 
PV immunoreactive neurons  
PV-IR neurons (Fig. 3) represent ~50% of all α1 subunit-positive neurons in the CA1 area 
and were all labeled for the α1 subunit, which outlined the soma and proximal dendrites 
and forms clusters co-localized with gephyrin (Fig. 3A). In addition, most PV-positive 
Results
 
135 
interneurons have isolated α2 subunit-positive clusters, mainly on their dendrites (Fig 3C). 
The α3 subunit-IR, when detected, was located intracellularly (Fig. 3E). In α10/0 mice, the 
density of α2 subunit-positive clusters was increased four-fold (Fig. 3D, 3G; Table 4), 
without change in subcellular localization. The increased α3 subunit-IR in PV-positive 
cells resulted in a 25-fold increase in the number of clusters colocalized with gephyrin 
(Fig. 3F-G; Table 4). The number of α3 subunit clusters in PV-positive interneurons from 
mutant mice was similar to the number of α1 subunit clusters counted on wildtype mice 
(Fig. 3G), but a decrease in extrasynaptic staining was evident. The total number of 
gephyrin clusters on PV-positive cells from mutant mice was increased by 43%, especially 
on proximal dendrites (Fig. 3B, G; Table 4), suggesting that GABAergic synaptic input on 
PV-positive cells is increased in α10/0 mice.  
CR immunoreactive neurons 
CR-IR neurons (Fig. 4) represent ~25% of the α1 subunit positive neurons in the CA1 area. 
They form two distinct subpopulations distinguished by the presence or absence of 
dendritic spines. Most aspiny CR-IR cells were α1 subunit-positive (Figure 4A), whereas 
spiny CR-IR cells were mostly α1 subunit-negative (Fig. 4B). Isolated α2 subunit clusters 
were seen on most spiny (Fig 4D) and a fraction of aspiny CR-positive cell dendrites, 
whereas the α3 subunit-IR was rarely detected in either cell type (Fig. 3F, Table 4). In 
α10/0 mice, the number of α2 subunit-positive clusters was increased almost 2-fold with 
unchanged cellular distribution (Fig. 4E, I; Table 4); likewise, the number of α3 subunit-
positive clusters increased significantly (over 8-fold), notably in aspiny cells, covering the 
soma and proximal dendrites (Fig. 4G, I; Table 4). The increase in α3 subunit staining was 
also seen in spiny cells, but was less pronounced (Fig. 4H). These changes were 
accompanied by a 218% increase in the number of gephyrin clusters (Table 4), which, like 
in PV-subunit cells, were all colocalized with α2 or α3 subunit clusters (Table 3). 
Therefore, GABAergic synaptic coverage of CR-positive cells in α10/0 mice was increased 
in aspiny cells, which normally express α1-GABAA receptors, but also in spiny cells, 
which appear largely devoid of gephyrin-labeled GABAergic synapses in wildtype mice. 
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Figure 3. Comparative distribution of GABAA receptor α1, α2 and α3 subunit (red) and gephyrin (blue) 
clusters in PV-immunoreactive (green) CA1 interneurons of wildtype (WT) (A, C, E) and α10/0 (B, D, F) 
mice, visualized by triple immunofluorescence staining and confocal laser scanning microscopy. All panels 
depict a single confocal section of cells located in the stratum oriens, close to the stratum pyramidale. A: In 
WT mice, the α1 subunit is located mostly extrasynaptically, outlining the soma and dendrites; clusters of α1 
subunit-IR are few but colocalized with gephyrin (arrowheads). B: In α10/0 mice an increase in the number of 
gephyrin clusters is observed. A1-B1: The difference in gephyrin clusters between WT and α10/0 mice is better 
seen at high magnification in proximal dendrite segments (taken from the boxed area in panels A and B. C-C1: 
In WT mice, most PV-immunoreactive cells contain only isolated α2 subunit clusters on their soma and 
proximal dendrites (arrowhead in C1). D-D1: In α10/0 mice an increased α2 subunit-IR is observed on some 
dendrites (arrowheads). Panels C1 and D1 are enlargement of the boxed areas in C and D. E: In WT mice, PV-
positive cells are devoid of α3 subunit clusters. F: In α10/0 mice, numerous α3 subunit clusters are evident on 
the soma and dendrites, colocalized with gephyrin (arrowheads). G: Quantification of gephyrin, α1, α2 and α3 
subunit clusters revealed the significant increase of gephyrin, α2 and α3 subunit clusters in α10/0 mice (n=6 
mice/genotype). The vast majority of α2 and α3 subunits are colocalized with gephyrin (see table 4), 
indicating a postsynaptic localization. Scale bars: A-D, 10 μm; E-F, 10 μm. 
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Figure 4. Comparative distribution of GABAA receptor α1, α2, α3 subunit (red) and gephyrin (blue) clusters 
in CR-immunoreactive (green) CA1 interneurons of wildtype (WT) (A, B, D, F) and α10/0 (C, E, G, H) mice, 
visualized by triple immunofluorescence staining. All pictures are taken from cells located close to the stratum 
pyramidale. A: In WT mice, smooth, aspiny CR cells are positive for the α1 subunit, which forms only few 
clusters colocalized with gephyrin. B: Beaded, spiny CR cells appear devoid of α1 subunit-IR and have few 
gephyrin clusters on their soma and dendrites. C: In α10/0 mice an increase in gephyrin clusters (arrowheads) 
occurs in both CR cell types, with a stronger increase in aspiny cells; this picture shows an example of a spiny 
CR cell. D: In wildtype mice, most CR cells present a small number of α2 subunit/gephyrin clusters on soma 
and dendrites (arrowheads). E: In α10/0 mice α2 subunit clusters are increased in CR-positive cells 
(arrowheads). F: In WT mice, CR cells appear devoid of α3 subunit clusters. G-H: In α10/0 mice α3 subunit 
clusters are found on the soma and dendrites of aspiny CR interneurons (G) and to a lesser extent in spiny CR 
cells (H-H1); the vast majority of α3 subunit clusters are colocalized with gephyrin. J: Quantification of 
gephyrin, α1, α2 and α3 subunit clusters revealed a significant increase of gephyrin, α2 and α3 clusters 
following deletion of the α1 subunit (n=5 mice/genotype). Scale bar: 10 μm (applies to all panels). 
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CB immunoreactive neurons 
CB-positive interneurons in the CA1 area (Fig. 5) were distinguished from pyramidal cells 
by their size, multipolar cells bodies, and localization. In contrast to PV- and CR-
immunoreactive neurons, α1 subunit-positive clusters were seen in only about 30% CB 
interneurons (Table 2). These clusters were located on the soma and dendrites and were 
colocalized with gephyrin; no diffuse (extrasynaptic) staining was evident (Fig. 5A). 
Although over 80% of CB interneurons were labeled for the α2 subunit in wildtype mice 
(Table 2), most of these cells carried only few α2 subunit clusters (Fig. 5C, J). However, a 
small subpopulation of CB-positive cells had a high density of postsynaptic α2 subunit 
clusters around their soma (Fig. 5D). These cells were located close to the pyramidal cell 
layer and might represent small "superficial" pyramidal cells, as described by (Baimbridge 
& Miller, 1982). In α10/0 mice, a significant, more than 2-fold, increase in the number of 
α2 subunit-positive clusters colocalized with gephyrin was observed on soma and dendrites 
of CB-IR cells (Fig 5E, I; Table 4). Finally, very few CB interneurons carried α3 subunit-
positive clusters (Fig. 5F, I) in wildtype mice. In mutant, however, a high density of α3 
subunit clusters was seen in about 30% of CB-positive cells in mutant mice (Table 2), of 
which only about 20% were colocalized with gephyrin (Fig. 5G-I). It was not possible to 
determine whether these interneurons correspond to those expressing α1-GABAA receptors 
in wildtype mice. Despite the increase in α2 subunit clusters, the overall density of 
gephyrin clusters was not increased significantly in CB-positive cells of α10/0 mice (Fig. 
5B, I), but they were frequently colocalized with either α2 or the α3 subunit clusters 
(Table 3). 
These results suggest that CB-positive interneurons undergo differential compensatory 
changes in α10/0 mice, although many of them do not normally express the α1 subunit. In 
most CB-interneurons, GABAergic synaptic input is preserved by upregulation of 
postsynaptic α2-GABAA receptors and, in a subset of cells, mainly extrasynaptic α3-
GABAA receptors (or postsynaptic receptors not associated with gephyrin) are formed in 
mutant mice. GABAergic regulation of CB interneurons is, therefore, different in wildtype 
and α10/0 mice.  
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Figure 5. Comparative distribution of GABAA receptor α1, α2, α3 subunit (red) and gephyrin (blue) clusters 
in CB-immunoreactive (green) CA1 interneurons of wildtype (WT) (A, C, D, F) and α10/0 (B, E, G, H) mice. 
Pictures were taken from cells located in stratum radiatum. A: In WT mice, a third of CB interneurons carry 
α1 subunit-positive clusters (arrowheads) partially colocalized with gephyrin; in this picture, the dendrites of 
CB-negative cells are strongly positive for the α1 subunit. B: In α10/0 mice no upregulation of gephyrin 
clusters occurs. C-D: In WT mice, the α2 subunit is either weakly detectable on dendrites of CB cells (C; 
arrowhead) or abundantly on soma (D-D1), always clustered and colocalized with gephyrin. E: An 
upregulation of the α2 subunit-IR, clustered and colocalized with gephyrin, is seen in CB-positive 
interneurons of α10/0 mice. F: In WT mice, CB-positive interneurons are devoid of α3 subunit clusters. G-H: 
In α10/0 mice, most CB-positive interneurons exhibit α3 subunit clusters on soma and dendrites, colocalized 
with gephyrin in about one third of these cells (compare G and H). J: Quantification of gephyrin, α1, α2 and 
α3 clusters reveals a significant increase of α2 and α3 subunit clusters, but not gephyrin clusters, following 
deletion of the α1 subunit (n=3 mice/genotype). The scale bar in A represents 10 μm in A-F and G-H and 7.5 
μm in D-D1. 
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NPY and SOM immunoreactive neurons 
NPY- and SOM-positive interneurons (Fig. 6) represent ~30% and ~10% of α1 subunit-
positive interneurons in the CA1 area, respectively. For both subtypes, 60% of interneurons 
were found to be positive for the α1 subunit (Fig. 6A, D, E, H; Table 2). Few α2 or α3 
subunit clusters were detected in these cell types (Fig. 6D, H). In α10/0 mice, no 
upregulation of α2 subunit was evident; however, numerous α3 subunit-positive clusters 
were seen, extensively colocalized with gephyrin (Fig 6C-D, G-H; Table 3). The number 
of gephyrin clusters was significantly increased in NPY-, but not SOM-positive 
interneurons in mutant mice (Fig 6B, F; Table 4).  
These observations suggest that only α3-GABAA receptors are upregulated in NPY- and, 
to a lesser extent, SOM-positive interneurons in α10/0 mice. In both cell types, most of 
these receptors are associated with gephyrin and, therefore, postsynaptic. 
In summary α10/0 mice exhibited an increase of gephyrin clusters in PV-, CR- and NPY-IR 
cells and retained the number of gephyrin clusters in CB- and SOM- IR cells. A general 
increase of α3 subunit clusters was evident in all cell types and, in addition, of α2 subunit 
clusters in PV-, CR- and CB-IR interneurons. The α2 subunit was always colocalized with 
gephyrin whereas the α3 subunit formed clusters that were sometimes devoid of gephyrin, 
especially in CB-IR cells.  
Phasic GABAergic transmission is partially impaired in CA1 interneurons of α10/0mice  
To determine whether GABAA receptor-mediated phasic and tonic inhibition is retained in 
interneurons of α10/0 mice, we performed whole-cell voltage-clamp recordings of sIPSCs 
and mIPSCs from CA1 stratum oriens interneurons. The cells to be recorded were 
identified visually by their bright somata and dendritic arborization.  
sIPSCs were seen in all interneurons recorded from both genotypes (Fig. 7A, B). Their 
mean frequency did not differ between wildtype and α10/0 mice (3.6 ± 0.5 and 3.3 ± 0.5 Hz, 
respectively; Fig. 7D; Table 5). However, their mean amplitude was slightly, non-
significantly reduced (Fig. 7C, E) whereas their mean decay time was prolonged by 62% 
(Fig. 7C, F; Table 5) in mutant mice. Application of 100 μM picrotoxin to the bath solution 
blocked all sIPSCs, indicating that they were GABAA receptor-mediated. The change in 
holding current after application of picrotoxin (Fig. 7A-B, right trace) was equal between 
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wildtype and α10/0 mice interneurons (21.5 pA and 22.1 pA, respectively), indicating that 
tonic inhibition was preserved.  
Application of diazepam (1 μM), which interacts indiscriminately with α1-, α2-, α3- and 
α5-GABAA receptors, increased sIPSC frequency, amplitude and decay time in both 
wildtype and α10/0 mice. Amplitude and decay time were increased in the same proportion 
in both genotypes (~15% increase in amplitude and ~30% increase in decay time constant) 
whereas the increase in sIPSC frequency after diazepam application was ~37% larger in 
α10/0 than in wildtype mice (data not shown).  
Recordings of mIPSCs revealed a significant decrease in mean frequency in interneurons 
of α10/0 mice (Fig. 8A-B, D) (2.6 ± 0.5 and 1.0 ± 0.5, respectively; Table 5), which 
contrasts with the increased number of gephyrin clusters reported above. The mean mIPSC 
amplitude was also decreased by ~25% in α10/0 mice compared to wildtype (Fig. 8C, E), 
while the mean decay time constant increased by 112% (Fig. 8C, F; Table 5). All mIPSCs 
were blocked with picrotoxin (not shown), indicating that they were GABAA receptor-
mediated.  
 
 
TABLE 5. Characteristics of sIPSC and mIPSC in CA1 interneurons 
 Number of cells Frequency, Hz Amplitude, pA Decay time 
constant, ms 
sIPSCs     
WT 6 3.6 ± 3.6 -43.6 ± 13.5 10.8 ± 5.0 
α10/0 6 3.3 ± 3.3 -37.7 ± 8.2 17.5 ± 3.6** 
% change from WT  -6.7  -13.4  62 
mIPSCs     
WT 9 2.6 ± 2.6 -36.9 ± 4.2 8.5 ± 1.4 
α10/0 6 1.0 ± 1.3** -27.7 ± 9.8* 18.1 ± 6.9* 
% change from WT  -61 -24.8 112.9 
Significant differences between average values in WT and α10/0 mice are indicated (Mann-Whitney test, 2-
tailed; *P<0.05; ** P<0.01). 
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Figure 6. 
Comparative distribution of 
GABAA receptor α1 and α3 
subunit (red) and gephyrin 
(blue) clusters in NPY- and 
SOM-immunoreactive CA1 
interneurons (green) of 
wildtype (WT) (A, E) and α10/0 
(B, C, F, G) mice, visualized 
by triple immunofluorescence 
staining. Pictures were taken 
from cells located in the 
stratum oriens. In WT mice the 
α1 subunit, detected in 57% 
NPY-positive cells (A) and 
64% SOM-positive cells (E), is 
prominent but forms few 
clusters co-localized with 
gephyrin. B, F: In α10/0 mice 
an increase in the number of 
gephyrin clusters is evident in 
NPY cells (B) but not in SOM 
cells (F). C, G: In both cell 
types numerous α3 subunit 
clusters colocalized with 
gephyrin are apparent in α10/0 
mice. D, H: Quantification of 
gephyrin, α1, α2 and α3 
clusters reveals a significant 
increase of gephyrin in NPY 
cells and α3 clusters in both 
cell types following deletion of 
the α1 subunit (n=3 
mice/genotype). The scale bar 
in A represent 10 μm in the left 
column and 8 μm in the right 
column. 
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Figure 7. Spontaneous inhibitory postsynaptic currents (sIPSCs) in CA1 stratum oriens interneurons from 
wildtype (WT) and α10/0 mice. A-B: Representative traces of sIPSCs recorded in an interneuron from a WT 
(A) and α10/0 mouse (B), in the absence (left) and presence of 100 μM (right) picrotoxin. The inward change 
in holding current induced by picrotoxin, denoting tonic inhibition, had the same amplitude in both genotypes 
(21.5 pA and 22.1 pA, respectively). C: Averaged traces from the interneurons in A (grey) and B (black). 
Note the small reduction in amplitude and the increase in decay time occurring in α10/0 mice. D: Cumulative 
probability distribution of sIPSC inter-event-intervals (IEI) in WT and α10/0 mice; no change in frequency is 
evident between genotypes. E: Cumulative probability distribution of sIPSC amplitude, which is not 
significantly different in α10/0 mice (P<0.3). F: cumulative probability distribution of sIPSC decay time 
constants, showing the significant increase in α10/0 mice (P<0.02). 
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Figure 8. Miniature inhibitory postsynaptic currents (mIPSCs) in stratum oriens CA1 interneurons from 
wildtype (WT) and α10/0 mice. A-B: Representative traces of mIPSCs recorded in WT (A) and α10/0 mice 
(B). C: Averaged traces from the interneurons in A (grey trace) and B (black trace). Note the significant 
reduction in amplitude and the increase in decay time in α10/0 mice. D-F: Cumulative probability distribution 
of mIPSC inter-event-intervals (IEI; D), amplitude (E), and decay time constants (F), showing a significant 
reduction in the frequency (P<0.001) and amplitude (P<0.03), but an increase in decay time constant 
(P<0.02) in α10/0 mice.  
 
Wildtype and α10/0mice have the same sensitivity to kainic acid-induced lesions 
To determine whether the compensatory changes in the organization of GABAA receptor 
subtypes are functionally relevant in vivo, we investigated whether the acute and chronic 
excitotoxic action of kainic acid is altered in α10/0 mice. To this end, adult mice received a 
unilateral intrahippocampal injection of kainic acid and were examined histologically after 
14 days post-treatment. This model was selected because it is extensively characterized, 
with kainic acid injection causing temporally distinct morphological alterations (Bouilleret 
et al., 2000a). Acutely, it causes degeneration of CA1 and CA3 pyramidal cells, along with 
loss of hilar cells and a large subset of interneurons in CA1 and the dentate gyrus (mostly 
affecting PV-positive cells); chronically, it induces on-going degeneration of most 
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pyramidal cells in CA1 and CA3 and a pronounced hypertrophy and dispersion of dentate 
gyrus granule cells, which is dependent on BDNF-induced signaling (Suzuki et al., 1995). 
Upon kainic acid injection, mice experience a non-convulsive status epilepticus, followed 
by a silent phase prior to onset of spontaneous recurrent focal seizures (Riban et al., 2002). 
This model therefore allows monitoring distinct effects of kainic acid along with sensitivity 
to convulsions and epileptogenesis. 
No difference in severity or duration of status epilepticus was observed in α10/0 mice 
compared to wildtype upon kainic acid injection. Examination of Nissl-stained sections 14 
days post-treatment revealed no different in lesion size or granule cell dispersion between 
genotypes (not shown). Finally, immunohistochemistry for interneuron markers revealed 
no difference in their susceptibility to kainate-induced toxicity (Fig. 9; compare to Fig. 2). 
Therefore, the compensatory changes occurring in α10/0 mice allow a “wildtype-like” 
response to kainic acid injection. Furthermore, replacing α1-GABAA receptors in PV-
positive interneurons by α2- and α3-GABAA receptors, which have distinct functional 
properties, does not make them more resistant to kainic acid, despite the slower kinetics of 
the corresponding receptors. 
 
Discussion 
The present study reveals extensive rearrangements of GABAA receptors and GABAergic 
circuits to compensate for the absence of the α1 subunit in CA1 interneurons. Unlike 
Purkinje cells, which remain devoid of functional GABAA receptors in α10/0 mice and lose 
a majority of GABAergic synapses on their dendrites (Fritschy et al., 2006), the density of 
gephyrin clusters, denoting postsynaptic sites, increases in CA1 interneurons, along with 
clusters of α3, and to a lesser extent, α2 subunit. This effect is cell-specific, since the 
density of gephyrin clusters remains unchanged in CB- and SOM-positive interneurons.  
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Figure 9. Similar alterations in the distribution of interneuron markers in kainic acid-treated wildtype (WT) 
and α10/0 mice, as seen in the injected hippocampal formation 14 days after treatment. At this time-point, 
dispersion of dentate gyrus (DG) granule cells causes an enlargement of this structure. In CA1 and CA3, 
degeneration of pyramidal cells is only partial. A-B: Almost complete loss of PV-IR in CA1 and DG is evident 
in both genotypes. Compare to Fig. 2 for the distribution pattern seen in control mice. C-D: The majority of 
CR-positive cells are retained in CA1 and CA3, along with the prominent innervation of the inner molecular 
layer of the DG. E-G: The majority of CB-positive interneurons are lost in CA1, along with a decreased 
staining of pyramidal cells. In contrast, CB-IR appears increased in DG granule cells and mossy fibers and is 
largely normal in CA3 in both genotypes. H, hilus. Scale bar: A-D, 200 μm; E-F, 150 μm. 
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Although previous studies had suggested that α1 subunit-positive CA1 interneurons 
express no other α subunit variant (Gao & Fritschy, 1994; Fritschy & Mohler, 1995; Pirker 
et al., 2000), we demonstrate here an unsuspected heterogeneity of GABAA receptors in 
these cells, with a majority of CR, CB, NPY, and SOM interneurons expressing a small 
number of α2 subunits-positive clusters, along with the α1 and/or α3 subunit. Even most 
PV interneurons, which predominantly express α1-GABAA receptors, also had a few α2 
subunit clusters on their dendrites. Thus, the detection of subunit clusters colocalized with 
gephyrin on identified interneurons in weakly fixed tissue (Schneider Gasser et al., 2006) 
provides improved sensitivity compared to the use of perfusion-fixed tissue. Strikingly, 
deletion of the α1 subunit gene caused a stronger increase in α3 than α2 subunit clusters. 
This observation suggests that the missing α1 subunit in mutant mice is not randomly 
replaced by another GABAA receptor subtype, but that the compensatory upregulation 
occurs in defined neuronal circuits. Several other findings support this conclusion: 1) the 
increase in α2 and α3 subunit clusters even occurs in cells that normally do not express the 
α1 subunit, such as most CB-positive interneurons; 2) the subcellular distribution of 
GABAA receptors in α10/0 mice is distinct from that seen in wildtype mice, notably due to a 
decrease in extrasynaptic staining and an increase in perisomatic clusters; 3) the increase in 
gephyrin clusters suggests formation of additional GABAergic synapses, although an 
upregulation from undetectable levels in pre-existing synapses cannot formally be ruled 
out. These morphological rearrangements were not sufficient to fully restore the function 
of α1-GABAA receptors, since the amplitude and frequency of mIPSPs were significantly 
reduced in interneurons from α10/0 mice, in line with previous results (Goldstein et al., 
2002). However, on the network level, GABAergic inhibition appears to be functional, 
since α10/0 mice are not more susceptible than wildtype mice to the acute and chronic 
excitotoxic and epileptogenic action of kainic acid.  
The major effect of the α1 subunit gene deletion is a loss of about 50% GABAA receptors 
in the brain (Sur et al., 2001; Kralic et al., 2002). Despite pronounced increase in protein 
content for several α subunit variants, the loss of α1 subunit is paralleled by a decrease in 
β2 and γ2 subunit (Kralic et al., 2006; Ogris et al., 2006), indicating that the α1 subunit is 
required for assembly of this major GABAA receptor subtype. All previous studies of α10/0 
mice have shown that the upregulation of GABAA receptor subunits does not involve a 
change in gene expression (Sur et al., 2001; Bosman et al., 2005; Ogris et al., 2006), 
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suggesting increased translation and/or reduced turnover of other GABAA receptor 
subtypes. Studying the thalamus and cerebellum, we have shown that α1-GABAA 
receptors are not “replaced” by these compensatory changes (Kralic et al., 2006). Rather, 
the α3 and α4 subunits are increased, without change in cellular or subcellular distribution. 
An extreme situation was seen in cerebellum, where Purkinje cells are devoid of functional 
GABAA receptors despite an 8-fold increase in α3 subunit clusters in the same tissue. 
These observations implied a change in GABAergic circuits and formation of novel 
synapses containing the up-regulated receptors. A more complex situation occurs in cells 
that co-express the α1 and α3 subunit. Thus, in olfactory bulb mitral cells of α10/0 mice, 
the loss of α1-GABAA receptors leads to a partial compensation by α3-GABAA receptors, 
mainly in GABAergic synapses formed on the soma; however, the number of functional 
synapses is reduced in mitral cell dendrites, with slower decay kinetics and lower 
amplitude of sIPSCs (Lagier et al., 2007), as observed here. In turn, these altered 
functional properties have major consequences on the network level, resulting in decreased 
frequency of γ oscillations induced by olfactory nerve stimulation (Lagier et al., 2007). 
These findings underscore the importance of GABAergic synapses for coordinated 
function of neuronal networks and demonstrate that each GABAA receptor subtype confers 
unique functional properties to brain circuits.  
The contrast between the very weak expression of the α3 subunit in CA1 interneurons (Fig. 
1), except for a specific subpopulation in stratum oriens (Brünig et al., 2002), and the 
strong immunoreactivity seen in α10/0 mice underscores the plasticity of this GABAA 
receptor subtype. Our quantitative analysis suggests that the α3 subunit “replaces” the 
missing α1 subunit, notably in PV- and NPY-positive interneurons. “De novo” expression 
of the α3 subunit appears unlikely. Rather, upregulation from low constitutive levels might 
be the mechanism of this striking compensatory change. It is of note that the number of α2 
and α3 subunit clusters in CB- and CR-positive interneurons of mutant mice largely 
exceeds the number of α1 subunit clusters in these cells in wildtype, indicating that the 
upregulation of these subunits is not a mere compensation, but reflects a reorganization of 
GABAergic circuits in the hippocampus, as had been noted previously in the cerebellum 
(Kralic et al., 2006). 
Aside from the prolongation in decay time constant, little effect of the mutation was seen 
in recordings of sIPSCs in interneurons from wildtype and α10/0 mice. Since the recorded 
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interneurons were not identified morphologically, it is not excluded that potential changes 
affecting only a specific class might have been overlooked. However, the prolongation of 
decay matches the general up-regulation of the α3 subunit in most interneurons in mutant 
mice. In line with the morphological results, GABAA receptors in interneurons remain 
sensitive to diazepam, as shown by an increased frequency and prolongation of sIPSCs in 
the presence of this drug. Also, tonic GABAA-mediated inhibition was not altered by the 
mutation, confirming that GABAergic transmission is largely retained in mutants. The 
latter result was surprising, since tonic inhibition in interneurons is likely mediated by 
GABAA receptors containing the δ subunit, along with α1 (Glykys et al., 2007). Since we 
failed to detect α4 and α5 subunit-IR in interneurons, the question remains open whether 
the δ subunit forms receptors with either α2 or α3 in mutant mice.  
The amplitude and decay time constant values of mIPSCs recorded here in stratum oriens 
interneurons are different from those reported for interneurons in stratum radiatum and 
stratum lacunosum-moleculare (Goldstein et al., 2002), suggesting either differences in 
recording conditions or in intrinsic properties of interneurons. However, the differences 
between genotypes were proportionally similar, and the values for mIPSC frequency were 
nearly identical between the two studies. Using non-stationary fluctuation analysis upon 
application of zolpidem, Goldstein et al. (2002) observed a reduction in the number of 
GABAA receptors open at the peak of mIPSCs, which they suggested explains the lower 
amplitude and frequency of mIPSCs in α10/0 mice. However, the marked reduction in 
mIPSC amplitude might be due to the lower GABA affinity of α3-GABAA receptor (Ebert 
et al., 1994; Verdoorn, 1994), rather than a reduction in the number of receptors in the 
synapse. The lower frequency of mIPSC might, in part, be secondary to their decreased 
amplitude but could also reflect a presynaptic effect. Since our morphological data point 
towards an increase in GABAergic synaptic coverage of interneurons, as reflected by the 
density of gephyrin clusters, a presynaptic alteration might include decreased presynaptic 
GABA release, due to partial filling of presynaptic vesicles, or to changes in GABA 
clearance in the synapse (Barberis et al., 2004). Such a phenomenon has been 
demonstrated to occur in GABAergic synapses from cultured neurons upon prolonged 
reduction of neuronal activity (Hartman et al., 2006). The 37% larger effect of diazepam 
on the frequency of mIPSPs in interneurons from mutant than wildtype mice (not shown) 
would also be compatible with a difference in GABAA receptor saturation between 
genotypes. Therefore, the possibility of a presynaptic deficit in transmitter release or 
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vesicular storage would be compatible with both morphological and functional data. 
However, such a deficit remains to be demonstrated and would imply that the absence of 
α1-GABAA receptors indirectly influences the maturation or function of presynaptic 
terminals. 
GABAergic input to CA1 interneurons is derived from intrinsic and extrinsic sources. 
Intrinsically, CR-positive interneurons and to a lesser extent CB and SOM interneurons 
innervate other interneurons (Seress et al., 1993; Freund & Gulyas, 1997; Gulyas et al., 
1999; Matyas et al., 2004). PV interneurons are also known to innervate each other (Meyer 
et al., 2002; Bartos et al., 2002), likely to maintain synchronized activity. Extrinsically, 
medial septal GABAergic cells projecting to the hippocampus selectively target 
interneurons (Freund & Antal, 1988; Freund & Gulyas, 1997). CR- and CB-positive cells 
receive fewer GABAergic synapses than PV interneurons (Gulyas et al., 1999), in line with 
the distribution of gephyrin clusters reported here (Fig. 3G, 4J, 5J). Assuming that a deficit 
in transmitter release or vesicular storage in the presynaptic GABAergic afferents of CA1 
interneurons underlies the decreased mIPSCs seen in α10/0 mice, the effect might occur 
either secondarily to a change in activity (Hartman et al., 2006) of either local CR-positive 
cells or septohippocampal neurons or it might reflect a deregulation of presynaptic control 
of transmitter release by a G-protein coupled receptor. 
The results obtained in kainic acid-treated mice provide two important cues about the 
function and regulation of hippocampal interneurons. First, they show that the differential 
vulnerability of interneurons subtypes to kainic acid (Bouilleret et al., 2000a, b) is not 
related to the expression of a specific GABAA receptor subtype, since replacing α1-
GABAA receptors by α3-GABAA receptors did not protect PV interneurons against kainic 
acid-induced acute degeneration. Secondly, they demonstrate that the functional 
compensations to the absence of the α1 subunit are operative and sufficient to produce 
stable neuronal networks that can resist kainic acid-induced excitation without becoming 
epileptic. In this mouse model, kainic acid injection induces a spreading wave of neuronal 
firing that is contained by synaptic inhibition, and leads secondarily to interictal activities 
(Le Duigou et al., 2005). The “normal” response of α10/0 mice to kainic acid-induced 
overexcitation strongly suggests that GABAergic inhibition is operative in the 
hippocampal formation of these mutants.  
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Altogether, the present results demonstrate a striking plasticity of GABAergic circuits in 
the hippocampal formation, and suggest that changes in inhibitory control of interneurons 
underlie the compensatory adaptations that occur to maintain the function of hippocampal 
networks in the absence of a major GABAA receptor subtype. Since GABAA receptors 
expressed in α10/0 neurons have different functional properties, the plasticity of 
GABAergic circuits goes beyond receptor replacement and likely includes formation of 
novel synaptic connections. These findings are of immediate relevance for the 
pathophysiology of temporal lobe epilepsy, in which GABAergic synapses remain active, 
but have novel properties due to extensive functional and morphological reorganization of 
GABAergic networks (Cossart et al., 2005). On a broader perspective, it is to be expected 
that compensatory changes that ensure stable function of neuronal networks in α10/0 mice 
are not limited to the GABAergic system, but comprise a broad array of homeostatic 
mechanisms designed to maintain network integrity after deletion of one key component 
(Marder & Goaillard, 2006). 
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  General Discussion 
In this thesis, the expression and functional role of different benzodiazepine-sensitive 
GABAA receptors in the CA1 area of the hippocampus has been investigated, as well as the 
changes that occur in GABAA receptor expression and function in interneurons to 
compensate for the complete loss of the α1-GABAA receptors. 
We assessed the functional involvement of α1-, α2-, α3- and α5-GABAA receptors in 
phasic and tonic forms of inhibition in pyramidal cells and interneurons, using as strategy 
knock-in mice carrying specific GABAA receptor subtypes made insensitive to diazepam 
(Wieland et al., 1992; Benson et al., 1998; Rudolph et al., 1999). A change in diazepam 
effect compared with wildtype mice was taken as evidence for the presence of the 
corresponding GABAA receptor subtype in the investigated cell types. Our work shows 
that is possible to identify GABAA receptor subtypes that mediate phasic and tonic 
inhibitory neurotransmission in a defined cell type, and that the function of the receptor is 
closely correlated with its subcellular distribution (Brunig et al., 2002). These results also 
contribute to a better understanding of the pharmacological actions of diazepam in the 
hippocampus, in particular through the modulation of tonic inhibition. 
The changes that occur in hippocampal interneurons to compensate for the complete loss of 
α1-GABAA receptors were investigated in knock-out mice with a targeted deletion of the 
α1 subunit (Vicini et al., 2001). We were able to show that the plasticity of GABAA 
receptors enabled them to preserve inhibitory transmission, and that this key component of 
the compensatory response is sufficient to protect against a pathological challenge such as 
kainic acid-induced seizures. 
Altogether our results contribute to a better understanding of the organization and function 
of the GABAAergic system, a necessary requirement for the understanding of the neuronal 
basis of behaviour.  
In the following, I will discuss the main findings of the different publications and their 
functional implications. 
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1. Functional role of GABAA receptors in pyramidal cells  
We investigated whether the differential subcellular distribution of GABAA receptors in 
pyramidal cells implies a differential participation in phasic and tonic inhibition. 
Traditionally, inhibitory transmission refers to fast phasic inhibition, which results from the 
activation of receptors immediately beneath the release site. However, spillover (diffusion 
of the neurotransmitter out of the synaptic cleft) can also activate perisynaptic or 
extrasynaptic receptors, resulting in IPSCs with slower kinetics. Moreover, tonic inhibition 
resulting from a steady state of open receptors with high affinity for ambient GABA, and 
preferentially located at extrasynaptic sites, carries a major fraction of the total inhibitory 
currents. This mode of GABAA receptor activation indicates that inhibition is a complex 
functional process that can also take place in a less spatially and temporally restricted 
manner. In addition, the relative contribution of phasic and tonic inhibition varies in 
different regions of the brain and in different cell types, which adds extra complexity to the 
system. We found that α1-GABAA receptors and α2-GABAA receptors, which are 
synaptically located in hippocampal pyramidal cells, participate exclusively in fast phasic 
inhibition and their different subcellular locations enables them to receive inputs from 
segregated circuits. Thus α2-GABAA receptors, which are located predominantly on the 
axon initial segment of pyramidal cells and on soma (Brunig et al., 2002), are mostly 
activated by external stimulation proximal to the cell soma, whereas α1-GABAA receptors, 
which predominate in dendritic layers (Brunig et al., 2002), are mostly activated by 
external stimulation distal to the soma. The activation of α1-GABAA receptors and α2-
GABAA receptors by specific interneurons shows that distinct GABAA receptor subtypes 
are involved in dendritic and somatic forms of inhibition, implying that they play a 
different role in synaptic integration and therefore modulate specific behavioural states. For 
example, it has been shown that somatic inhibition enforces precise coincidence detection 
of excitatory inputs to the soma, whereas dendritic inhibition sums incoming activity over 
broader time windows (Pouille and Scanziani, 2001). Also, recurrent inhibition can rapidly 
shift from soma to dendrites, recruiting two distinct inhibitory circuits according to the 
onset and rate of action potentials (Pouille and Scanziani, 2004). Additionally, in vivo 
studies have demonstrated that networks of different interneurons innervating distinct 
domains of pyramidal cells coordinate the activity of the cells (Klausberger et al., 2003) 
and are implicated in synchronizing cortical neurons at various frequencies through 
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different GABAA receptors (Somogyi and Klausberger, 2005). α3-GABAA receptors were 
immunohistochemically and functionally not detected in pyramidal cells.  
We also showed that under intact GABA uptake, α5-GABAA receptors that are largely 
extrasynaptically located in pyramidal cells (Brunig et al., 2002; Crestani et al., 2002) 
participate in slow events and in tonic inhibition. Although a pool of α5-GABAA receptors 
has been proven to have a synaptic localization (Serwanski et al., 2006) and to mediate fast 
phasic inhibition from cells innervating distal pyramidal cells (Thomson et al., 2000), we 
could not detect a contribution of these receptors to fast phasic inhibition, probably 
because they mediate a minor fraction of sIPSCs; moreover the preferentially perisynaptic 
and extrasynaptic location was confirmed because under enhanced GABA spillover, more 
α5-GABAA receptors were recruited, and enhanced slow, but not fast, currents in the CA1 
area.  
We showed that slow events and tonic inhibition share the same pool of extrasynaptic 
receptors, because a low dose of picrotoxin preferentially blocked both slow events and 
tonic currents, but not fast events. This reflects the higher affinity of extrasynaptic 
receptors for GABA, and their persistent activation. Differences in tonic conductance 
recorded in CA1 adult hippocampal pyramidal cells are evident across species; under intact 
GABA uptake, pyramidal cells from guinea-pig do not show any tonic conductance 
(Semyanov et al., 2004), whereas in rats (Scimemi et al., 2005), and even more 
pronouncedly in mice (Stell and Mody, 2002; Caraiscos et al., 2004), tonic inhibition is 
detected.  
The literature is not consistent on the effectiveness of different antagonists in selectively 
blocking phasic or tonic receptors in CA1 pyramidal cells. For example, gabazine 
(SR95531) is reported to selectively block phasic events at a concentration of 10 μM (Bai 
et al., 2001), but in our recordings, 10 μM gabazine completely blocked phasic and tonic 
conductances, which is in agreement with results from Stell and Mody (2002). Thus, to 
selectively block tonic or phasic inhibition, one needs to have into account not only the 
affinity of the receptors for the antagonist, but also the variability in ambient GABA 
according to the species, brain area and experimental conditions.  
Slow sIPSCs occur infrequently and are difficult to evoke, suggesting that cells underlying 
these events have a low spontaneous firing rate and a unique position. The spatial 
restrictions of the axonal projections and the level of spontaneous firing activity of 
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different classes of interneurons provide the identity of the cells underlying fast and slow 
events. Basket cells, axo-axonic, bistratified and horizontal trilaminar cells underlie fast 
sIPSCs, because they project exclusively to somatic and perisomatic regions in the stratum 
pyramidale and in the proximal stratum radiatum. Interneurons in stratum lacunosum-
moleculare are likely to underlie slow sIPSCs, because they project exclusively to dendritic 
regions. A possible candidate to generate slow IPSCs are the neurogliaform cells, which in 
the somatosensory cortex predominantly target the dendritic spines of pyramidal neurons 
and are capable of eliciting slow IPSPs through the combined recruitment of GABAA and 
GABAB receptors (Tamas et al., 2003).  
The variability in kinetics in the sIPSCs may result from binding or gating properties of the 
GABAA receptors, but may also originate from fluctuations in the postsynaptic receptor 
number and/or in the transmitter concentration. Dendritic IPSCs are slower to decay 
because the transmitter is present in the synaptic cleft for an extended period of time. This 
hypothesis is consistent with our observation that the GABA uptake inhibitor NO711 
prolonged the slow decay phase of slow sIPSCs. 
The preferential extrasynaptic location of α5-GABAA receptors, and therefore their role in 
tonic inhibition (Caraiscos et al., 2004; Prenosil et al., 2006; Marchionni et al., 2007), 
appears to be a critical element in the regulation of the acquisition and expression of 
associative memory. α5 subunit knock-in mice, α5(H105R), which have a partial deficit of 
α5-GABAA receptors in the hippocampus, improved their performance in trace-fear 
conditioning, a hippocampus-dependent memory task (Crestani et al., 2002). In addition, 
these mutants display a resistance to the extinction of conditional fear over several days 
(Yee et al., 2004). Moreover, in α5 knock-out mice, a significantly improved performance 
in a water-maze model of spatial learning has been observed (Collinson et al., 2002). 
Furthermore, compounds selective for α5-GABAA receptors (L-655,708) have been 
reported to enhance the performance of wildtype rats in terms of encoding and recall 
processes in the Morris water-maze test (Chambers et al., 2004; Atack et al., 2006). In a 
mouse hippocampal slice model, L-655,708 was able to enhance the long-term potentiation 
produced by a theta burst stimulation, consistent with a potential role for the α5-GABAA 
receptors in processes involving synaptic plasticity, such as learning and memory (Atack et 
al., 2006).  
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α5-GABAA receptors are also involved in: prepulse inhibition and locomotor activity 
(Hauser et al., 2005); tolerance to the sedative action of diazepam (van Rijnsoever et al., 
2004); sedation (partially) (Savic et al., 2007); generation of γ oscillations (Towers et al., 
2004) and epilepsy (Scimemi et al., 2005). 
In most brain areas, tonic inhibition is modulated by δ-GABAA receptors (Brickley et al., 
2001; Stell et al., 2003), which are diazepam-insensitive receptors potentiated by 
neurosteroids, with high affinity for GABA, slow desensitization and high sensitivity to 
ethanol (Wallner et al., 2003; Yeung et al., 2003; Mtchedlishvili and Kapur, 2006). 
However, in hippocampal pyramidal cells, α5-GABAA receptors, which are diazepam 
sensitive and have a lower affinity for GABA, were shown to be involved in tonic 
inhibition (Caraiscos et al., 2004; Prenosil et al., 2006). It should be noted, however, that 
only under increased GABA concentrations are α5-GABAA receptors involved in tonic 
inhibition in pyramidal cells (Caraiscos et al., 2004); at low ambient GABA 
concentrations, the activation of δ-subunit-containing GABAA receptors predominates 
(Scimemi et al., 2005). The relative contribution of diazepam-sensitive and diazepam-
insensitive receptors to tonic inhibition in the same cell type implies an adaptive plasticity 
of the tonic current in the presence of enhanced or low ambient GABA, probably to ensure 
tonic current flow into pyramidal cells and avoid hyperexcitability. This is evidenced in 
mice lacking the α5 subunit, where a homeostatic upregulation of δ subunits maintains 
nearly 50% of residual tonic currents in CA1 pyramidal cells, preventing them from 
expressing hyperexcitability (Glykys and Mody, 2006). Our main findings of the study are 
summarized in Figure 1. 
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Figure 1. Diagrammatic representation of the subcellular distribution of GABAA receptor subtypes in 
CA1 hippocampal pyramidal cell and their established functional roles. CCK, cholecystokinin; PV, 
parvalbumin. Graph modified from (Fritschy and Brunig, 2003; Farrant and Nusser, 2005; Mohler et al., 
2005; Rudolph and Mohler, 2006) 
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2. Tonic inhibition in interneurons 
2.1. GABAA receptors involved in tonic inhibition in CA1 interneurons 
We investigated the involvement of different GABAA receptor subtypes in tonic inhibition 
in interneurons. Morphological data shows that α1 and δ subunits are commonly expressed 
in interneurons; the α3 subunit is expressed in a subset of interneurons located in stratum 
oriens and hilus (Brunig et al., 2002); and the α2 and α5 subunits are virtually absent 
(Fritschy and Mohler, 1995; Pirker et al., 2000). We found that under intact GABA uptake 
most interneurons in stratum oriens and radiatum present tonic inhibition mediated by α1-
GABAA receptors, confirming morphological data (Gao and Fritschy, 1994). According to 
the literature, two main types of α1-GABAA receptor assemblies could be present in 
interneurons: α1/δ assemblies for extrasynaptic diazepam-insensitive GABAA receptors 
involved in tonic inhibition (Glykys et al., 2007), and α1/γ2 for diazepam-sensitive 
receptors involved in phasic inhibition (Somogyi et al., 1996). We also showed that tonic 
inhibition was diazepam sensitive, so the subunit composition of extrasynaptic α1-GABAA 
receptors in CA1 interneurons includes α1βxγ2 in addition to α1βxδ−receptors. Moreover, 
although α1βxγ2 GABAA receptors are highly enriched in synapses, more receptors are 
found outside than inside synaptic junctions (Nusser et al., 1995). Triple immunostaining 
for the α1, δ and γ2 subunits could clarify whether one or more α1-GABAA receptor 
assemblies are present in any given CA1 interneuron or whether they are segregated 
between different cell types. In double knock-in mice for the α2 and α3 subunits, most 
interneurons had an increase in holding current after diazepam application similar to 
wildtype mice, but in nearly 25% of the interneurons no effect of diazepam was observed. 
In double knock-in mice for the α1 and α2 subunits, the effect of diazepam on holding 
current was completely abolished in all except one of the interneurons. Thus α2-GABAA 
receptors may be involved in tonic inhibition in nearly 25% of the hippocampal 
interneurons. α2 subunits were reported to be mostly located in synaptic sites (Brunig et 
al., 2002) and to be absent in CA1 interneurons (Fritschy and Mohler, 1995), so the 
involvement of α2-GABAA receptors in tonic inhibition is a novel result. The α3 subunit 
could also be involved in tonic inhibition in the cells that were shown to express this 
subunit. 
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Altogether, our results showed: 1) α1-GABAA receptors, which are the most abundant in 
the brain, can also be involved in different functional roles according to their cellular and 
subcellular location. In pyramidal cells, α1-GABAA receptors are involved in phasic 
inhibition while in interneurons, they are mostly involved in tonic inhibition. 2) α2-
GABAA receptors are involved in phasic inhibition in pyramidal cells and are present in 
dendrites from several interneurons clustered and colocalized with gephyrin, thus they are 
assumed to be synaptically located. In some interneurons, α2-GABAA receptors also 
participate in tonic inhibition. 3) α3-GABAA receptors are absent in pyramidal cells and 
most interneurons. 4) α5-GABAA receptors are only present in pyramidal cells and are 
involved in slow inhibitory currents and in tonic inhibition. α5-GABAA receptors are 
mostly activated under conditions of raised extracellular GABA. The apparent involvement 
of α1- and α2-GABAA receptors containing the γ2 subunit in tonic inhibition opens new 
questions about the functional role of GABAA receptors. If several GABAA receptor 
isoforms are indeed responsible for tonic currents, this could be an attractive target for the 
development of improved drug therapies against pathologies such as epilepsy.  
 
2.2. Strata differences in tonic conductance in interneurons: Functional 
role of GABA transporters?  
In the second study we also showed that under intact GABA uptake, interneurons in 
stratum oriens and stratum radiatum differ in their extent of tonic conductance. 
Interneurons in stratum oriens showed nearly double the amount of tonic conductance 
compared to interneurons in stratum radiatum. In stratum lacunosum-moleculare, some 
cells completely lacked tonic conductance. As indicated previously, α1-GABAA receptors 
were mostly involved in tonic inhibition in interneurons, so the layer-specific difference in 
tonic currents was not due to differences in GABAA receptor composition (desensitization 
and mean open time). Rather, it resulted from differences in GABA release or uptake. It 
has been shown that changes in presynaptic activity and release modify the magnitude of 
the tonic conductance. For example, an increase in interneuron firing also increases tonic 
conductance in pyramidal cells (Kullmann and Semyanov, 2002), whereas the blockade of 
action-potential firing reduces tonic conductance (Petrini et al., 2004). Likewise in 
cerebellar granule cells, the facilitation of GABA release causes an increase in tonic 
conductance (Rossi et al., 2003). Inhibitory interneurons can fire repetitively at rates much 
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higher than excitatory neurons and with a higher probability of release. This means that 
interneurons with a high-frequency train of action potentials should have longer-lasting 
transmitter release and thereby more GABA could spill out of the synaptic cleft and 
contribute to tonic inhibition. To confirm this hypothesis, I tried to investigate the different 
firing patterns of interneurons present in each stratum. In stratum oriens, most registered 
interneurons did indeed have a spiking-pattern frequency between 40 and 60 Hz, whereas 
in stratum radiatum, most interneurons had a spiking-pattern frequency between 10 and 20 
Hz.  
The firing properties of a cell do not dictate its tonic inhibitory conductance; interneurons 
in stratum radiatum and lacunosum-moleculare showed a consistently reduced tonic 
conductance and larger cell capacitance independent of their spiking properties, but a 
group of high-frequency firing interneurons located in stratum lacunosum-moleculare 
lacked tonic conductance. This indicates that tonic conductance can be cell-type specific.  
Another source of variability between strata are the local GABAergic inputs. It is possible 
that stratum oriens interneurons receive more inputs than stratum radiatum and lacunosum-
moleculare interneurons, reflected by the higher amount of interneurons present in stratum 
oriens. 
A second possible explanation for the strata difference in tonic inhibition lies in the uptake 
by GABA transporters. There has been relatively little focus on the role of GABA 
transporters in regulating the level of tonic inhibition in the hippocampus. In rat CA1 area, 
a lower expression of GAT-1 mRNA (the main neuronal GABA plasma-membrane 
transporter) in interneurons of stratum oriens compared with those of stratum 
radiatum/lacunosum-moleculare was observed (Engel et al., 1998). It has also been shown 
that GABA transporters modulate the level of tonic inhibition by trying to maintain 
ambient GABA concentrations close to a set point, such as the resting potential of the cells 
(Richerson and Wu, 2003). This means that the equilibrium for the extracellular GABA 
concentration changes to modulate the level of tonic inhibition in response to neuronal 
activity and in response to the transmembrane gradients for GABA, chloride and sodium. It 
is likely that the function of GABA transporters varies among different types of 
interneurons as it varies among different types of synapses (Chiu et al., 2002). To better 
support the possibility of changes in GAT-1 expression according to strata and/or 
according to interneuron type, in situ hybridization with mRNA specific for GAT-1 in 
GAD67-GFP mice would be necessary. Another complementary approach would be to 
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measure the effect of NO-711 on IPSCs from stratum oriens and stratum radiatum 
interneurons.  
The dynamic properties of GABA transporters are an extra complexity in the inhibitory 
system and are a potential source of investigation, because these molecules contribute to a 
variety of pathological conditions and are the targets of several drugs. In epilepsy, for 
example, reversal of the GABA transporter is likely to occur during seizures and regulation 
of tonic inhibition may modulate seizure threshold. To know whether anticonvulsant drugs 
such as tiagabine also block the transporter reversal is of greatest significance in this field. 
Tonic inhibition is also highly sensitive to modulation by other clinically relevant 
compounds, like endogenous neuroactive steroids (Stell et al., 2003), intravenous and 
inhalation anaesthetics, and ethanol (Sundstrom-Poromaa et al., 2002; Glykys et al., 2007). 
So far most δ-GABAA receptors have been shown to be selectively modulated by 
neurosteroids and ethanol, but tonic activation can probably also involve other types of 
receptors depending on the level of ambient GABA.  
 
3. Plasticity of the GABAergic system  
The results from the functional studies are in line with previous results showing that 
GABAA receptor subtypes are tailor-made to fulfil specific functional requirements. In the 
third part of the thesis, I therefore investigated how the GABAergic system copes with the 
deletion of the α1 subunit gene. To this end I developed a new immunostaining protocol 
based on the weak fixation of acute brain slices (Publication 3). With this new protocol, an 
optimal simultaneous detection of neurochemical markers (PV, CR, CB, NPY and SOM), 
GABAA receptors and gephyrin was achieved in triple-labelling experiments. The 
preparation of living slices prior to weak tissue fixation, helped to preserve the cell 
morphology while minimising epitope masking of postsynaptic proteins, which occurs in 
perfusion-fixed tissue.  
In all identified interneurons in wildtype mice, α3, α4 and α5 subunits were absent but α2 
subunits were clustered and colocalized with gephyrin predominantly on the dendrites of 
several interneurons. Combined with the electrophysiological results, this finding extends 
our knowledge of the expression of GABAA receptors by demonstrating the existence of 
α2-GABAA receptors in interneurons.  
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Although the α1 subunit is the most abundant (around 50%), α10/0 mice exhibit a mild 
phenotype due in part to compensatory alterations in the GABAergic system (Kralic et al., 
2002; Kralic et al., 2006; Ogris et al., 2006). In α10/0 mice a general compensatory increase 
in α2, α3 and α4 subunits is observed in different brain areas with unchanged regional and 
subcellular distributions (Kralic et al., 2006). In α10/0 mice, a replacement of the α1 by the 
α3 subunit occurred in interneurons that normally express the α1 subunit: 100% PV-, 
53 ± 5 % CR-, 33 ± 8 % CB-; 57 ± 4 % NPY- and 64 ± 6 % SOM-positive cells. 
Hippocampal interneurons normally do not show α3 subunit expression. However it is 
unlikely that the upregulation of the α3 subunit resulted from a change in gene expression, 
most probably all interneurons in the hippocampus do express the α3 subunit at very low 
levels that are undetectable by immunostaining techniques. In order to know at which level 
the compensatory changes occurred in hippocampal interneurons, further studies from gene 
and mRNA expression should be performed. 
All up-regulated α3-GABAA receptors in interneurons were clustered and colocalized with 
gephyrin, suggesting that an increase in synaptic inputs had occurred, perhaps by a switch 
of tonic towards phasic signalling. Surprisingly, sIPSC recordings showed no change either 
in tonic signalling or in the number of phasic events compared to wildtype mice. α2- and 
α3-GABAA receptors have a lower affinity for GABA than α1-GABAA receptors (Ebert et 
al., 1994; Verdoorn, 1994), implying that their level of synaptic activation could be low, 
and therefore more synaptic inputs were required to compensate for the loss of α1-GABAA 
receptors. Moreover the slower kinetics of α3-GABAA receptors and their slow 
desensitization may be enough to preserve the tonic conductance. This receptor 
reorganization suggests a rearrangement of GABAergic circuits. Interestingly, when kainic 
acid was applied to induce epilepsy, no difference in severity or duration of status 
epilepticus was observed in α10/0 compared to wildtype mice, confirming that the GABAA 
mediated transmission was well preserved.  
This study also showed an increase in α2 synaptic receptors on interneurons that are 
normally α2 positive, and on pyramidal cells. Therefore an overall increase of synaptic 
inputs is seen in α10/0 mice in both pyramidal cells and interneurons. The increase in 
synaptic inputs is cell specific, since the density of gephyrin clusters in CB- and SOM-
positive interneurons remains unchanged. Apparently, in α10/0 mice, the α2 subunit is 
overexpressed on α2 positive cells and the α3 subunit is upregulated on normally α1-
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positive cells. In the α10/0 mice, mIPSCs showed a reduced amplitude and frequency of 
events compared to wildtype, suggesting either that many events fell into the noise level 
due to the changes in biophysical properties of the α2- and α3-GABAA receptors or that 
there was impaired GABAergic signalling compared to wildtype mice. The reduced 
frequency is not observed under normal action-potential release because the high GABA 
levels can saturate all synaptic receptors. The reduced amplitude and frequency could also 
be attributed to a change in quantal size so that in α10/0 mice, a reduction in GABA 
vesicular contents may occur. No direct proof of this hypothesis exists, but it cannot be 
excluded that presynaptic changes occur in response to a loss of postsynaptic GABAA 
receptors. Future investigations of GABA quantal size and content, and the influence of 
postsynaptic GABAA receptor expression, will consolidate our understanding of the 
homeostatic inhibitory machinery. 
Altogether, our results showed the remarkable plasticity of the GABAAergic system in the 
hippocampus to maintain a normal phenotype in the absence of a major GABAA receptor 
subtype. This plasticity includes not only expression of other GABAA receptors but also an 
increase in synaptic connections and therefore a total rearrangement of the neuronal 
networks. This network rearrangement seems to be sufficient to prevent overexcitation, as 
observed by the similar response to kainic acid injection in wildtype and α10/0 mice but is 
well probable that other adaptatory changes like in different channel densities may also 
occur in α10/0 hippocampal interneurons.  
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